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In animals, the study of antibiotic resistance in bacteria has been focused on
organisms that are pathogenic in human or animal hosts. The development of
antibiotic resistance in commensal bacteria is also of concern because they may act
as a reservoir of resistance genes. This thesis aimed to determine levels of resistance
to veterinary and medical antibiotics in the commensal Escherichia coli of calves, to
explore the genotypic diversity of isolates, and to study the molecular mechanism
and transfer dynamics of resistance to apramycin.
The antibiotic sensitivity testing of calf faecal E. coli, obtained by weekly sampling,
demonstrated that there was resistance to beta-lactams, cephalosporins, streptomycin,
trimethoprim, chloramphenicol, tetracycline and sulphamethoxazole. These
resistance phenotypes had not been selected for on antibiotic-containing media,
indicating a high prevalence of the corresponding resistance determinants.
Five hundred and forty three isolates were genotyped by pulsed-field gel
electrophoresis. Examination of the patterns generated by restriction with Xbal and
analysed with BioNumerics software revealed a total of 55 different genotypes.
Ampicillin resistant isolates were more diverse (24 genotypes) than apramycin or
nalidixic acid resistant isolates (5 and 2 genotypes respectively). Apramycin
resistance (aprR) was conferred by three conjugative plasmids, pUK2001, pUK2002
and pUK2003, of sizes 91, 115 and 181Kb respectively. All aprR plasmids conferred
cross-resistance to the medical antibiotics tobramycin and gentamicin. Plasmids
pUK2002 and pUK2003 also carried tetracycline and streptomycin resistance.
Plasmid pUK2001 demonstrated very high transfer frequencies (4.12x10" during 7
hrs mating), horizontal spread to three different genotypes, and an apparent fitness
advantage in vitro.
This thesis shows a very high prevalence of antibiotic resistance genes in the
commensal faecal flora of food-producing calves. This may have significant
implications for the transmission of resistance genes to human clinical bacteria.
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MIC minimum inhibitory concentration
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PCR polymerase chain reaction
PEN penicillin
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QRDR quinolone resistance determining region
vi
R recipient
RAPD random amplified polymorphic DNA
rep-PCR repetitive element polymerase chain reaction
RNA ribonucleic acid
rpm revolutions per minute
SDW sterile distilled water

















1.1 Antibiotic targets of action 1
1.2 Mechanisms of antibiotic resistance 2




1.3d Transposons and integrons 7
1.4 Ecology of E. coli in farm animals 8
1.5 Agricultural uses of antibiotics 10
1.6 Effects of antibiotic usage in food animals 11
1.6a Negative effects of antibiotic use in food animals 11
i) Selection of resistant bacteria 11
ii) Antibiotic residues contaminating foodstuffs 13
iii) Selection of antibiotic resistant zoonotic pathogens 14
iv) Selection of antibiotic resistant commensals 15
1.6b Advantages of antibiotic use in food animals 17
1.7 Conclusions 18
1.8 Aims of the thesis 20
Chapter 2. Materials and reagents
2.1 Study animals and treatment records 21
2.2 Bacterial isolates 22
2.3 Bacterial identification 23
2.4 Antimicrobial agents 24
viii
2.5 Media
2.6 Chemicals buffers and enzymes
25
25
Chapter 3. Antimicrobial susceptibility testing
3.1 Introduction 26
3.2 Materials and Methods 29
3.2a Bacterial isolates 29
3.2b Susceptibility testing 30
3.2c Statistical analyses 31
3.3 Results 33
3.3a Reproducibility values 33
3.3b Sensitivity of associations between antibiotics to variation
between replicates 34
3.3c Proportions of resistance 36
3.3d Between-population comparison of susceptibility proportions 40
3.4 Discussion 44
3.4a Assessment of levels and sources of variation within the
methodology 44
3.4b Proportions of resistance 48
3.4c Associations between phenotypes 50
3.5 Concluding remarks 51
Chapter 4. Genotyping
4.1 Introduction 53
4.2 Materials and Methods 58
4.2a Bacterial isolates 58
ix
4.2b Pulsed-field gel electrophoresis 60
4.2c Cluster analysis 61
4.2d Statistics 61
4.3 Results 62
4.3a Population diversity and richness 62
4.3b Genotype diversity 70
4.3c Within-sample diversity 72
4.3d Population diversity as a function of calf age 74
4.3e Genotype diversity as a function of sampling date 82
4.4 Discussion 85
4.4a Population diversity 86
4.4b Genotype diversity 89
4.4c Within sample diversity 90
4.4d Population diversity as a function of calf age 91
4.4e Population diversity as a function of sampling date 92
4.5 Concluding remarks 93
Chapter 5. Molecular mechanism of apramycin resistance
5.1 Introduction 95
5.2 Materials and Methods 95
5.2a Bacterial isolates 95
5.2b Antibiotic sensitivity 96
5.2c Pulsed-field gel electrophoresis 96
5.2d Conjugation experiments 96
5.2e Tlasmid analysis 97
5.2fAmplification of the aac(3)-IV gene 97
5.2g Statistical analysis 98
5.3 Results 98
5.3a Detection of aprR E. coli PFGE types 98
x
5.3b Plasmid analysis 100
5.3c Transfer frequencies 101
5.3d Amplification of the aac(3)IV gene 104
5.4 Discussion 105
Chapter 6. The study ofplasmid dynamics
6.1 Introduction 110
6.2 Materials and Methods 111
6.2a Bacterial strains and plasmids 111
6.2b Conjugations 112
6.2c Estimates of plasmid transfer frequencies and rates 113
6.2d Model theory 113
6.2e Growth curves 115
6.2f Statistics 115
6.3 Results 116
6.3a Effect ofmating time on estimates of plasmid transfer frequency 116
6.3b Transfer rates estimated by the end-point method 117
6.3c Variation in transfer frequency/rate with different methodology 122
6.3d Modelling plasmid transfer in batch culture 124
6.4 Discussion 132
6.4a In what manner do plasmid transfer frequency estimates vary as a
function ofmating time? 133
6.4b What are the advantages and disadvantages of each technique? 134
6.4c How do the transfer frequencies/rates measured by each of the
methods compare? 136
6.4d Does the published model of bacterial cell growth and plasmid
transfer fit the experimental data of pUK2002 transfer in batch
culture? 138
6.4e If the model does not fit, what biological processes are occurring
xi
which are not taken into account by the model?




Chapter 7. Competitive fitness costs of apramycin resistance plasmids
7.1 Introduction 144
7.2 Materials and methods 145
7.2a Bacterial strains and plasmids 145
5.2b Five hour growth rate comparisons 145
7.2c Five hour competition study 146
7.2d Five day competition experiments 146
7.2e Reproducibility of viable count method 147
7.2f Statistical analyses 148
7.3 Results 149
7.3a Variation introduced by the viable count method 149
7.3b Five hour growth rate comparisons 150
7.3c Five hour growth in direct competition 156
7.3d Five day growth in direct competition 157
7.4 Discussion 159
Chapter 8. The search for extended-spectrum beta-lactamases
8.1 Introduction 164
8.2 Materials and methods 166
8.2a Bacterial isolates 166
8.2b Salmonella outbreak 167
8.2c Antibiotic sensitivity 167
xii
8.2d Determination of the presence of an ESBL 168
8.2e Amplification of 6/«tem-i and 6/flshv-i 168
8.3 Results 169
8.3a Antibiotic susceptibility 169
8.3b Determination of the presence of an ESBL 171
8.3c Amplification of bla^uA and WasHV-i in S. Enteritidis 020003 171
8.4 Discussion 172
Chapter 9. Discussion 175
References 180
Appendices 210
Appendix 1. Results of a sensitivity analysis to determine how different
parameters influence the output of the plasmid transfer in batch
culture model. 210
Appendix 2. Results of different combinations of the three parameters
found to enhance the fit of the model to the experimental data. 216
xiii
List of Tables
1.1 Summary of antibiotic classes and their targets of action. 2
1.2 Examples ofmechanisms conferring resistance to specific antibiotics. 3
2.1 Antibiotic treatment records for calves sampled in this study and
calves housed with sampled calves. 21
2.2 Characteristics and sources of bacterial strains used in this work. 23
2.3 Antimicrobial agents, solvents and their suppliers. 24
3.1 Isolates investigated in this study, and the populations and numbers
of calves from which they were obtained. 30
3.2 Categorisation of kappa values according to Everitt (1989). 31
3.3 Repeat classification of isolates by antibiotic susceptibility at two
breakpoint concentrations. 34
3.4 Significance of variation generated by different grouping methods,
assessed by Pearson's %-squared test. 35
3.5 Association in levels of susceptibility between antibiotics of the
same family. 41
3.6 Association between resistance to an antibiotic, and resistant
population compared to the unselected population. 42
3.7 Association in level of susceptibility between antibiotics to which
resistance is commonly carried on plasmids. 43
4.1 Numbers of isolates from each population and calf, typed by PFGE. 59
4.2 Diversity measures of the nalR, aprR, ampR and unselected populations. 69
4.3 Genotypes found within the calf commensal E. coli for which no genotypic
diversity was found following PFGE typing with Xbal. 71
4.4 Genotypes found within the calf commensal E. coli for which diversity
within a type was found following PFGE typing with Xbal. 72
4.5 Genotypes and dates of detection of isolates obtained from calf 687. 75
4.6 Genotypes and dates of detection of isolates obtained from calf 693. 76
4.7 Genotypes and dates of detection of isolates obtained from calf 694. 77
4.8 Genotypes and dates of detection of isolates obtained from calf 690. 79
4.9 Presence or absence of genotypes detected in calves 687, 693,694 and 690. 81
xiv
5.1 Calves from which aprR E. coli were isolated, calf antibiotic treatments and
age, dates of aprR E. coli detection, and number and genotype of aprR isolates. 99
5.2 Plasmid transfer frequencies of pUK2001, pUK2002 and pUK2003,
measured on different antibiotic containing selective plates. 102
5.3 MICs ofwild type aprR E. coli donor isolates, and the transconjugants
formed after the conjugation of the aprR plasmids into J53. 103
6.1 Mean transfer frequencies (T/Do) and number of replicates used in
estimates. 117
6.2 Mean transfer rates and confidence intervals for the transfer of pUK2002
from J53 into J62-2 measured after different mating times by the end-point
method. 120
6.3 Mean plasmid transfer frequencies as measured by the end-point method
and mean plasmid transfer frequencies as measured by T/Do. 121
6.4 Mean transfer rates of pUK2002 into J62-2 and MG1655. 122
7.1. Descriptive statistics of data from method A and method B. 150
7.2 Relative fitness estimates and selection rate constants ofMG1655
harbouring plasmid pUK2001, pUK2002 or pUK2003, in direct
competition with MG1655kan. 158
8.1 Susceptibilities of 16 ampR isolates selected for further study to p-lactams
and cephalopsorins. 170
8.2 Comparison of blaTEM from S. Enteritidis 020003 and published Wotem-Ij
and WatEM-52 sequences. 172
xv
List ofFigures
3.1 Comparison of the proportions of resistance of ampR, aprR, nalR and
unselected populations to (3-lactams and quinolones. 37
3.2 Comparison of the prevalence of resistance of ampR, aprR, nalR and
unselected populations to the cephalosporins. 38
3.3 Comparison of the prevalence of resistance of ampR, aprR, nalR and
unselected populations to the aminoglycosides and other classes of antibiotic. 39
3.4 Variation in susceptibility classification due to breakpoint position. 45
4.1a PFGE genotypes in the apramycin resistant population. 63
4.1b PFGE types in the nalidixic acid resistant population. 63
4.1c PFGE types in the ampicillin resistant population. 64
4.Id PFGE types in the unselected population. 65
4.2 Numbers of lineages in the unselected, ampR, and aprR populations plotted
against increasing percentage similarity as calculated by the dice coefficient. 66
4.3 Rank abundance curve of the 543 commensal E. coli genotyped by PFGE
in this study. 67
4.4 Rank abundance curves of the unselected, ampR, aprR, and nalR populations. 68
4.5 Within-sample diversity presented as the number of genotypes detected
within a sample from the aprR, ampR, nalR, and unselected populations. 73
4.6 Genotype prevalence with calf age of unselected and selected (ampR, aprR
and nalR) isolates obtained from calf 687. 75
4.7 Genotype prevalence with calf age of unselected and selected (ampR, aprR
and nalR) isolates obtained from calf 693. 76
4.8 Genotype prevalence with calf age of unselected and selected (ampR? aprR
and nalR) isolates obtained from calf 694. 77
4.9 Genotype prevalence with calf age of unselected and selected (ampR? apr
and nalR) isolates obtained from calf 690. 79
4.10 Genotype prevalence within the unselected population. 83
4.11 Genotype prevalence within the ampR population. 84
4.12 Genotype prevalence within the nalR population. 85
xvi
5.1 Dates of detection and prevalence of the five different aprR E. coli
genotypes.
5.2 EcoRl plasmid types and the host genotypes from which they were isolated
5.3 Mean transfer frequencies of pUK2001 into 14 different recipients from
the unselected E. coli commensal population.
6.1 The effect ofmating time on estimates of plasmid transfer frequency as
determined by T/Do-
6.2 Eight replicate growth curves of J53 harbouring plasmid pUK2002 in
10ml LB.
6.3 Geometric mean growth curve of J53 harbouring pUK2002 10ml of LB.
6.4 Four replicate experiments showing the effect ofmating time on estimates
of plasmid transfer rate ofpUK2002 from J53 into J62-2, as measured by
the end-point method.
6.5 A comparison of four replicate experiments to study plasmid transfer.
6.6 Population dynamics during pUK2002 transfer from J53 to J62-2, using the
average plasmid transfer frequency over each of the time points.
6.7 The effect of a lag in conjugation on the dynamics of pUK2002 transfer
between E. coli J53 and J62-2.
6.8 The effect of 0.5,1 and 1.5hrs lag in growth on the D and R populations.
6.9 The effect of plasmid transfer rate on the R and T populations.
6.10 Best fit of the model to the experimental data, using measured plasmid
transfer rate.
7.1 Spread of counts obtained when repeat dilutions of the same bacterial
culture was diluted and plated out 30 times, and when 30 repeat aliquots of
the same culture were plated out.
7.2 Replicate growth curves of a, MG1655pUK2002; b, J53pUK2002;
c, MG1655kan; and d, J53 in lOmL LB.
7.3 Geometric mean growth curves ofMG1655pUK2002, MG1655kan,
J53pUK2002 and J53 in lOmL LB.
7.4 Replicate growth curves of a, MG1655pUK2002; b, J53pUK2002;
c, MG1655kan; and d, J53 in lOmL MM.
xvii
7.5 Geometric mean growth curves ofMG1655pUK2002, MG1655kan,
J53pUK2002 and J53 in lOmL MM.
8.1 MICs of 52 isolates to amoxicillin, cefotaxime, ceftazidime, and these
antibiotics in combination with clavulanic acid.
xviii
Chapter 1. Introduction
Since the introduction of antibiotics to human medicine in the 1940s, and later to
animal husbandry and veterinary medicine, microbial resistance to these drugs has
been on the increase. The massive and often inappropriate use of antimicrobials in
human and veterinary medicine, in agriculture and aquaculture, combined with the
dramatic reduction in the number of new antimicrobial agents coming onto the
market has led to a growing resistance problem. This complex and global
phenomenon is threatening the successful management of human infectious disease.
This introductory chapter will take the form of six sections. Firstly, the antibiotic
targets of action, the mechanisms by which bacteria may become resistant to different
antibiotics, and the processes implementing the dissemination of antibiotic resistance
genes will be described. Following this, information available on the ecology of E.
coli in animals will be reviewed. Finally, the use of antibiotics in food-production
animals will be described, before the literature documenting the impact of this usage
is reviewed.
1.1 Antibiotic targets of action.
Antibiotics should act on targets present in bacterial cells with minimal host cell
damage. The target may not be present in animal or human cells (e.g. a cell wall), or
the antibiotic can only enter bacterial cells (e.g. tetracyclines), or the antibiotic binds
selectively to the target in bacterial cells but not in mammalian cells (e.g.
aminoglycosides). The first antibiotics in general use were the penicillins, which
specifically target the synthesis of the bacterial cell wall. The resemblance of the
penicillins (and other (3-lactam antibiotics) to the substrate of the transpeptidase
enzyme, causes the inhibition of this enzyme. This prevents the cross-linking of the
peptidoglycan subunits, which are key components of the bacterial cell wall. Other
targets of action of antibiotics include the inhibition ofprotein synthesis, of
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tetrahydrofolate synthesis, and of the synthesis of nucleic acids. Representative
antibiotics exhibiting these mechanisms of action are listed in Table 1.1.
Table 1.1 Summary of antibiotic classes and their targets of action.
Target Antibiotic class Antibiotics




























Adapted from Amyes et al., 1996.
1.2 Mechanisms of antibiotic resistance.
Bacteria may evade the action of an antibiotic by intrinsic or acquired mechanisms.
The former is species specific and so determines the spectrum of activity of the drug,
whereas the latter is only present in a subpopulation of a species. Specific
mechanisms by which bacteria may become resistant to an antibiotic are listed in
Table 1.2.
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Table 1.2 Examples ofmechanisms conferring resistance to specific antibiotics.
Resistance
mechanism







Transferable Levy & McMurry, 1974.
Transferable or chromosomal Abraham & Chain, 1940.
Transferable or chromosomal Benveniste & Davies, 1971






Cox ef at., 1964
Amyes & Smith, 1974
Young & Amyes, 1985
The resistance mechanisms listed in Table 1.2 are specific to a particular antibiotic,
however bacteria may also be intrinsically resistant to a broad spectrum of
antibiotics. The reduced number of porins on the outer membrane ofAcinetobacter
baumanii confers reduced susceptibility to a range of antibiotics, by limiting the
extent of antibiotic penetration into the cell (Quale et al., 2003). Multiple antibiotic
resistant (Mar) E. coli mutants have decreased susceptibility to many different classes
of antibiotics (including tetracycline, ampicillin, nalidixic acid, rifampicin and
chloramphenicol) (Cohen et al., 1993). Phage mediated deletion of genes encoding
an efflux pump (acrAB) restored the original susceptibility of an E. coli Mar mutant,
indicating that the AcrAB efflux pump plays a major role in the Mar phenotype
(Okusu et al., 1996).
1.3 Mechanisms enabling the dissemination of resistance genes
Although intrinsic resistance to particular antibiotics may limit choices of antibiotics
available for treatment, of greater concern is the acquisition of resistance by sensitive
bacteria. This may occur by the processes of transduction, transformation and
conjugation. These three processes will be described, before the importance of
transposable elements (namely transposons and integrons) that make up mobile
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resistance elements are discussed in the context of the dissemination of resistance.
1,3a Transduction.
Transduction is mediated by bacteriophages. As these generally have limited host
ranges, Davies & Webb (1998) considered transduction less important in the
dissemination of resistance genes than conjugation. However, Olsen et ah, (1974)
have described two phage types capable of infecting any Gram-negative bacterium
carrying the resistance plasmid RP1, so could theoretically transfer DNA between
unrelated species. During transduction the DNA is carried within the phage particle
and so is protected from degradation. This has led to suggestions that in natural
habitats transduction as a mechanism of gene transfer may be as important as
transformation or conjugation (Zeph et al., 1988).
Jiang & Paul (1998) used a mathematical model to predict the potential for gene
transduction in the marine environment. The model was based on one phage-host
transduction system studied in vitro, and assumed that all marine phages are always
infective and that no other factor (such as temperature, pH, non-specific attachment
of phage to other particles) influenced transduction rates. The value of a numerical
extrapolation of in vitro transduction frequencies is unclear because of these
assumptions, in addition to the knowledge that transduction rates differ with different
phage-host systems (Ichige et al., 1989).
1.3b Transformation
Transformation is the intragenic recombination of chromosomal genes encoding
sensitive drug targets, with related genes from other bacteria to form mosaic genes
that encode resistant drug targets (Carlson et al., 1983). The selection pressure
provided by antibiotic usage has promoted the spread ofmosaic genes encoding
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penicillin resistant penicillin binding proteins (PBPs) among Streptococcus spp.
(Dowson et al., 1990) and sulphonamide resistant dihydropterate synthase (dhps)
among Neisseria spp. (Fermer et al., 1995). Tetracycline resistance, encoded by tetB,
has also been reported to be disseminated by transformation, between Haemophilus
spp. and Moraxella catarhalis (Roberts et al., 1991).
Although most bacteria can be shown to be competent under certain conditions
(Dubnau 1991; Smith et al., 1981), natural transformation has been reported to occur
in a limited number of genera (Carlson et al., 1983; Catlin, 1960; Frischer et al.,
1990; Goldberg et al., 1966; Juni & Janik, 1969; Lacks et al., 1975; Mathis &
Scocca, 1982; Rudin et al., 1974; Wang & Taylor, 1990). Transformation has been
considered less important than conjugation as a mechanism for dissemination of
resistance genes (Roy 1999). This is because transformation requires the presence of
DNA from genetically distinct bacteria in the immediate environment of the
bacterium, a DNA uptake system, and a mechanism for the permanent incorporation
of recruited DNA into the host chromosome. This is usually mediated by recA
(Fischer & Haas, 2004; Pearce et al., 1995). Although transformation appears to be
rare, antibiotic usage provides an intense selective pressure on the complex microbial
populations of the gastrointestinal tract. In this environment gene exchange may
involve many steps between unrelated bacteria. The efficiency at which transfer
occurs is not important if one considers that only a very small number of resistant
bacteria are needed to survive and replicate to create clinical problems.
1.3c Conjugation
The transfer ofDNA by conjugation requires direct contact between donor and
recipient. The genetic elements that are self-transferable by conjugation are plasmids
and transposons. Conjugative plasmids can transfer efficiently between different
genera of the same Gram-stain group. Although conjugative plasmids can transfer
between Gram-positive and Gram-negative bacteria they are often unable to replicate
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in the new host because their host range for replication is less broad than that for
transfer (Verma et al., 1989). Certain plasmids are however, capable of replication in
a bacterium of different Gram-stain but are non-conjugative (Gormley & Davies,
1991; Goze & Ehrlich, 1980).
Transfer of a non-conjugative plasmid may occur by the presence of a co-resident
self-transmissible plasmid providing, in trans, a conjugative system to mobilise the
co-resident non-conjugative plasmid. Replicative transposons may also enable the
transfer of non-conjugative plasmids (Deneer et al., 1982; Shoemaker et al., 1986;
Valentine et al., 1988). These two mechanisms of transferring non-mobilisable
plasmids may permit plasmid transfer between Gram-negative and Gram-positive
bacteria (Doucet-Populaire et al., 1992), and so enhance the fluidity of genetic
transfer in mixed bacterial populations, such as the intestinal flora of animals and
humans.
Similarities between plasmids as evidence supportive for in vivo transfer have been
described on the basis of common resistance patterns (Smith 1975), incompatibility
groups (Grant & Pittard, 1974; Levy, 1976) and plasmid molecular weight (Kruse &
Sorum, 1994; Nijsten et al., 1995). More convincing evidence for plasmid similarity
would be provided by restriction enzyme digests of the plasmid using more than one
enzyme, yielding identical banding patterns with each enzyme, because plasmids of
apparently identical sizes may prove to be different after restriction analysis.
Plasmids encoding aminoglycoside 3-N-acetyltransferase (conferring apramycin and
gentamicin resistance) have been found in isolates from cattle and humans (Chaslus-
Dancla et al., 1991). A high degree of genetic homology was detected by preparing
plasmid DNA and restricting with three different restriction enzymes, thus providing
good evidence for plasmid exchange between bacteria of human and animal origin.
Using the same method, identical apramycin resistance plasmids have been found in
E. coli and S. typhimurium isolated from calves, where prior to apramycin treatment
of the animals, the plasmid had only been found in E. coli. (Hunter et al., 1992).
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Conjugative transposons are discrete DNA sequences capable of self-excision and
integration into DNA, which are normally integrated into a bacterial genome (Franke
& Clewell, 1981). Many multiple-antibiotic resistant Streptococcus and
Staphylococcus spp. from clinical isolates have large conjugative transposons (Le
Bouguenec et al., 1990). Plasmids have not been identified in these strains suggesting
that conjugal transposons were responsible for the spread ofmultiple resistance
observed (Scott, 1992).
Conjugative transposons were first identified in Gram-positive cocci (Franke &
Clewell, 1981; Shoemaker et al., 1980), but since then, have also been found in a
number ofGram-negative bacteria including Neisseria gonorrhoeae (Swartley et al.,
1993), Haemophilus ducreyi (Roberts, 1990), and Bacteriodes spp. (Nikolich et al.,
1994a). Conjugative transposons are thought to make a considerable contribution to
the spread of resistance genes amongst Bacteroides and other bacteria transiently
colonising the human intestine (Salyers & Shoemaker, 1996). However this opinion
is based on the detection of tetQ, (which is most commonly located on conjugative
transposons in Bacteroides spp. (Nikolich et al., 1994b)) as an indicator of the
presence of a conjugative transposon in this species (Salyers & Shoemaker, 1996). At
present, conjugative transposons have not been found in E. coli.
1.3d Transposons and integrons
The incorporation ofDNA, in the form of transposons and integrons, into mobile
elements results in the evolution of resistance determinant plasmids (R plasmids)
(Collis et al., 1993), which may then be spread via conjugation (Antunes et al., 2004;
Heir et al., 2004; Pezzella et al., 2004).
The importance of transposons and integrons is due not only to their ability to
enhance the dissemination of resistance genes, but also their ability to integrate into
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the bacterial chromosome permitting the persistence of the resistance genes carried.
Transposons have been implicated in the spread of tetracycline resistance in
Neisseria spp. (Swartley et al., 1993) and Bacteroides spp. (Nikolich et al., 1994b),
the spread of P-lactamase enzymes in Proteus mirabilis, E. coli (Naas et al., 2003)
and amongst Salmonella spp. (Orman et al., 2002), and the spread of trimethoprim
resistance (linked to streptomycin resistance in 8/12 plasmids examined) in clinical
E. coli (Towner et al., 1982). Integrons are commonly found on plasmids (Briggs &
Fratamico, 1999), but recently a new gene conferring resistance to chloramphenicol
and florfenicol has been described that is surrounded by two class I integrons, on the
S. typhimurium chromosome (Arcangioli et al., 1999). This has been speculated to
allow persistence of resistance genes in the absence of antibiotic selection (Threlfall
et al., 1994). In a study of sulphonamide resistance in Enterobacteriaceae, stable
integration of sull and sulll into transposons and plasmids was deduced as the
mechanism responsible for the extremely efficient dissemination of these genes in the
Gram-negative bacteria studied (Radstrom et al., 1991).
1.4 Ecology ofE. coli in farm animals
E. coli typically colonise the lower intestine of new-born mammals within hours.
Smith & Crabb (1961) studied the faecal flora of healthy calves, and found large
numbers of E. coli (approximately 105 cfu/g), Clostridium welchii and streptococci
after 1 day. Colonising E. coli are thought to be acquired from the environment, other
animals, directly from faeces, or from contaminated food or water (Maison &
Richardson, 1981). After ingestion, E. coli may be present in the lumen of the
intestine, or may persist in the intestine for longer periods of time by adhering to the
intestinal mucosa (Freter et al., 1983) with type 1 somatic pili (Freter, 1981). Certain
strains of E. coli are found to persist for several weeks or months (Sears & Brownlee
1952; Hinton, 1986) before being replaced by other strains. Caugant et al. (1981),
suggest that genetic diversity among E. coli strains transiently colonising the
gastrointestinal tract is attributable to successive invasion by E. coli from
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environmental sources, although in this study only 22 faecal samples were obtained
over a period of eleven months.
Factors influencing E. coli ecology are unclear, partly because of a limited number of
studies on the subject, inadequate typing or sampling protocols, and because only a
tiny proportion ofE. coli present in an animal can be studied in any detail. Diet has
been found to influence E. coli numbers (Diez-Gonzalez et al., 1998; Hovde et al.,
1999; Kruse et al., 2003), in addition to stress, disease, composition of other
intestinal flora (Hartl & Dykhuizen, 1984; Shedlofsky & Freter, 1974), animal
management practices (Hinton et al., 1984) and host genome (Toivanen et al., 2001).
Antibiotic treatment also affects the ecology ofE. coli in farm animals (Delsol et al.,
2003; Dunlop et al., 1998). Resistance to antimicrobial agents is caused by the use of
these agents in any dose and over any time period exerting a selective pressure on the
microbial population. Those micro-organisms harbouring a mutation(s) in the drug
target site, or those that have acquired novel biochemical activities conferring
resistance, will survive to produce progeny bearing the same resistance determinants.
The selective pressures responsible for the emergence of resistant bacteria in cattle
include antibiotic usage for therapy, prophylaxis and growth promotion. There has
been considerable debate over the past 40 years on whether antibiotics administered
to animals can lead to the selection of resistant bacteria that, on entering the food
chain, may result in human infection by these less sensitive strains. In 1969, human
health concerns over the widespread use of antimicrobial agents as growth promoters
precipitated the appointment of the Swann Committee. Its report (Swann committee
1969), stated that "the administration ofantibiotics to farm livestock, particularly at
sub-therapeutic levels, poses certain hazards to human and animal health". More
precisely, that this practice had resulted in the emergence of resistant enteric bacteria
whose resistance determinants were transmissible to other bacteria, and that these
more resistant strains were transferable from animals to man.
A description of the use of antibiotics in agriculture now follows, after which the
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potential impact this has on the agricultural industry and on public health is
reviewed.
1.5 Agricultural uses of antibiotics
In the UK in 2002, 484 tonnes of active antimicrobial agents were sold for use in
food animals (Veterinary Medicines Directorate, 2002). In farm animals, antibiotics
are used therapeutically to treat disease (e.g. calf pneumonia and neonatal E. coli
infections), prophylactically to prevent disease, and thirdly as growth promoting
agents. Ten percent of the antibiotics used in agriculture are given therapeutically, the
remainder are used as growth promoters and prophylactic agents (Chadwick &
Goode, 1997).
Although the exact mechanisms of action of growth promoters is unknown, the
administration of these agents to animals results in an increase in weight gain
(between 3 and 5% depending on the species (Select Committee on Science and
Technology, 1998). Growth promoters are thought to interact with microbial flora of
the gastrointestinal tract, improving digestion, absorption and metabolism, and may
suppress infectious disease and metabolic and fermentation disorders (Feighner &
Dashkevicz, 1987). Animals fed growth promoters require less food and produce less
waste (Gaskins et al., 2002). Growth promoters have allowed savings to be made on
space, labour and cost of rearing farm animals, because of the concurrent reduction in
the occurrence of disease associated with stress and overcrowding. This has lead to
increased intensification of farming practices albeit alongside continuing criticism
that growth promoters are being used to substitute good husbandry and hygiene
(Select Committee on Science and Technology, 1998).
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1.6 Effects of antibiotic usage in food animals
The negative effects of antibiotic usage in animal agriculture include a reduction in
the effective life of antibiotics used in animal therapy, foodstuff contamination with
antibiotic residues, and the selection of resistant bacteria, both zoonotic and
commensal. However, antibiotic use in food animals is required for the treatment of
bacterial diseases, resulting in healthier animals and subsequent economic benefits.
Reports of the negative effects of antibiotic usage in food production animals will be
reviewed first, followed by the advantages of such antibiotic use.
1.6a Negative effects of antibiotic use in food animals
i) Selection ofresistant bacteria
The use of antibiotics in farm animals will select for resistant bacteria (Levy, 1987),
in the same way that antibiotic use in humans has selected for resistant bacteria.
Antibiotics used prophylactically are usually administered to groups of animals and
may occur over prolonged periods of time. Salyers (1999b) described this method of
administration as being more likely to lead to the emergence of resistant strains than
prophylactic use in human medicine, because of the numbers of animals involved.
There appears to be no concrete evidence that this is the case.
The amount of antibiotic used and the time frame of administration are important
parameters affecting the frequency at which resistant bacteria arise. Lipsitch & Levin
(1997) have used mathematical models to predict the emergence of resistance during
antibiotic treatment. Here they show how the probability of a resistant mutant
appearing depends on the initial size of the susceptible population, cell division,
mutation and net killing rates. If the killing rate of the susceptible bacteria is low
compared to the rate of cell division, the likelihood of a resistant mutant appearing is
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increased. The model predicts a shorter time span before the appearance of the first
mutant if the killing rate is slower, consistent with observations made by others that
sub-inhibitory concentrations of antibiotic may be effective in selecting for resistant
mutants (Haas et al., 1990; Tenney et al., 1983).
The concentrations of antibiotic used for growth promotion are described as
subtherapeutic (Donabedian, et al., 2003a; Johnston, 1998). This term gives the
impression that the concentrations used are too low to affect bacterial growth and
hence select for resistant populations. Although these concentrations are ineffective
for therapy, they may still exert a slight selective pressure on a bacterium, allowing it
to grow and acquire new DNA or accumulate mutations increasing its resistance to
the drug (Aarestrup et al., 2000; Boerlin et al., 2001; Emborg et al., 2003).
The emergence of resistant bacteria through the use of antibiotics in food production
animals may lead to treatment failures and economic problems for the individual
farmer and on a wider scale, the agricultural industry. This is exemplified by an
outbreak ofmulti-resistant Salmonella typhimurium that occurred in 1998 on a calf
farm in Arizona. The deaths ofmany calves due to the outbreak resulted in the farm
going out of business (Salyers, 1999b).
It has been suggested that if antibiotic selection is continuous, as is the case with the
use of growth promoters, bacteria may accumulate compensatory mutations allowing
maintenance of their resistance mechanisms without a concurrent reduction in fitness
in the absence of the antibiotic (Salyers, 1999b). There are now a few studies
reporting an in vitro amelioration of the cost of antibiotic resistance (Dahlberg &
Chao, 2003; Lenski et al., 1994; Schrag et al., 1997). Bouma & Lenski (1988)
demonstrated that carriage of a plasmid encoding chloramphenicol and tetracycline
resistance by E. coli B, reduced bacterial fitness in the absence of chloramphenicol.
After 500 generations of culture in the presence of chloramphenicol, the plasmid
enhanced the fitness of its host even in the absence of antibiotic. Sequencing and
characterisation of the nature of the genetic change would be required to validate
12
such a conclusion. Additionally, no controls were used to ensure that the genes
encoding resistance were being expressed in each generation, as gene repression in
the absence of antibiotic may be effective in reducing the cost of resistance.
If fitness costs associated with an antibiotic resistant phenotype are compensated for
by adaptive mutations, why are many bacteria still sensitive to drugs introduced some
40 years ago e.g. P-lactams, trimethoprim (Livermore et al., 2000) and tetracyclines
(Osterblad, 2000)? According to DANMAP (1998), glycopeptide resistant isolates
(measured as resistance to avoparcin) from broilers have decreased from 82% in
1995 to 9% in 1998, coinciding with a Danish ban in 1995 on the use of avoparcin as
a growth promoter. Similarly, avilamycin has not been used since 1998 and a decline
in resistant enterococci from broilers from 79% in 1996 to 29% in 1998 has been
demonstrated (DANMAP, 1998). These results are suggestive of a fitness
disadvantage associated with the acquisition of a specific antibiotic resistance
mechanism.
ii) Antibiotic residues contaminatingfoodstuffs
Antibiotics used in food animal production may remain in the animal's tissues, and
following ingestion of the meat the residues may select for resistant bacteria in the
intestine of the consumer (Anadon et al., 1999; McCracken et al., 1976). A major
flaw in many of these experiments is that the meat products are usually consumed
after cooking, yet raw tissue is often studied (Anadon et al., 1999). Antibiotic
residues in foodstuffs are likely to constitute a comparatively minor threat to public
health in comparison to the massive use of antibiotics directly administered to
humans both in hospitals and in the community (Corpet, 1987; Levy, 1998). Laws
governing the number of days an animal should be antibiotic free prior to slaughter
are also in place to protect consumers from the risk of antibiotic residues in
foodstuffs.
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in) Selection ofantibiotic resistant zoonotic pathogens
The potential hazard posed by the selection of zoonotic pathogens (e.g. Salmonella
spp. Campylobacter spp. and E. coli 0157:H7) follows the contamination of
foodstuffs and subsequent human infection where antibiotic therapy is compromised
by resistance determinants carried by the pathogen. It has proved difficult to find
clear-cut results demonstrating that this kind of scenario is occurring. In addition, as
gastroenteritis caused by these pathogens is generally not treated with antibiotics
(indeed their use is contraindicated in the case of salmonellosis and E. coli 0157:H7
infection), this potential hazard has been deemed unimportant (Linton, 1984).
Evidence supporting the transmission of antibiotic resistant E. coli from poultry to
the human gut, following ingestion of cooked chicken is provided by Linton (1977b).
After handling E. coli of poultry origin only 1 of 5 volunteers were found to be
excreting resistant E. coli. The strain from the poultry and that recovered from the
faeces of the volunteer were declared identical based on their antibiotic resistance
pattern, plasmid profiles and serotyping. A greater number of volunteers and
genotyping by PFGE would provide more definitive evidence.
Studies by Endtz et ah, (1991) on quinolone resistance in Campylobacter have
shown an increase in the prevalence of resistant strains coinciding with the extensive
use of enrofloxacin in poultry. The conclusions drawn that the resistance observed is
mainly due to the use of this drug in the poultry industry, is substantiated by evidence
that person to person transmission of Campylobacter is rare (Skirrow, 1977).
The spread of chloramphenicol resistant Salmonella newport from dairy farms to
hamburgers resulting in human illness has been reported by Spika et al. (1987). A
risk factor identified by Spika et al. (1987), for illness caused by chloramphenicol-
resistant Salmonella was the use ofpenicillin or tetracycline in the month prior to
onset. The use of these drugs may provide those bacteria harbouring a multiple
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antibiotic resistance plasmid to outgrow other salmonellae ingested at the same time,
resulting in an infection by the resistant strains. However there is some evidence that
strains of salmonellae carrying multi-resistance plasmids may be more virulent than
sensitive ones due to an increased persistence of plasmid bearing host organisms in
the intestine (Timoney & Linton, 1982).
Other examples of the transmission of resistant bacteria from animals to humans
include indistinguishable glycopeptide-resistant enterococci isolated from turkeys
and their farmer in The Netherlands (van den Bogaard et al., 1997), and highly
similar ceftriaxone-resistant Salmonella enterica serovar Typhimurium in a child and
cattle in Nebraska (Fey et al., 2000). Similar to the study by Spika et al. (1987), in
this latter report, the child had received extensive treatment with p-lactam antibiotics
(a 10-day course of amoxycillin-clavulanate, prophylaxis with ampicillin-sulbactam
before appendectomy, then post operative treatment with amoxycillin-clavulanate)
prior to the onset of Salmonellosis. These treatments are likely to have selected for
the ceftriaxone-resistant strain. One problem with these studies is that the
environmental reservoir of such isolates is not examined, and so the possibility of
acquisition of the resistant strain from the environment cannot be excluded.
The literature on the transmission of resistant bacteria from animals to humans is
limited. This may be because resistance is not looked for in these illnesses as
antibiotics are rarely used, but also because zoonoses are preventable by taking the
appropriate care with food preparation.
iv) Selection ofantibiotic resistant commensals
The use of antibiotics in agriculture increases resistance levels in animal commensal
bacteria (Van den Bogaard & Stobberingh, 2000). The contamination ofmeat in
abattoirs by these commensals is inevitable (Howe et al., 1976b; Linton et al., 1977b)
but the extent to which resistant strains are transferred into the human intestine is
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unknown.
To date, there appears to be only one report describing how the ingestion of resistant
bacteria resulted directly in failed therapy, and this case does not imply
contamination from the farm or processing. Ingestion of food contaminated with
methicillin resistant Staphylococcus aureus (MRSA) resulted in an outbreak of
MRSA (Kluytmans et al., 1995). However, the index patient was severely
immunocompromised and had taken oral ciprofloxacin and antacids (respectively,
these two drugs may have selected for the MRSA strain and neutralised gastric acid
used as a defence against infection). This kind of scenario is likely to be extremely
unusual, but demonstrates food as a vector for resistant organisms.
There are a few reports stating that the antibiotic-resistant organisms causing illness
in humans are different strains to those prevalent in animals. Nijsten et al. (1996)
reported that the resistance of the faecal E. coli of pig farmers and their pigs are
distinctly different. Similarly, urinary tract infections in women working in poultry
processing plants were found to be caused by E. coli with different antibiotic resistant
patterns to those isolated from the poultry (Parsonnet & Kass, 1987). In contrast to
this, studies on vancomycin-resistant enterococci (VRE) have shown that the same
ribotypes isolated from poultry were forming part of the normal bowel flora in
humans (Bates et al., 1994). The selection of these strains by antibiotic usage in
hospitals was suggested as an explanation for the emergence ofVRE in hospitals.
Whether or not one particular resistant bacterial strain is directly responsible for
human illness is unimportant if one considers that if a bacterium carrying resistance
determinants colonises the human gut (even just transiently), there is potential for the
spread of these determinants to other intestinal flora. Teuber & Perreten (2000) have
reported that the exchange of resistance genes between bacteria from uncooked meat
or unpasteurized cheese, and human bowel flora (Enterococcus spp.) during passage
through the intestine is highly probable. Again, the degree ofmovement of resistance
genes, between bacteria colonising the human bowel, is unknown (Salyers, 1999b).
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Evidence that horizontal gene transfer does occur in the intestine is provided by
Nickolich et al., (1994b), where tetQ in Prevotella ruminicola from animals had
greater than 95% DNA similarity to tetQ from human colonic Bacteroides spp. Based
on DNA sequences flanking the gene the authors suggest transfer occurred from
humans to animals.
Similarly, almost identical copies (> 99% DNA sequence identity) of the ermG gene,
encoding erythromycin resistance, have been found in Bacillus sphaericus and
Bacteroides spp. These are found in soil and in the human colon respectively (Cooper
et al., 1996). Ingested soil bacteria may have transferred the gene, which is found on
r r
a conjugative transposon (Tc Em 7853) to Bacteroides species in the human gut. It is
unclear as to in which bacteria the gene is most likely to have arisen. Bacteria that
colonise soil may encounter bacteriocins and antibiotics produced by other soil
bacteria, but bacteria that normally colonise the human intestine may be dosed with
various antibiotics, usually not intended to have an effect on commensal bowel flora
such as Bacteroides.
This example illustrates an important flaw in retrospective studies, in that the
direction of transfer is difficult to prove with absolute certainty. There are many
examples of laboratory experiments demonstrating gene transfer between diverse
bacteria (Doucet-Populaire et al., 1992; Chaslus-Dancla et al., 1986; Gordon, 1992;
Hunter et al., 1992). These are reviewed by Mazodier & Davies (1991) and are often
used to obtain evidence of intergenic transfer of resistance determinants in nature.
Intergenic transfer observed in such laboratory experiments is not conclusive
evidence that this occurs in nature.
1.6b Advantages of antibiotic use in food animals
Antimicrobial chemotherapy is vital for the treatment and prevention of bacterial
diseases in animals (e.g. calf pneumonia, mastitis and neonatal E. coli infections),
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which may cause pain and distress or be potentially fatal. For bacterial diseases
where vaccines are unavailable, the treatment of animals with antibiotics is necessary
for both humane reasons and for economic reasons (preventing further spread of the
etiological agent).
Antibiotic usage in food animals may reduce the loads of salmonellae and
Campylobacter shed by food animals, thereby helping to diminish the risk to humans
from these zoonoses (Phillips et al., 2004).
Growth promoters increase rates of bodyweight gain, but may also reduce incidences
of acute pneumonia and metabolic and fermentative disorders in cattle, and improve
heat tolerance and immune status (Gaskins et al., 2002).
The European ban on the use of several growth promoting agents has resulted in
decreases in avoparcin resistant animal enterococci (DANMAP, 2002), virginiamycin
resistant enterococci in chickens (DANMAP, 2002), and human vancomycin
resistant enterococci (van den Bogaard et al., 2000). However, some therapeutic uses
of antibiotics have increased as a direct result of this ban (Casewell et al., 2003). In
Denmark increases in tetracycline, penicillins, sulphonamides, macrolides and
aminoglycosides have followed the ban on growth promoters (DANMAP, 2002).
Similarly, increases in therapeutic use of antibiotics followed the 1986 growth
promoter ban in Sweden (Wierup, 2001).
1.7 Conclusions
This review describes the targets of antibiotics and the mechanisms by which bacteria
may acquire resistance against antibiotics. Once resistance has evolved in a
bacterium, the genes for this resistance mechanism may be spread to other bacteria of
the same or of different species, by the processes of transduction, transformation and
conjugation.
18
Antibiotics are used in animal husbandry for the treatment of disease, prophylaxis,
and growth promotion. This usage results in the selection of antibiotic resistant
zoonotic and commensal bacteria.
E. coli is one of the normal microbial constituents of the gastrointestinal tract of
mammals, and colonises the mammalian intestine within hours of birth. Although
some factors influencing intestinal E. coli ecology have been characterised, there is
little data available on the ecology of commensal E. coli of healthy food animals. The
need for surveillance of antimicrobial resistance in both pathogenic and commensal
bacteria has been stressed by many governmental and non-governmental bodies, and
by independent scientists (Caprioli et al., 2000; Jones, 2000; Masterton, 2000;
O'Brien, 1997; Salyers, 1999a; World Health Organisation, 1997). Against a
backdrop of debate on the risks to human health posed by antibiotic usage in animal
husbandry (Phillips et al., 2004), a better understanding of the ecology of commensal
E. coli in healthy food animals, the levels of antibiotic resistance present, and the
mechanisms of antibiotic resistance harboured by this population is required.
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1.8 Aims of the thesis
Although there have been previous studies on antibiotic resistance, these were
performed without the benefit ofmodern molecular techniques. The overall aim of
this project is to examine the epidemiology of resistant bacteria in a cohort of
animals in close geographic proximity. The more specific aims of the thesis are listed
below:
• Determine the antibiotic sensitivities of calf faecal commensal E. coli to a
range of veterinary and medical antibiotics.
• Determine the genotypic diversity of calf faecal commensal E. coli.
• Determine the mechanism of resistance to apramycin in the commensal E.
coli population.
• Explore the use of a mathematical model in characterising the dynamics of
resistance plasmid transfer.
• Determine whether apramycin resistance plasmids confer a competitive
fitness disadvantage on a host bacterium.
• Determine whether calf faecal commensal E. coli harbour extended-spectrum
P-lactamase enzymes.
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Chapter 2. Materials and Reagents
2.1 Study animals and treatment records
Eleven beef-suckler calves on a non-organic Scottish farm, born between 14th
September and the 1st of October 2001 were studied. The sampled calves were part of
a cohort of 49 calves, which were kept separate from all other animals on the farm.
The only treatments received by these 49 calves are shown Table 2.1. Four of the
eleven calves sampled in this study received antibiotic treatment(s). These calves are
highlighted in blue.
Table 2.1 Antibiotic treatment records for calves sampled in this study (blue calf
Ids), and calves housed with sampled calves (black calf IDs).
Calf ID Treatment date Disease
Antibacterial agent
Generic name Trade name
688 09/10/01 pneumonia enrofloxacin Baytril Max
693 21/11/01 pneumonia tylosin Tylan
23/11/01 pneumonia florfenicol Nuflor
05/12/01 pneumonia florfenicol Nuflor
697 01/10/01 navel ill enrofloxacin Baytril Max
09/10/01 navel ill tylosin Tylan
12/11/01 navel ill tylosin Tylan 200
698 01/10/01 navel ill enrofloxacin Baytril Max
699 09/10/01 navel ill tylosin Tylan
711 30/10/01 navel ill enrofloxacin Baytril Max
06/11/01 scouring amoxicillin + clavulanic acid Synulox bolus
09/11/01 navel ill tylosin Tylan200
717 20/12/01 pneumonia oxytetracycline Terramycin LA
719 09/11/01 navel ill tylosin Tylan200
720 09/11/01 navel ill tylosin Tylan200
722 05/12/01 pneumonia florfenicol Nuflor
723 05/12/01 scouring amoxicillin + clavulanic acid Synulox bolus
20/12/01 pneumonia oxytetracycline Terramycin LA
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2.2 Bacterial isolates
Rectal faecal samples were taken within 48h of birth. Calves were subsequently
sampled approximately weekly until the 14th January 2002 excepting two weeks at
Christmas and New Year. Samples were stored at 4°C and processed within 48h of
collection. Samples were diluted 1:10 in maximum recovery diluent (Oxoid,
Basingstoke, UK). Ten microlitres of each suspension was spread onto Chromocult
TBX (tryptone bile X-glucuronide) agar (Merck, Darmstadt, Germany),
incorporating 16mg/L ampicillin, or 8mg/L apramycin, or 8mg/L nalidixic acid
(Sigma) or without antibiotics. Following overnight incubation at 44°C,
glucuronidase positive E. coli were picked from each plate showing growth. The
number ofpicks taken per plate differed depending on the number of colonies
present, but in all cases, every discrete colony present on the plate was picked.
Colonies were purified by subculturing twice on MacConkey agar (Oxoid,
Basingstoke, UK), and then stored at -70°C on cryogenic beads (Mast Diagnostics,
Germany). Other bacterial strains used in this study are listed in table 2.2.
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Table 2.2 Characteristics and sources of bacterial strains used in this work.
Bacterial Strain Characteristics Source
E. coli NCTC10418 Standard strain R. Paton (Edinburgh University)
P. aeruginosa NCTC10662 Standard strain R. Paton (Edinburgh University)
S. aureus NCTC6571 Standard strain R. Paton (Edinburgh University)
E. coli NCTC11560 TEM-1 positive strain R. Paton (Edinburgh University)
E. coli 39R861 Plasmid sizing standard Scottish Salmonella Reference
Laboratory, Glasgow
E. coli V517 Plasmid sizing standard Scottish Salmonella Reference
Laboratory, Glasgow
S. enterica serovar Enteritidis Outbreak strain Scottish Salmonella Reference
Laboratory, Glasgow
E. coli MG1655 Standard strain A. Roe, ZAP laboratory
(Edinburgh University)
E. coli MG1655kan Kanamycin resistance in
place of lacZY genes
A. Roe, ZAP laboratory
(Edinburgh University)
E. coli J53 Pro~ Met' S.G.B.Amyes, MC laboratory
(Edinburgh University)





Glucuronidase positive E. coli were identified by the growth of blue colonies on
TBX agar following overnight incubation at 44°C.
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2.4 Antimicrobial agents
Antimicrobial agents, solvents, and supplier information is listed in table 2.3.
Antibiotic stock solutions were prepared on the day of use and diluted with sterile
distilled water if necessary.
Table 2.3 Antimicrobial agents, solvents and their suppliers.
Antimicrobial agent Solvent Supplier
Amoxyclavulanic acid Sterile distilled water (SDW) Smithkline Beecham
Ampicillin SDW Sigma-Aldrich
Apramycin SDW Sigma-Aldrich






Ceftazidime SDW Glaxo laboratories
Ceftizoxime SDW Fujisaun Pharmaceuticals
Cefuroxime SDW Sigma-Aldrich
Cephalothin SDW Eli Lilly Phamaceuticals
Chloramphenicol Ethanol and SDW Sigma-Aldrich
Ciprofloxacin SDW Bayer pic
Enrofloxacin SDW Fluka
Gentamicin SDW Sigma-Aldrich
Nalidixic acid SDW Sigma-Aldrich
Penicillin SDW Sigma-Aldrich
Rifampicin Ethanol and SDW Marion Merrell Ltd.
Streptomycin SDW Sigma-Aldrich
Sulphamethoxazole O.lMNaOH and SDW Sigma-Aldrich
Tetracycline SDW Sigma-Aldrich
Tobramycin SDW Sigma-Aldrich
Trimethoprim SDW and lactic acid Sigma-Aldrich
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2.5 Media
MacConkey agar, Nutrient agar (NA) and broth (NB), Iso-sensitest agar (1ST) and
broth were obtained from Oxoid (Basingstoke, UK). Lennox L Broth (LB) was
purchased from GibcoBRL Life Technologies Ltd. (Paisley, UK) and Chromocult
TBX (tryptone bile X-glucuronide) agar from Merck (Darmstadt, Germany). All
media were made up with distilled water according to the manufacturer's instructions
and autoclaved at 121°C and 15psi for 15minutes prior to use.
2.6 Chemicals buffers and enzymes
Chemicals were supplied by Sigma-Aldrich (Poole, UK) unless otherwise stated and
solutions made up with distilled water. Saline was made with 0.85% (w/v) NaCl. All
solutions and buffers were sterilised by autoclaving at 121°C and 15psi for 15
minutes prior to use. Restriction enzymes and PCR reagents were purchased from
Promega.
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Chapter 3. Antimicrobial Susceptibility Testing
3.1 Introduction
The overall aims of this chapter are three fold: firstly, to identify isolates
demonstrating interesting resistance phenotypes for further study (for example, to
identify resistance to cephalosporins, which are not used on the animals from which
these isolates came, or to detect the emergence of a resistance phenotype). Secondly,
to determine the prevalence of resistance amongst E. coli populations selected on
ampicillin, apramycin or nalidixic acid containing agar, to a wide range of
antimicrobial agents, and to compare these profiles to isolates taken from an
unselected population. Thirdly, resistance profiles were compared using statistical
tests to determine whether resistance to an antibiotic conferred resistance to other
antibiotics of the same family or to other unrelated antibiotics, and to determine
whether plasmid-mediated resistance genes were commonly associated with each
other.
In research laboratories, in vitro antimicrobial susceptibility testing is commonly
performed by the determination of the minimum inhibitory concentration (MIC) of
an antibiotic to the test organism. This is considered the gold standard of sensitivity
tests (Andrews, 2001), and for research purposes is usually carried out with the test
antibiotic incorporated into agar plates. A complete range of antibiotic plates
containing doubling dilutions of an antibiotic are prepared by adding agar to freshly
prepared antibiotic stock solutions. Bacterial cultures, grown overnight in an orbital
shaker, are diluted in sterile saline and amultipoint inoculator is used to replicate test
cultures onto the plates. Inoculated plates are incubated at 37°C for 16-20 hours and
the MIC (the lowest concentration of antibiotic required to inhibit all visible growth)
of the antibiotic is read (Andrews, 2001).
Although this method gives the maximum information about the sensitivity of an
isolate to an antibiotic, it is time consuming and expensive (Wheat, 2001), so a
compromise method is often employed whereby one or two concentrations of an
26
antibiotic are used. Commonly the antibiotic is incorporated into filter paper discs or
agar (Hutchison, 1954). This method is usually referred to as the 'breakpoint'
technique (Wheat, 2001). Understandably, clinical and routine laboratories testing
hundreds of isolates often employ disc sensitivity tests, or agar dilution tests using
one breakpoint (Edwards, 2003; Wheat, 2001) to enable an isolate to be classified as
sensitive or resistant to a drug. Some researchers also use breakpoint techniques
where MIC values would be more informative, even when looking at very low
numbers (< 40) of isolates (Son et al., 1997).
In this study 410 isolates were to be tested for sensitivity to 25 different antibiotics.
To produce MICs for all isolates against all antibiotics would comprise 10,250 tests.
Therefore, a breakpoint method of testing was employed whereby a low and high
breakpoint concentration of antibiotic was incorporated into agar plates. The use of
two breakpoints facilitated the categorisation of isolates into susceptible (S),
intermediately resistant (I) and resistant (R) groups. This method had an advantage
over using antibiotic discs as it enabled many isolates (n = 33) to be tested on one
plate and enabled concentrations of antibiotics relevant to this study to be used.
There is no global standard methodology for MIC tests (Bronzwaer et al., 2002), and
many European countries (Germany, The Netherlands, Sweden, Spain, Britain,
France and Norway) have issued national guidelines. Methodology may vary in the
testing method used (MIC determination by agar dilution or Etest, or disc diffusion),
the source of reagents and media, and the interpretive criteria used (Tenover et al.,
2001). In Europe, the National Committee for Clinical Laboratory Standards
(NCCLS) guidelines are the most frequently followed (Bronzwaer et al., 2002),
however The British Society for Antimicrobial Chemotherapy (BSAC) methodology
is followed in many British laboratories because it uses MIC ranges and breakpoints
most applicable to British clinical isolates. This study had different aims to those of
clinical laboratories. One of the aims of this susceptibility profiling was to detect the
emergence of reduced susceptibility in E. coli isolated from calf rectal faecal
samples, not the presence of clinically relevant levels of resistance with any view to
treatment. In this way BSAC methodology was followed but breakpoints specific to
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this study were used, as those recommended by the BSAC were not suitable. This
has the disadvantage that the results generated cannot be directly compared with
other studies using these guidelines. However, it is unlikely that the results would be
comparable even with BSAC or NCCLS recommended breakpoints, because the
method of selecting out isolates for study would bias any prevalence comparisons
with other studies.
Phenotypic susceptibility testing has a number of shortcomings (Andrews, 2001;
Bergeron & Ouellette, 1998) and inaccuracies of susceptibility testing in
Enterobacteriaceae have been detected for disc diffusion (Block et al., 1998), agar
dilution, and automated (e.g. MicroScan and Vitek) testing methodologies (Steward
et al., 1999). Variation between repeat tests may arise from the use of different media
(Andrews et al., 2002; Koeth et al., 2002) or variation in inoculum density (BSAC,
2004). This may be because of differences between spectophotometers or human
error in visual judgement of density (BSAC, 2004). With disc diffusion assays the
antibiotic content of filter paper discs has been found to vary depending on the
manufacturer (Darville & Lovering, 2003). The detection of variation within repeat
tests of established and routinely used methodologies emphasises the need for
validation of the breakpoint method used in this study and the quantification and
analysis of any variation detected. Therefore, this chapter will firstly assess the levels
and sources of variation within the susceptibility testing technique used. This was
achieved by completion of the following:
a) Quantification ofvariation between replicate tests.
b) Reproducibility values for this method.
c) Assessment of the sensitivity of the comparison of susceptibility profiles
between populations to variation between replicates.
After an assessment of the variation present when using this methodology, the
original aims of the susceptibility profiling will be addressed. These are summarised
as follows:
a) To determine the susceptibility profiles of bovine commensal E. coli, selected
from ampicillin, apramycin or nalidixic acid resistant populations.
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b) To determine if any associations exist between resistance phenotypes.
Resistance genes are commonly found in gene cassettes (Antunes et al., 2004;
Heir et al., 2004; Pezzella et al., 2004). These are formed by the action of
integrons, which are capable of poaching genes from the environment and
incorporating them into bacterial genetic elements (e.g. a plasmid or
transposon) (Collis et al., 1993). It was therefore hypothesised that resistance
to an antibiotic may be linked to resistance to another unrelated antibiotic as
well as to antibiotics of the same family. Association between resistance to
antibiotics of the same family, between unrelated antibiotics (i.e. different
mechanisms are used to confer resistance), and finally amongst antibiotics to
which resistance is commonly plasmid-mediated were examined.
c) To compare the susceptibility profiles of these populations with an unselected
population to establish whether certain resistance profiles are specific to a
population, and whether isolates from resistant populations more commonly
harbour other resistance genes than do isolates from the unselected
population.
d) To identify isolates of interest for further study of the molecular mechanisms
conferring the resistance phenotype.
3.2 Materials and Methods
3.2a Bacterial isolates
Four hundred and ten bovine commensal E. coli were investigated. The numbers of
isolates from the unselected population and from each of the antibiotic resistant
populations, selected as described in Chapter 2, are shown in Table 3.1.
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Table 3.1 Isolates investigated in this study, and the populations and numbers of
calves from which they were obtained.
Population Number of isolates Number of calves
Unselected (P) 188 9
Ampicillin resistant (AmpR) 183 9
Apramycin resistant (AprR) 12 6
Nalidixic acid resistant (NalR) 27 4
To ensure that each plate contained the correct amount of active antibiotic, three
different BSAC recommended standard control strains (E. coli NCTC10418,
Pseudomonas aeruginosa NCTC10662, and Staphylococcus aureus NCTC6571)
exhibiting different levels of sensitivity to the antibiotics were included on every
antibiotic plate. The use of three controls maximised the likelihood of spanning the
sensitive, intermediate and resistant categories of the antibiotics under test.
3.2b Susceptibility testing
To categorise isolates as being sensitive (S), resistant (R), or of intermediate level
resistance (I) to an antibiotic, a high and low breakpoint were used. The breakpoints
were chosen to detect the emergence of resistance and identify isolates of interest for
further study. They are listed in Table 3.3.
Molten IsoSensitest (1ST) agar, cooled to 55°C was added to freshly prepared
antibiotic stock solutions. Bacterial cultures, grown overnight in an orbital shaker (at
37°C and 200 rpm) were diluted five hundred-fold in sterile saline and a multipoint
inoculator (Denley, UK) used to replicate test cultures onto the plates giving an
inoculum of approximately 106 colony forming units (cfu) per spot. Inoculated
plates were dried and incubated at 37°C for 16-20h. Colonies growing on both the
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low and high breakpoint plates were classified as R, those growing only on the low
breakpoint plate, I, and those growing on neither were classified S. All isolates were
inoculated onto agar plates containing no antibiotic to ensure that any inhibition of
growth on test plates was due to the presence of the antibiotic.
3.2c Statistical analyses
In order to explore repeatability and determine sources of variation within the
breakpoint methodology employed, susceptibility profiling of each isolate was
determined twice. The reproducibility of the results obtained from the replicates was
assessed in two ways. Firstly, the level of agreement between replicates was
described using the kappa statistic. This semi-quantitative approach measures
pairwise agreement between the two repeat classifications, and is corrected for
chance agreement. Table 3.2 categorises the ranges of kappa according to Everitt
(1989). Commonly researchers use 0.6 as a cut off level (Landis & Koch, 1977) with
values of 0.6 or greater indicating acceptable levels of variability.
Table 3.2 Categorisation of kappa values according to Everitt (1989).
Kappa value Category





Kappa values test the null hypothesis that there is no more agreement than might
occur by chance, but because kappa is a semi-quantitative statistic that does not
quantify the significance of any differences between repeat experiments, Wilcoxson
signed ranks tests were calculated in addition to kappa values.
31
Susceptibility profiles were used to study any associations between antibiotics, for
example whether resistance to one antibiotic conferred resistance to other antibiotics
with the same mechanism of action (same antibiotic family). In order to do this, it
was important to establish whether associations between antibiotics would be
sensitive to variation in replicate results. This was examined using Pearson's Chi-
squared proportions tests, because the associations between antibiotics were to be
analysed by comparing proportions of S, I, or R isolates. Two different methods were
used to select what data would be used in any subsequent proportions based tests.
Firstly, only those results for which replicates were identical would be included in
the analysis (method 1). The second approach (method 2) included all results,
however where the replicates differed between S and I or I and R, these isolates were
allocated into the S or R group respectively. The relative proportions of S, I or R
isolates to a particular antibiotic were compared between the two methods. If the
relative proportions did not alter between the two methods, method 2 could be used
to analyse any associations, thereby allowing the maximum number of isolates to be
included in the test giving it more power.
The hypothesis that resistance to an antibiotic was associated with resistance to other
antibiotics within the same family, was studied by comparing the proportions of S, I,
and R isolates to both the antibiotics being studied, using the G-test of association
(Sokal & Rohlf, 1995). The same test was used to determine whether associations
existed between plasmid-borne antibiotic resistance mechanisms.
To examine the hypothesis that isolates from resistant populations (i.e. AmpR, AprR
or NalR isolates) were more likely to harbour other resistance genes, proportions of
isolates resistant to a particular antibiotic were compared between the resistant
population and the unselected (P) population with Pearson's Chi-squared tests. In all




The completion of repeat susceptibility profiles for each isolate demonstrated that
whilst both repeat results were partially validated by three NCTC control strains
there were often discrepancies between the replicates. The reproducibility of the
breakpoints used, as assessed semi-quantitatively by the kappa statistic are listed in
Table 3.3. According to Everitt's criteria (Everitt, 1989) 18 of 25 antibiotics
(highlighted in green) demonstrated substantial agreement between repeat
experiments.
The Wilcoxson signed ranks tests are also listed in Table 3.3. A P-value greater than
0.05 indicates that the replicate means did not differ significantly. Replicate means
that did differ significantly have P-values less than 0.05, and these are printed in
bold.
Table 3.3 shows that although no replicates were S in one and R in another, a
significant level of variation is present amongst replicates for 16 of the 25 antibiotics
used.
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Table 3.3 Repeat classification of isolates, by antibiotic susceptibility at two
breakpoint concentrations. Antibiotics are ordered according to decreasing
percentage similarity between repeat classifications. P values refer to Wilcoxson
signed ranks tests. The numbers of isolates that shifted resistance category between
repeat experiments are listed in the final two columns.
Antibiotic Breakpoints
(mg/L)




Ciprofloxacin 1 / 4 409 0 0 0 1 0 0 0 0 >0 999 1 100 0 0
Sulphamethoxazole 32 /128 194 0 0 0 0 0 0 0 216 >0.999 1 100 0 0
Enrofloxacin 1 / 4 408 0 0 1 1 0 0 0 0 0.3185 06656 99 8 0 1
Tobramycin 2/8 393 0 0 3 0 0 0 0 14 0.0835 0.9 99.3 0 3
Trimethoprim 4 /16 344 1 0 0 0 3 0 2 60 0.4148 0 9459 98 5 4 2
Nalidixic acid 1 / 8 0 3 0 2 345 1 0 1 58 0.7062 0 9335 98.3 4 3
Chloramphenicol 8/32 355 4 0 1 0 3 0 0 47 0.034 0.9135 98 7 1
Ceftizoxime 2 /16 370 6 0 5 27 0 0 0 2 0.7636 0.8268 97.3 6 5
Gentamicin 2/8 392 0 0 4 2 0 0 8 4 0.0005 0.6144 97.1 0 12
Aztreonam 2/8 323 0 0 2 34 1 0 13 37 0.0005 0 8897 96.1 1 15
Ampicillin 4/32 131 11 0 4 3 0 0 1 260 0 1338 0.919 96 1 11 5
Cefotaxime 2/16 386 6 0 16 2 3 0 0 0 0.0331 0.1304 94.6 9 16
Ceftazidime 4 / 16 330 16 0 6 50 5 0 1 2 0.0082 0.7595 93.2 21 7
Penicillin 0.12/32 0 0 0 2 137 13 0 28 230 0.0095 0.781 89.5 13 30
Azlocillin 16/64 54 33 0 9 100 2 0 0 212 0.0001 0.824 89.3 35 9
Cefuroxime 8/32 312 16 0 5 35 28 0 1 13 <0.0001 06584 87 8 44 6
Rifampicin 0.5/1 1 0 0 0 7 57 0 3 342 <0.0001 0.1746 85.4 57 3
Cephalothin 4/16 35 24 0 24 224 4 0 15 84 0.1397 0 6987 83.7 28 39
Cefoxitin 8/32 259 53 0 15 40 0 0 0 43 <0.0001 0.6315 83.4 53 15
Streptomycin 4/32 135 2 0 25 60 18 0 56 114 <0.0001 0 6289 75 4 20 81
Tetracycline 1 / 64 18 7 0 78 104 12 0 13 178 <0.0001 0.5719 73.2 19 91
Azithromycin 0.5/4 1 1 0 0 280 101 0 17 10 <0.0001 0.0538 71 102 17
Cephradine 8/32 132 93 0 36 65 0 0 1 83 <0.0001 0 5031 68.3 93 37
Amoxyclavulanic acid 2/8 0 6 0 3 84 13 0 124 180 <0.0001 0 3199 64 4 19 127
Apramycin 4/32 227 9 0 146 16 0 0 0 12 <0.0001 0 1625 62.2 9 146
S, susceptible; I, intermediate level resistance; R, Resistant; S-S, I-I, and R-R, the same classification
on both replicates; S-l, S-R, I-S, I-R, R-S, and R-l, different classification between replicate
experiments. Yellow shading indicates identical classifications between replicates, and green shading
indicates substantial agreement between replicates. Significant P values are highlighted in bold.
3.3.b Sensitivity ofassociations between antibiotics to variation between replicates.
Table 3.3 demonstrates that for some of the antibiotics variation occurred between
replicate experiments. On account of this variation, two methods were used to select
which data would be used in subsequent statistical tests. Method 1 used only those
results for which replicates were identical and method 2 included all results but
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grouped any isolates with replicates differing between S and I, or I and R as S or R
respectively. The impact of using one method over the other, as assessed by
Pearson's x-squared tests, are shown in Table 3.4
Table 3.4 Significance of variation generated by different grouping methods,
assessed by Pearson's x-squared test.
Antibiotic X-squared P -value
Ciprofloxacin 0 1
























In the lower part of Table 3.4 are listed eight antibiotics with significant P-values.
For these antibiotics the selection of data by either method 1 or 2 makes a significant
difference to the proportions of S, I and R isolates, and so any further statistical tests
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based on relative proportions could only be performed on those data for which repeat
experiments yielded the same susceptibility phenotype. Comparing these results with
Table 3.3, one can see that all these antibiotics show significant differences between
replicate experiments, with the exception of cephalothin. In this case the columns
indicating numbers of isolates that shifted resistance category between repeat
experiments (columns headed "Increased resistance" and "Decreased resistance")
showed similar numbers (28 and 39). A significant difference between replicate
classifications is not recorded by the Wilcoxson signed ranks test, because it
measures significant differences in a directional manner. In this way, the two shifts
cancel each other out, preventing the detection of a significance difference between
the replicates.
The proportions of resistant, intermediately resistant and sensitive isolates did not
differ significantly between the two different grouping methods (P > 0.05) for 17 of
the 25 antibiotics tested. For these drugs subsequent statistical analysis based on
proportions were performed on data grouped by method 2, permitting the use of the
maximum number of results and thereby giving more power to each test.
3.3.C Proportions of resistance
The four populations ofE. coli (ampR, aprR, nalR, and unselected E. coli populations)
were analysed to determine the sensitivities of isolates to 25 antibiotics. Figures 3 .1
to 3.3 show the proportions of resistance to these antibiotics within the different
populations. In these figures P is the unselected population, A, the ampR, R, the aprR,
and X, the nalR population. Resistance is shaded red, intermediate level resistance,
orange, and sensitive, yellow. Sensitivity is shown as a percentage of the total
number of isolates. It is important to note that the number of isolates in the
population may affect these proportions. The unselected and ampK populations are
much more comparable than the nalR and aprR populations as they comprise similar
large numbers of isolates (188 and 183 respectively). The nalR and aprR populations
only represent 27 and 12 isolates respectively.
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Figure 3.1 Comparison of the proportions of resistance of amp , aprR, nalR and
unselected populations to (3-lactams and quinolones.
Beta-lactams Quinolones
P. unselected; A, ampR, R. aprR; X, nalR; red. resistant; orange, intermediate resistance; blue, sensitive.
Figure 3.1 demonstrates that most isolates (408 / 410) were intermediately or fully
resistant to penicillin. The ampR population had the highest proportion ot resistance
to amoxyclavulanic acid, azlocillin and aztreonam. The unselected and aprR
populations had similar proportions of resistance to ampicillin (0.26 and 0.25) and
azlocillin (0.24 and 0.25). All nalR isolates (n = 27) were resistant to penicillin,
ampicillin and azlocillin, but demonstrated diversity in their susceptibility to
amoxyclavulanic acid and aztreonam.
A high prevalence of nalidixic acid resistance (intermediate or high level) was
detected in all populations, but only two isolates were intermediately resistant to the
fluoroquinolones (ciprofloxacin and enrofloxacin), and these isolates were picked
from unselective plates.
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Figure 3.2 Comparison of the prevalence of resistance of ampR, aprR, nalR and
unselected populations to the cephalosporins.
P. unselectcd; A. ampR„ R. aprR; X, nalR; red. resistant; orange, intermediate resistance; blue, sensitive.
The graphs in Figure 3.2 are ordered according to the generation of cephalosporin.
The 1st generation cephalosporins (cephalothin and cephradine) are on the left hand
side, the 2nd generation (cefoxitin and cefuroxime) in the centre, and the 3rd
generation cephalosporins (ceftazidime, cefotaxime and ceftizoxime) are to the right.
There is a general trend towards increasing susceptibility with the newer (3rd
generation) cephalosporins. Resistance (red shading) to ceftazidime and ceftizoxime
is more prevalent in the unselected population than the ampR population.
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Figure 3.3 Comparison of the prevalence of resistance of ampR, aprR, nalR and
unselected populations to the aminoglycosides and other classes of antibiotic.
Aminoglycosides
P, unselcctcd; A, ampR, R. aprR; X. naIR; red. resistant; orange, intermediate resistance; blue, sensitive.
The apr population contained only 12 isolates, however all susceptibility classes
were observed when isolates were profiled with streptomycin (Figure 3.3). The vast
majority of isolates had decreased susceptibility to rifampicin, because of the barrier
function of the gram-negative outer membrane in preventing entry of this antibiotic
(Burman et al., 1972).
A greater percentage of ampR isolates also demonstrate reduced susceptibility to
streptomycin, trimethoprim, chloramphenicol, tetracycline and sulphamethoxazole,
than did the unselected population. Therefore, it is hypothesised that resistance to
ampicillin may be linked to resistance to other antibiotics by the carriage of a multi¬
drug resistance plasmid. Similarly, the aprR population has a higher prevalence of
tetracycline and sulphamethoxazole resistance than the unselected population, which
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may be due to the presence of a plasmid harbouring these resistance determinants
within the aprR population. These hypotheses are examined in the following section.
3.3.dBetween-population comparison ofsusceptibilityproportions
This section aims to address the following three hypotheses:
i) Resistance to an antibiotic confers resistance to other antibiotics of
the same family.
ii) Isolates from resistant populations more commonly harbour other
resistance genes.
iii) Plasmid mediated resistance genes are commonly associated with
each other.
i) Resistance to an antibiotic confers resistance to other antibiotics ofthe same
family.
This hypothesis acts as a positive control for the G-tests, because resistance to an
antibiotic commonly confers resistance to other antibiotics of the same family (Amyes
et al., 1996). To examine this hypothesis, the proportions of S, I and R isolates, to one
antibiotic were compared to those of another antibiotic from the same antibiotic
family (i.e. with the same mechanism of antibacterial action). Representative
antibiotics from different families were used in the analysis, the results ofwhich are
listed in Table 3.5.
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Table 3.5 Association in level of susceptibility between antibiotics of the same
family.
Antibiotics compared G value P -value
Amoxyclavulanic acid Ampicillin 95.76 <0.0001
Amoxyclavulanic acid Aztreonam 65.49 <0.0001
Amoxyclavulanic acid Cephalothin 80.79 <0.0001
Amoxyclavulanic acid Ceftazidime 42.44 <0.0001
Cephalothin Ceftazidime 169.18 <0.0001
Apramycin Gentamicin 45.69 <0.0001
Apramycin Streptomycin 6.35 0.1747
These results support the hypothesis that resistance to an antibiotic confers cross-
resistance to other antibiotics of the same family. All tests of association between
levels of susceptibility to antibiotics of the same family yielded highly significant
positive associations (P < 0.0001), except apramycin verses streptomycin. This result
was expected because the enzyme conferring resistance to apramycin does not confer
cross-resistance to streptomycin (Brau et al., 1984) even though both antibiotics are
aminoglycosides. This test was performed on proportions of S, I and R isolates
grouped with either method 1 or method 2, depending on the results of section c. As
a check, tests were repeated using the more conservative method (method 1), where
only those results for which repeat classification yielded the same resistance
phenotype. The same significant associations were found.
ii) Isolates from resistant populations more commonly harbour other resistance
genes.
Pearson's %-squared test was used to determine whether isolates from the ampR and
nalR populations had a significantly greater proportion of resistance to other
antibiotics than isolates from the unselected population. The aprR population was not
included in the study as it contained only 12 isolates, which would result in an
unreliable test. In this analysis, resistance was classified as either the number ofR
isolates or the number of non-sensitive (R + I) isolates in the population. Different
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definitions of resistance may be used in each comparison as long as the same
definition is used within a comparison. This is because the question being addressed
is whether there is an association between increases in resistance and the type of
population. Representative antibiotics were chosen for this analysis based on their
different mechanisms of action, and the results of this analysis are shown in Table
3.6.
Table 3.6 Association between resistance to an antibiotic, and resistant population
compared to the unselected population.
R isolates only R +1 isolates
Population Antibiotic I2 P -value I2 P -value
AmpR Apramycin NA NA 1.11 0.292
Nalidixic acid 2.37 0.124 0.757 0.384*
Trimethoprim 40.98 <0.0001 40.98 <0.0001
Chloramphenicol 12.45 0.0004 21.919 <0.0001
Tetracycline 15.58 0.0001 3.285 0.07
Sulphamethoxazole 115.45 <0.0001 115.45 <0.0001
NalR Ampicillin 54.41 <0.0001 51.17 <0.0001
Apramycin NA NA 0.08 0.777*
Trimethoprim 4.724 0.03* 4.724 0.03*
Chloramphenicol 149.33 <0.0001* 149.33 <0.0001
Tetracycline 0.0451 0.8318 1.4965 0.2212*
Sulphamethoxazole 66.03 <0.0001 66.03 <0.0001
* Indicates expected frequencies of <5. NA indicates no R isolates were present in one of the
populations. R, resistant isolates; I, intermediately resistant isolates.
The ability of the test to detect an increase or decrease in the proportion of resistance
between the two populations requires adequate numbers of isolates to be present in
the contingency table. This ultimately depends on the ability of the breakpoints used
to partition the population, which will differ between antibiotics. The only instance
for which the definition of resistance does make a difference to the significance of
any association is the presence of tetracycline resistance in the ampR population. This
is because of a large number of isolates in the comparison with intermediate level
resistance (41/183 isolates in the ampR population were intermediately resistant to
tetracycline, results not shown). The addition of all I isolates into the R group
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dramatically affects the numbers ofR isolates used in the test. The results of Table
3.6 indicate that high level tetracycline resistance (MIC > 64mg/L) is significantly
associated with ampicillin resistance. Ampicillin resistant isolates were also
significantly associated with resistance to trimethoprim, chloramphenicol, and
sulphamethoxozole (Table 3.6)
Nalidixic acid resistant isolates were significantly associated with
sulphamethoxozole and ampicillin resistance. The significance of the association
between nalidixic acid resistance and chloramphenicol and trimethoprim resistance
should be interpreted with caution because the expected frequencies were fewer than
five.
iii) Plasmid mediated resistance genes are commonly associatedwith each other.
To examine this hypothesis, the proportions of S, I and R isolates, to either ampicillin
or apramycin were compared to those of other antibiotics to which resistance is
commonly plasmid mediated. These results are shown in Table 3.7.
Table 3.7 Association in level of susceptibility between antibiotics to which
resistance is commonly carried on plasmids.




















Resistance to ampicillin is significantly associated with resistance to
chloramphenicol, sulphamethoxazole, tetracycline and trimethoprim (Table 3.7).
These conclusions support those of section ii (Table 3.6). AprR isolates were only
significantly associated with tetracycline resistance indicating the presence of an
apramycin resistance plasmid that also harbours tetracycline resistance. All
associations were positive.
3.4 Discussion
This study aimed to determine the susceptibility profiles of 410 isolates to 25
different antibiotics. The number of tests involved meant that the determination of
full MICs for each isolate was not practical, and so a breakpoint method of testing
was used. By repeating each profile twice, variation arising from this methodology
could be measured.
3.4a Assessment of levels and sources ofvariation within the methodology
Although three control organisms recommended by the BSAC (Andrews, 2001) were
included in each experiment (NCTC 10418, NCTC 6571 and NCTC 10662) a
significant level of variation was detected with 16 antibiotics, and a less than
satisfactory level of reproducibility was observed with seven. Some experimental
errors may have remained undetected if the MICs of these standard strains were not
close to the breakpoint concentrations chosen.
Discrepancies between replicates can arise from slight variations in inoculum,
degradation of antibiotic over time, and variation in reading the plates (BSAC, 2004),
but this should be minimal if a single protocol is adhered to and results are recorded
by the same operator, as was done in this study. The variation observed is due to the
positioning of the breakpoints. The effect ofbreakpoint positioning on classification




Figure 3.4 Variation in susceptibility classification due to breakpoint position.
Figure 3.4 shows a population of bacteria with a range of susceptibilities to an
antibiotic, given as MIC values. The population comprises two discrete groups, those
that are sensitive, and those that are resistant to the antibiotic. This bimodal
distribution is typical of a number of antibiotics used in this study, and is caused by
the acquisition of a resistance mechanism resulting in a characteristic increase in
MIC. If a breakpoint is positioned at point A, any sight variations in concentration of
antibiotic because of degradation of the drug or inaccuracies in making the antibiotic
plates will not affect the number of isolates classified as R or S. In contrast, if the
breakpoint is positioned at point B, slight variations in antibiotic concentration may
result in concentration C being the actual concentration of antibiotic used. This will
result in a decrease in the number of isolates that are classed as R, and a
corresponding increase in those classed as I. With prior knowledge as to the range of
MICs expected within a given population, breakpoint concentrations can be used
which, like concentration A, split the population into discrete groups. No information
was available on the susceptibilities expected from the isolates examined in this
study. To acquire this knowledge would require the completion of full MICs on a
very large subset, if not all of the isolates. This is because the isolates are expected to
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have extremely varied susceptibility profiles because some were selected on
antibiotics prior to isolation and others were not.
The presence of variation between replicates results from the position of the
breakpoints used. The extent of the variation observed also differs between the
different antibiotics. This is because it depends on the MIC of the majority of the
isolates to that antibiotic and the mechanism of resistance to the antibiotic.
According to the BSAC (Andrews, 2001) a variation of plus or minus one two-fold
dilution is acceptable when assessing whether a control strain in a sensitivity test has
its correct MIC. In this study, if the majority of isolates had an MIC to a particular
antibiotic that was at the breakpoint concentration used, repeat experiments could
easily result in two different resistance phenotypes being reported because ofminor
experimental errors. This may explain why many isolates were sensitive to
apramycin, azlocillin, cefoxitin, cephradine, or tetracycline in one experiment and
demonstrated intermediate level resistance in the repeat experiment.
The isolates in this study varied in their susceptibility to different classes of
antibiotic, because of the initial selection of isolates either on media containing an
antibiotic or on media without antibiotic supplementation. This range of
susceptibilities is a good way of testing the true ability of the breakpoints used to
classify isolates into resistance phenotypes. Quality control of susceptibility testing
has in the past been conducted with a high proportion of susceptible isolates (Chen et
al., 1995) resulting in an unfair test of the methodology.
The mechanism by which bacteria acquire resistance to an antibiotic is also of
importance when assessing the effect of variation due to breakpoint position. The
categorisation of isolates into the three groups with very few discrepancies between
repeats will be obtained where the presence of a resistance mechanism results in
large increases in MIC, forming discrete populations, and the breakpoints used have
been at positions suitable for distinguishing these populations.
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Sulphonamide resistance is mediated by the production of dihydropteroate synthetase
with reduced affinity for sulphonamides, but not para-aminobenzoic acid (a precursor
in the bacterial metabolic pathway for the synthesis of tetrahydrofolate) (Wise &
Abou-Donia, 1975). In this way, the inhibitory effect of the antibiotic is bypassed
resulting in a dramatic increase in MIC. The difference in MIC between sensitive and
resistant isolates is large enough that no I isolates were identified with these
breakpoints. Therefore, the breakpoints used must be both present in the trough of
the bimodal curve resulting in unambiguous categorisation. This may also be the case
with trimethoprim, where there are few (n = 6) discrepancies between replicates.
Trimethoprim resistance occurs by the production of an altered dihydrofolate
reductase enzyme (the trimethoprim target) (Amyes & Smith, 1974) resulting in a
large increase in MIC.
In contrast, Livermore & Chen (1999) describe the occurrence of a high frequency of
resistant P. aeruginosa isolates in UK laboratories being reported as sensitive. The
high rate ofmiscategorisation was thought to be due to the unimodal distribution of
MIC values. Where a breakpoint cuts the tail of a unimodal distribution, resistance
classification by this breakpoint is prone to be erratic, compared to a breakpoint
present in between the two discrete populations of a bimodal distribution. This is
likely to be the reason for discrepancies in categorisation of susceptibility, and hence
the low Kappa values, of the breakpoint tests used in this study to apramycin,
cephradine and amoxyclavulanic acid. Here different resistance mechanisms can
occur resulting in different MIC values. These include enzymatic modification of
apramycin, enzymatic degradation and reduced permeability of the ((-lactams and
cephalosporins (Moosden, 1997), and efflux pumps capable of removing these
antibiotics (Edgar & Bibi, 1997; Rosenberg et al., 2000). This will lead to a greater
number of possible MIC values present in the population. Efflux pumps may also
play a role in resistance to the quinolones, chloramphenicol and other ((-lactams
(Sulavik et al., 2001), but the presence of variation between replicates again depends
on the position of the breakpoints in relation to the range ofMIC values in the
population.
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The extent of the variation occurring between replicate experiments differed between
the antibiotics. This needed to be considered before examining the presence of any
associations between resistance phenotypes. Recently, statistics have been applied to
the determination of associations between cyclohexane resistance and multiple
antibiotic resistance (Randall et al., 2001). Here isolates were classified as S or R
based on the results of disc diffusion assays, but the presence of any variation in the
categorisation of susceptibility was not examined prior to the determination of any
associations between resistance phenotypes. The identification of antibiotics for
which the classification was ambiguous would have been a useful addition to the
study.
3.4b Proportions ofresistance
In the unselected population, resistance amongst the B-lactam antibiotics was
detected against penicillin, ampicillin, azlocillin and amoxyclavulanic acid, which
indicates that these strains represent a substantial proportion of the calves' intestinal
flora. The sampled calves were not treated with any 8-lactams, but penicillin was
used to treat two calves reared with the sampled calves. The detection of p-lactam
resistance in a high proportion of commensal E. coli may reflect cross-contamination
of resistant strains between treated and untreated calves, or a high prevalence of p-
lactam resistant strains in the calves' immediate environment. Environmental
sampling and resistance phenotyping would be required to test this hypothesis.
As was expected, many of the isolates selected on ampicillin plates showed cross
resistance to other B-lactams, although 120 / 183 of this population were sensitive to
aztreonam suggesting that the predominate B-lactamases do not hydrolyse this
monobactam.
A low proportion of isolates were resistant to the 3rd generation cephalosporins (eight
isolates were ceftazidime resistant and two were ceftizoxime resistant). Surprisingly,
resistance to these antibiotics was more common in the unselected population than
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the ampR. Resistance to the 3rd generation cephalosporins commonly occurs by
mutation of the P-lactamase genes Muwma or blasm-i causing an extended spectrum
of activity of the corresponding enzyme (Bradford, 2001). Therefore, TEM-1 and
SHV-1 enzymes were expected to be more prevalent in the ampR population than
those from the unselected population. The mechanism of resistance may be the
presence of a cephaloporinase (Alvarez et al, 2004; Zhao et al., 2001) or an efflux
pump (Nikaido et al., 1998). This is discussed in more detail in Chapter 8.
Only two isolates demonstrated reduced susceptibility to the fluoroquinolones
enrofloxacin and ciprofloxacin. These were picked from unselective plates.
Resistance to the quinolones in E. coli commonly occurs by mutation in the gyrA
gene (Oram & Fisher, 1991), or reduced levels of quinolone accumulation (Cohen et
al., 1988; Hirai et al., 1986a). A single mutation in the quinolone resistance
determining region ofgyrA confers high level nalidixic acid resistance and low level
ciprofloxacin resistance (MIC < 4mg/L) (Vila et al., 1994). This would explain the
resistance phenotype observed, but it is surprising that none of the isolates from the
nalR population demonstrated this phenotype. Alternatively, the intermediate level
resistance to the fluoroquinolones in these two isolates may be due to a reduction in
quionolone accumulation. A decrease in the number ofOmpF porins (the outer
membrane protein channel through which fluoroquinolones are thought to diffuse)
has previously been correlated with a 4-fold increase in resistance to both nalidixic
acid and ciprofloxacin (Hirai et al., 1986a; Hirai et al., 1986b). Active efflux of
quinolones has also been found to contribute to the final MIC of a strain to varying
degrees (Everett et al., 1996; Martinez et al., 1998). Sequencing of the QRDR of the
gyrA gene, studies of drug accumulation, and outer membrane protein western blots
would be required to test these hypotheses.
Although the apr population comprised only 12 isolates, all levels of streptomycin
resistance (S, I, and R) were observed. This indicates variation in the mechanism of
streptomycin resistance within the aprR isolates. A number of different streptomycin
resistance genes have been identified (Heinzel et al., 1988; Hollingshead & Vapnek,
1985; Scholz et al., 1989) in addition to resistance due to ribosomal alteration (Traub
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& Nomura, 1968) and loss of permeability (Zelazna-Kowalska, 1977), all ofwhich
may contribute to the variations in resistance profiles observed within this small
group.
3.4c Associations between phenotypes
The prevalence graphs comparing resistance phenotypes between the four
populations, indicated that the nalR population harboured resistance to ampicillin,
sulphamethoxozole, chloramphenicol and trimethoprim, more commonly than the
unselected population. When this was examined statistically a significant positive
association was found between these four antibiotics and the nalR population (P <
0.05). This association is unlikely to be due to any specific propensity for strains
harbouring a chromosomal mutation conferring nalidixic acid resistance to acquire
these resistance genes. These results can be explained by the presence of a limited
number of genotypes in the nalR population, of which the most prevalent strain also
harbours multiple antibiotic resistances. If few other nalR genotypes are present the
results of the test will be biased. The extent of clonality within the nalR population is
examined by PFGE in chapter 4.
The prevalence graphs also indicated that resistance to trimethoprim,
chloramphenicol, tetracycline, and sulphamethoxazole is more common in ampR
isolates than isolates from the unselected population. Again, when these potential
associations were examined statistically, a positive association was found between
each of these antibiotics and the ampR population (P < 0.05). This is likely to be due
to the presence of (a) multidrug resistance plasmid(s), which are commonly found in
isolates from food-producing animals (Marshall et al., 1990; Mee & Nikoletti, 1983;
Oppegaard et al., 2001). The highly significant level of association between these
resistance genes and ampicillin resistance, detected by the G-test of association also
supports this hypothesis.
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The ability of integrons, present in mobile elements, to acquire antibiotic resistance
genes from other replicons is well documented (Bass et al., 1999; Collis et al., 1993).
This results in the formation of gene cassettes (reviewed by Recchia & Hall, 1995)
containing a number of resistance genes, either on conjugative transposons, or
transposons within plasmids (Antunes et al., 2004; Heir et al., 2004; Pezzella et al.,
2004). To examine whether or not the antibiotic resistances identified are present on
one plasmid, transfer frequencies can be compared when the different antibiotics are
used as selective agents for transfer. This method is described in more detail in
chapter 5, where transfer frequencies were used to determine which resistance genes
were present on aprR plasmids.
The aprR population had a higher prevalence of tetracycline and sulphamethoxazole
resistance than the unselected population, which may be due to the presence of a
plasmid harbouring these resistance determinants within the aprR population. When
the significance of any associations between apramycin resistance and other plasmid
mediated resistance genes were assessed using the G-test, a significant association
was only found between apramycin and tetracycline resistance. This suggests that
within the aprR population is a plasmid carrying apramycin and tetracycline
resistance. Because no apramycin (or other aminoglycosides) or tetracycline was
used to treat the animals from which these isolates came, the presence of this plasmid
is of interest, and is the focus of chapter 5.
3.5 Concluding remarks
The use of two breakpoint concentrations of an antibiotic allowed a large number of
isolates (410) to be screened for susceptibility where the usual practice of
determining actual MICs by doubling dilution would be unmanageable. Although
different degrees of variation were present within replicate experiments,
quantification of this variation permitted valid conclusions to be drawn, and enabled
the identification of a number of isolates of interest for further study.
ft
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These included the detection of intermediate or high level resistance to 3rd generation
cephalosporins. These isolates may harbour ESBLs, previously undetected in
Scottish food animals, and will be examined in molecular detail in Chapter 8.
The limited diversity of resistance phenotypes within the nalR populations suggested
a greater degree of clonality within these isolates compared to the ampR, aprR and
unselected populations. The extent of this possible clonality is examined in Chapter 4
using a combination of genotyping by pulsed-field gel electrophoresis, and
mathematical estimates ofpopulation diversity.
Positive associations between a number of resistance determinants were identified,
suggesting the existence ofmultidrug resistance plasmids. The presence of a plasmid
harbouring apramycin and tetracycline is of special interest, as there appears to be no
obvious selective pressure maintaining these plasmids. A detailed study on the types
of apramycin resistance plasmid, their spread, and the competitive fitness cost of a




The epidemiology of antibiotic resistance in pathogenic E. coli is well documented
(Chaslus-Dancla el al., 1991; Hartman et al., 2003; Oethinger et al., 1998; Kern el
al., 2002; Shen et al., 1999), but much less is known about the epidemiology of
antibiotic resistance in commensal E. coli. To study this requires a prior
understanding of the epidemiology of the commensal E. coli at the sub-species level.
This includes the estimation of strain diversity within this population, and
information on factors that may affect diversity (for example, calf age, antibiotic
treatment and diet). This chapter aims to achieve a better understanding of the
diversity ofE. coli present within the calf study group. The genotyping results
presented in this chapter will also be used in chapter 5 to aid the understanding of the
epidemiology of apramycin resistance.
This introduction comprises two parts. Firstly, the different methods of typing
bacteria will be discussed, with justification for the method chosen in this study.
Secondly, the specific aims of this chapter will be described in detail.
The species E. coli is commonly described as being clonal (Ochman & Selander,
1984; 0rskov et al., 1990; Selander & Levin, 1980). A clone is defined as "any
microbial isolate belonging to a set ofmicrobial isolates that have been recovered
independently from different sources, in different locations, and perhaps at different
times, but showing so many identical phenotypic and genetic traits that the most
likely explanation for this identity is a common origin" (Eisenstein, 1990).
As more advanced typing techniques become available, a greater degree of diversity
is being detected within this species, bringing into question this idea of clonality
within the E. coli species. Clonality between strains can never be absolute as it
depends on the discriminatory power of the techniques used to type the isolates. The
more discriminatory the technique, the more certain one will be of any observed
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clonality. Therefore to examine strain diversity within the E. coli population, and
look for clonal relationships, a highly discriminatory method of distinguishing strains
is required.
Before the advent of genotypic methods, epidemiology ofE. coli was examined by
serotyping and antibiotic resistance profiling (Eisenstein, 1990). These methods may
be useful in studies of the pathogenesis of infections or in patient management
(Gemmell, 1999), but are inadequate for exploring E. coli population structure.
Antibiotic resistance markers, if present on transferable plasmids, may be spread
horizontally under selective pressure or may be lost in the absence of selection (Jones
et al., 1980), and a substantial amount of chromosomal variation has been detected
within some serotypes (Whittam et al., 1993). These factors mean that genotypic
approaches are essential for studying E. coli population diversity.
A number of genotypic typing methods are now in use in both clinical and research
laboratories. Ribotyping is based on restriction fragment length polymorphism of
ribosomal RNA genes (Tarkka et al., 1994) and has been applied to the
differentiation of E. coli 0157 isolates from other E. coli (Hahm et al., 2003). The
differentiation ofE. coli 0157 was successful by this method, which also had the
advantage of identifying three isolates that were misclassified as E. coli by the
cultivation method used. However, ribotyping has been reported to be ineffective at
discriminating between isolates within the 0157:H7 serotype (Martin et al., 1996).
The recent use of ribotyping and multilocus enzyme electrophoresis (MLEE) (where
strains are typed by the electrophoretic mobility patterns ofmultiple metabolic
enzymes) (Selander et al., 1986), to determine the clonal structure of avian E. coli
strains, highlighted MLEE as a better method to discriminate between strains
(Silveira et al., 2003). The main disadvantage ofMLEE is that typing is based on the
structure of between 5 and 15 enzymes, rather than the whole genome.
A number of PCR-based methods are also used in bacterial phylogenetics, including
random amplified polymorphic DNA (RAPD) (Power, 1996), arbitrary fragment
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length polymorphism (AFLP) (Vos et al., 1995), and repetitive element PCR (rep-
PCR) (Versalovic et al., 1991).
RAPD-PCR uses short primers with sequences not directed at any specific genomic
sequence, which hybridise at random sites in the DNA to initiate amplification
(Welsh & McClelland, 1990). This method was applied to the typing of£. coli from
beef cattle faeces, carcasses and ground beef (Aslam et al., 2002), leading the authors
to conclude that E. coli contamination ofground beef originated from cattle faeces.
However, RAPD-PCR was found to be less reproducible and less discriminatory than
PFGE when these two methods were used to trace fluoroquinolone resistant E. coli
isolated from cancer patients (Tascini et al., 1999). Other criticisms of RAPD-PCR
have been described, including variation in fingerprints due to DNA or primer
concentration and staining methodology (Van Belkum et al., 1993), and difficulties
in comparison ofpatterns between gels and between laboratories (Power, 1996).
Other PCR based methods, although relatively cheap and rapid, are also associated
with problems that limit their use for studying the population diversity ofE. coli.
AFLP-PCR uses PCR primers generated by enzymatic digestion of the DNA, which
are then used in subsequent PCR of other isolates (Vos et al., 1995). Problems arise
if the DNA used is not highly purified and of high quality, leading to artificial
amplification (Mueller & Wolfenbarger, 1999). The production of an insufficient
number of fragments may also lead to incorrect conclusions of clonal identity
(Mueller & Wolfenbarger, 1999).
Rep-PCR is based on the amplification of repetitive intergenic consensus sequences,
and was used to type pathogenic and non-pathogenic E. coli (Johnson & O'Bryan,
2000). In this study rep-PCR failed to resolve all the major pylogenetic groups
previously identified by MLEE, significantly limiting the use of this methodology as
a typing tool for E. coli. Although here one may argue that the use of a genotypic
typing method (i.e. rep-PCR) is a more accurate way to determine genetic relatedness
than MLEE, as the latter does not compare the genome directly, but compares the
structure of 5 -15 proteins expressed by the genome (Dijkshoorn & Towner, 2001).
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In a comparative study, AFLP, rep-PCR, ribotyping and PFGE were applied to the
subtyping of foodbourne and environmental E. coli isolates (Hahm et al., 2003). All
methods were able to differentiate the 0157 serotype, but the phylogenetic
relationships between the isolates differed depending on the typing method chosen.
In this study, PFGE was found to be the most effective method of subtyping E. coli
0157. Noller et al. (2003) also report similar findings recommending the use of
PFGE typing.
Taking into account the advantages and limitations of the typing methods used
previously to study E. coli population structure, PFGE was chosen as the method
with which to type the commensal E. coli in this work. The perceived problems
associated with this technique are that it is relatively expensive and labour intensive,
and where highly diverse patterns are found it cannot be used to determine
evolutionary relationships. There are few studies where this method has been used to
type commensal E. coli, but it is a highly discriminatory method and the results are
extremely reproducible (Osek 2000).
This chapter aims to address four hypotheses, which are outlined below.
1. Commonly, one isolate per faecal sample is examined in epidemiological
studies, however it is hypothesised that different genotypes are present in one
faecal sample. How commonly this occurs will give an indication of whether
or not one isolate per faecal sample is adequate for epidemiological studies.
2. Population diversity can be quantified by statistical estimates. Ecologists and
evolutionary biologists have developed statistical approaches to estimating
diversity within and between populations (Chao, 1987; Colwell &
Coddington, 1994; Martin 2002). To test whether these methods are
applicable to the microbial diversity data in this chapter, both Simpson's
diversity index, and the Chaol richness estimator will be used. Once the
different methods for quantifying diversity have been explored, they will be
used, in addition to non-quantitative graphical methods, to test hypotheses 3.
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3. Bacteria may become resistant to ampicillin and apramycin by the acquisition
of a plasmid (Chaslus-Dancla et aI., 1991; Heffron et al., 1975). In contrast,
nalidixic acid resistance is commonly acquired through mutation of the
gyrase and topoisomerase genes (Vila et al., 1994). As the mechanisms of
resistance acquisition between the resistant populations are different, it is
hypothesised that population diversity will also differ between these
populations. The unselected population is hypothesised to be the most diverse
because it comprises all the other resistant populations in addition to any non-
resistant strains.
4. Lastly, because the total numbers ofE. colt have previously been found to
decrease with increasing calf age (Hoyle et al., 2004) it was hypothesised that
the population diversity may also change as the calves mature. The intestine
of a newborn calf is initially sterile, but is rapidly colonised by different
strains from both the environment and from other calves and dams (Hartyl &
Dykhuizen, 1984). In ecological terms, Andrews & Hall (1986) consider a
given population to comprise two different strategists, those that rely on high
rates of reproduction to survive in the community (r strategists), and those
that rely on optimal utilisation of available resources (K strategists).
Selection for r strategists occurs in un-crowded conditions, but when
resources are limited their populations crash. In contrast, K strategists depend
on specific adaptations to an environment and therefore compete better in
crowded and resource limited conditions. The E. co/i population diversity is
hypothesised to decrease with calf age because the early colonisers, most of
which will be r strategists, are eventually out competed by K strategists,
which have specific adaptations to the environment and tend to be more
stable and permanent members of the community (Atlas & Bartha, 1998).
This hypothesis will be tested statistically to determine whether the numbers
of genotypes detected change significantly with increasing calf age.
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4.2 Materials and Methods
4.2a Bacterial isolates
The isolates used in this study were collected as described in chapter 2. Table 4.1
lists the isolates used in this study, sampling dates, and the calves from which they
were obtained. In total 543 commensal E. coli were examined by PFGE, comprising
139 unselected isolates, 208 ampR, 45 aprR and 151 nalR isolates.
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Table 4.1 Numbers of isolates from each population and calf, typed by PFGE.
Number of isolates genotyped
Calf Sampling date unselected ampR aprR nalR
684 14.09 1
17.09 6 8 12













































































4.2b Pulsed-fieldgel electrophoresis (PFGE)
PFGE was performed as described by Gautom (1997). Briefly, a single colony or
cryopreservative bead was used to inoculate 10 ml LB broth for incubation at 37°C
with shaking (150 rpm) for 16 to 18 hours. Cultures were harvested by centrifugation
at room temperature at 2,190 x,g (3,600 rpm) for 12 min. The cells were washed in
SE (75mM NaCl, pH 8.0; 25mM EDTA, pH 8.0) by centrifugation and the optical
density adjusted to 1.40 at a wavelength of 610nm. Chromosomal-grade agarose
(Bio-Rad Laboratories, Hercules, Calif.) was prepared in TE buffer (lOmM Tris;
ImM EDTA, pH 8.0) to a final concentration of 1.5%. Equal volumes of agarose and
cell suspension were mixed and dispensed into plug moulds (Bio-Rad Laboratories).
Following solidification, plugs were transferred into lysis buffer (50mM Tris, pH
8.0; 50mM EDTA, pH 8.0; 1% sarcosine; 1 mg proteinase K per ml) for 24 h
incubation at 55°C. Plugs were then washed eight times with TE for 15 min at 4°C,
and then left overnight in TE at 4°C. Unless used that day, plugs were stored in TE at
4°C for up to three months. One third of a plug was then preincubated in 200pl of 1 x
Xbal buffer (Promega) for 1 hour at room temperature. The buffer was removed and
replaced with a fresh mixture containing 50U ofXbal (Promega) in 1 x restriction
buffer and incubated at 37°C for 16 to 20 hours. Following a briefwash in 0 .5M
Tris-borate-EDTA (TBE) (45mM Tris base, 45mM boric acid, ImM EDTA, pH 8.0),
electrophoresis of the samples was performed on the CHEF-mapper (Bio-Rad
Laboratories) system using pulsed-field certified agarose (Bio-Rad Laboratories)
with 2 litres of 0.5M TBE running buffer (45mM Tris base, 45mM boric acid, ImM
EDTA, pH 8.0). A lambda ladder PFGE marker (New England Biolabs) was run
between every six samples. The following electrophoretic conditions were used:
initial switch time, 2.1s; final switch time, 54.2s; run time, 22 hours; angle, 120°;
gradient, 6.0 V/cm; temperature, 14°C; ramping factor, linear. After electrophoresis
the gels were stained for 30 min in 300ml of sterile distilled water containing 300pl
of ethidium bromide (lmg/ml), destained for 1 hour in 1 litre of sterile distilled
water, and then photographed with the Gel-Doc 2000 system (Bio-Rad).
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4.2c Cluster analysis
TIF images of the PFGE gels were exported into BioNumerics software for further
analysis and comparison. PFGE fingerprints were compared using the Dice similarity
coefficient and clustered by the unweighted pair group method using arithmetic
averages (UPGME). PFGE patterns were interpreted according to criterion suggested
by Tenover et al(1995).
Optimisation and position tolerances, calculated with BioNumerics software, were
set at 1%. 629 PFGE patterns (86 ofwhich were repeats to check consistency) from
the commensal E. coli isolated in this study, in addition to 150 copies of the lambda
ladder PFGE marker were used in the determination of the optimal position tolerance
and optimisation settings. Similarity matrices were calculated for all entries in the
database with a range of position tolerance values. The optimal value is that which
resulted in high similarity scores within groups of the same genotype (or repeat lanes
of the lambda ladder PFGE marker), and as low as possible similarity scores between
groups of different genotypes. The optimal values were also able to distinguish
similar types within a genotype, i .e. subtypes of a genotype, for example, with one
band difference. The optimisation settings were calculated in the same way. With the
543 isolates used in this study, a position tolerance and optimisation value of 1%
permitted easy and clear identification of different genotypes, but also gave good
specificity within a genotype, as isolates with one band difference were clustered
within a genotype.
4.2d Statistics
Genotype richness was estimated using the Chaol richness estimate. This estimator
has been found to be useful for microbial data sets (Hughes et al., 2001), which are
commonly skewed towards the low abundance classes. Genotype richness was




where S0bs is the number of species or genotypes observed, n\, the number of
genotypes observed once, and m, the number of genotypes observed twice.
Population diversity was quantified by Simpson's diversity index;
where n, is the number of individuals of the z'th species or genotype, and N is the
number of individuals or genotypes in the population. In this chapter, D = 1 -C is
given as the index of diversity because it increases with increasing diversity. This
index measures the probability that two isolates taken at random from the population
will be of the same genotype.
The effect of calf age, sampling date, and population on genotype richness was
analysed with generalised linear models (Crawley, 2002). Population was split into
two categories; selected (i.e. antibiotic resistant) or unselected.
4.3 Results
4.3a Population diversity and richness
Population diversity may be expressed as the number of genotypes present (genotype
richness), or as the evenness of spread of the genotypes present (diversity). In this
chapter the terms richness and diversity will be used to distinguish these two
meanings. The genotype richness within the unselected, ampR, aprR and nalR
populations was studied using all typed isolates irrespective of calf or sampling date.
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Figures 4.1a-d show dendrograms of the different genotypes present within each
population. Subtypes within six of the genotypes were detected (with < 2 band
differences from the majority type of a genotype), and these are also included in the
figures. The subtypes within a genotype will be described and discussed in section
4.3b; genotypic diversity.
Percentage similarity Xba\ PFGE pattern Genotype
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Figure 4.1a PFGE genotypes in the apramycin resistant population. Percentage
similarity is given on the scale above the dendrogram. Subtypes of a genotype are
designated a number after the genotype letter.
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Figure 4.1b PFGE types in the nalidixic acid resistant population. Percentage
similarity is given on the scale above the dendrogram. Subtypes of a genotype are
designated a number after the genotype letter.
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Figure 4.1c PFGE types in the ampicillin resistant population. Percentage similarity
is given on the scale above the dendrogram. Subtypes of a genotype are designated a
number after the genotype letter.
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Figure 4.1d PFGE types in the unselected population. Percentage similarity is given
on the scale above the dendrogram. Subtypes of a genotype are designated a number
after the genotype letter.
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The highest number of genotypes is found within the unselected population (30
genotypes, two of which contained subtypes) (Figure 4 Id). Of the selected
populations, the ampR population contained the most genotypes (26 genotypes)
(Figure 4 Ic), and the nalR population the least (two genotypes) (Figure 4.1b). Five
genotypes were found in the aprR population (Figure 4. la). In total 55 genotypes
were detected within the 543 commensal E. coh examined in this study.
Within a given population, diversity may be expressed not only as the number of
genotypes detected but also as the relatedness between genotypes. To compare the
clustering patterns of each population (excluding the nalK population as it only
contains two genotypes), the numbers of lineages were plotted against increasing
percentage similarity (Figure 4.2) as calculated by the dice coefficient. These plots
are similar to lineage-per-time plots (Martin, 2002) except that percentage similarity
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Figure 4.2 Numbers of lineages in the unselected, ampR, and aprR populations
plotted against increasing percentage similarity as calculated by the dice coefficient
A hypothetical low diversity lineage is plotted in grey dashes as a comparison to
these populations.
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Figure 4.2 compares the relatedness of the unselected, ampR and aprR lineages. A
dendrogram in which there are many closely related lineages would produce a
convex curve as shown by the example lineage in Figure 4.2. A concave curve is
produced when a large amount of diversity between lineages is present near to the
root of the dendrogram. All three populations have concave curves, and there is very
little difference between the unselected and the ampR curves. One curve is not
obviously more concave than the other. This indicates that the diversity between the
different genotypes within these two populations is very similar. In support of this,
the maximum percentage difference found between genotypes of the unselected and
ampR populations were 52% and 51% respectively.
The diversity within the unselected, ampR, aprR and nalR populations were further
explored using rank abundance curves. Figure 4.3 shows the total diversity found
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Figure 4.3 Rank abundance curve of the 543 commensal E. coli genotyped by PFGE
in this study.
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Figure 4.4 Rank abundance curves of a; the unselected population, b; amp , c; apr ,
and d; nalR populations.
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The rank abundance of each genotype, irrespective of the population from which it
was obtained, is shown in Figure 4.3. Although the data may be biased by the use of
different numbers ofmultiple isolates from each faecal sample, the shape of this rank
abundance curve is typical of a superdiverse community, as is expected. In Figure
4.3, it can be seen that population contains a few abundant genotypes and many rare
genotypes. This produces a long right-hand tail on the rank abundance curve.
Comparing the curve of the unselected population (Figure 4.4a) to that of the ampR
population (Figure 4.4b) reveals very little difference between them. In terms of
richness, the ampR population has fewer genotypes, but the evenness of spread of
genotypes between the ampR and the unselected population are very similar. The
diversity of the ampR population is substantially greater than that of the aprR and nalR
populations (Figure 4.4c and d).
Finally, the diversity within each of the four populations was compared qualitatively
using diversity indices. The two diversity measures used evaluate different aspects of
the term diversity. Chaol is a species richness estimate, whereas Simpson's diversity
index (C) measures the probability of finding two identical genotypes when two
isolates are taken at random from a population. Table 4.2 shows the diversity of the
four populations according to these diversity measures. 1-Simpson's index
(designated D), is given in Table 4.2, so that D increases with increasing diversity.
Table 4.2 Diversity measures of the nalR, aprR, ampR and unselected populations.
No. of No. of Diversity measure
Population isolates genotypes found Chaol 1-Simpson's (D)
(richness estimate) (diversity index)
NalR 151 2 2 0.241
AprR 45 5 9 0.592
AmpR 208 26 49 0.899
Unselected 139 30 46 0.858
The species richness estimate Chaol predicts that the least number of genotypes will
be found in the natR population (Table 4.2). This is quite reasonable because in E.
coli resistance to nalidixic acid commonly occurs by mutation in the quinolone
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resistance determining region of the gyrA gene (Vila et al., 1994). This is not a
transferable resistance mechanism and so the number of genotypes harbouring this
resistance gene are likely to be less than if it was carried on a transferable element
(as are the apramycin and ampicillin resistance determinants). The ampR population
is predicted to have the most number of genotypes (n = 49), but it is unclear whether
the differences in diversity or richness of the ampR and the unselected population are
significant (Table 4.2). Similarly, Simpson's diversity index also predicts the ampR
population to be the most diverse. Qualitatively, the two diversity measures predict
the same trends, with the nalR population being the least diverse and the ampR, the
most.
To explore the robustness of the Chaol richness estimate, one fifth of the isolates
from each population were randomly excluded from the analysis. Identical richness
estimates were produced with these reduced data sets of the nalR and aprR
populations, but not with the ampR or unselected populations. The reduced ampR
population was predicted to contain 35 genotypes (as opposed to 49, see Table 4.2),
and the reduced unselected population was estimated to comprise 48 genotypes
(rather than 46). Therefore, smaller sample sizes had the greatest effect on the most
diverse populations, and much less of an effect on lower diversity populations.
4.3b Genotype diversity
Isolates within 24 of the 55 genotypes had identical band patterns following
digestion with Xba\. These genotypes and the populations from which they were
obtained are summarised in Table 4.3.
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Table 4.3 Genotypes found within the calf commensal E. coli for which no




B 9 apr (8), amp (1)
C 8 apr
F 14 plain(4), amp (10)
G 2 amp
1 12 amp
J 64 amp (46), plain (18)
K 4 amp

















Uniques 1 per group apr (2), amp (9), plain (14)
Diversity within a genotype was found in six genotypes. These genotypes were split
into subtypes designated by the genotype letter then the number of the subtype. The
subtypes are numbered sequentially according to the number of isolates within them.
Thus, subtype 1 of a genotype contains the majority of isolates within this genotype.
In Table 4.4 these genotypes and subtypes are summarised. The number of isolates
within a subtype is given, in addition to the band changes of these isolates compared
to the majority band pattern of the genotype.
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Table 4.4 Genotypes found within the calf commensal E. coli for which diversity
within a type was found following PFGE typing with Xbal. The populations from
which these isolates were obtained are listed in addition to the band changes of these









A 27 apr (27) A1 NA 25
A2 531 bp replaced by 563bp 2
D 158 nal (130), amp (28) D1 NA 102
D2 106bp missing 47
D3 94bp missing 7
D4 34bp missing 2
E 32 nal (21), amp (5), plain (6) E1 NA 19
E2 151 bp missing 10
E3 151 bp replaced by 159bp 3
H 20 amp (20) H1 NA 19
H2 139bp missing 1
S 7 plain S1 NA 6
S2 57bp band extra 1
U 7 plain U1 NA 6
U2 355bp replaced by 418bp, 172bp band extra 1
NA, these are the majority genotypes against which the subgroup patterns were compared.
Within the six genotypes listed in Table 4.4, all but one subtype differed from the
majority subtype by one band difference (i.e. 1 band shifted, missing or extra). The
subtype of genotype U (U2) had a two-band difference from the majority subtype
Ul.
4.3c Within-sample diversity
The diversity of genotypes present within one sample was examined with each
population. The number of genotypes detected as a function of the number of isolates



























Figure 4.5 Within-sample diversity presented as the number of genotypes detected
within a sample from the a; aprR, b; amp'\ c; nalR, and d; unselected populations.
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The number of isolates obtained from a sample varied because the criterion for
picking colonies was to pick the maximum possible numbers of discrete colonies. In
some samples many colonies were present, but in others either low numbers of
colonies grew or those that were present were not discrete. Where the same numbers
of picks were obtained from more than one sample, the different numbers of
genotypes detected in each of these samples are plotted on the graphs in different
shades.
When up to 10 colonies were picked from the apramycin plates, a maximum of only
three different genotypes were detected (Figure 4.5a). When up to 16 colonies were
obtained from a nalidixic acid containing plate, the maximum number of genotypes
detected was only two (Figure 4.5c). A maximum of four different genotypes were
detected amongst 12 colonies from an ampicillin plate (Figure 4.5b). These results
are in contrast to those obtained for the unselective plates where six colonies on one
plate contained six different genotypes (Figure 4.5d). The within-sample diversity
appeared to level off at a maximum of four genotypes per sample in the ampR
population when up to 23 different colonies were obtained from a sample. In the
unselected population, within sample diversity was not consistent. Only one
genotype was found amongst 23 colonies from one sample, in contrast to the
detection of a different genotype in all of six isolates obtained from another sample
(Figure 4.5d).
4.3d Population diversity as a function ofcalfage
To determine if the number and types of commensal E. coli changed with calf age,
genotypes from calves 687, 690, 693 and 694 were studied in more detail. These
calves were selected for this analysis because they had a good spread of isolates over
at least four consecutive sampling dates since birth. None of the calves received any
direct antibiotic treatment during the sampling dates used in this analysis (see
materials and methods for treatment record details). Figures 4.6, 4.7, 4.8 and 4.9
show the genotypes detected from calves 687, 690, 693 and 694 respectively. The
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genotypes detected on each of the weeks after birth are given as a percentage of the
total number of isolates obtained on that date. In each graph, the x-axis is split into
two groups to present the genotype prevalence from the unselected (U) and selected
(S) (comprising ampR, aprR and nalR isolates) populations. All unique genotypes are
shaded in grey. The other genotypes are indicated with colours that are consistent
between the graphs. Below each figure is a table containing a breakdown ofwhich
genotypes were present in each of the unselected, ampR, aprR and nalR populations,




Number of isolates (Genotypes detected)
Total unselected ampR aprR nalR
17. 09. 01 0 24 24 (L)
26. 09. 01 1 14 9 (L,J,F) 4 (J) 1 (D)
01.10. 01 2 11 6 (J.F) 5 (J,F)
09. 10. 01 3 10 6 (S) 4(F)
17. 10. 01 4 19 4 (F,S,17) 4(F) 10 (A) 1 (E)
24 10. 01 5 10 10 (A)
12. 11. 01 6 3 3(A)
Figure 4.6 and Table 4.5 Figure 4.6 shows the genotype prevalence with calf age of
unselected (U) and selected (ampR, aprR and nalR) (S) isolates obtained from calf
687. Table 4.5 lists the dates of detection, exact numbers of each genotype and
populations from which they were isolated.
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No resistant isolates were detected within 48hrs of birth of calf 687 (week 0,
sampling date 17.09.02) (Figure 4.6). After one week, resistant isolates were
detected. The ampR genotypes J and F were detected in the selected population for at
least two consecutive weeks. These genotypes were both present in the unselected
population on more than one occasion, indicating a high prevalence of these strains.
The nalR isolate obtained in the first week was different to that obtained in the fourth
week (D and E respectively). The waves of different colours across Figure 4.6 are
indicative of different genotypes becoming the dominant type and then being




































Number of isolates (Genotypes detected)
Total unselected ampR aprR nalR
26. 09. 01 0 26 6 (W) 9 (R,K,D) 4 (B.2) 7(D)
01.10. 01 1 16 6(E) 5(E) 5(E)
09. 10. 01 2 27 6 (J) 6 (J) 15 (D,E)
17. 10. 01 3 15 9 (L) 6 (L)
Figure 4.7 and Table 4.6 Figure 4.7 shows the genotype prevalence with calf age of
unselected (U) and selected (ampR, aprR and nalR) (S) isolates obtained from calf
693. Table 4.6 lists the dates of detection, exact numbers of each genotype and
populations from which they were isolated.
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In contrast to calf 687, the most genotypic diversity within the commensal E. coli of
calf 693 occurred in the first sample (taken within 48h of birth) (Figure 4.7). On this
date, isolates were obtained from all four populations (unselected, ampR, aprR and
nalR). However, a week later (01.10.01), when isolates were obtained from the
unselected, ampR and nalR populations, all isolates were found to be of the same
genotype (E). The fact that this genotype accounted for all six of the isolates obtained
from an unselective plate indicates that this strain occurred at a high prevalence on
this date. This high prevalence of a strain resistant to ampicillin and nalidixic acid
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Calf age Number of Isolates (Genotypes detected)
Date (weeks) Total unselected ampR aprR nalR
26. 09. 01 0 26 6 (uniques) 6(J,8) 8(C) 6(D)
01.10. 01 1 9 5 (T,L,W) 4(0)
09. 10. 01 2 34 6 (L) 12 (AB,D) 16(D)
17. 10. 01 3 7 7(U)
Figure 4.8 and Table 4.7. Figure 4.8 shows the genotype prevalence with calf age of
unselected (U) and selected (ampR, aprR and nalR) (S) isolates obtained from calf
694. Table 4.7 lists the dates of detection, exact numbers of each genotype, and
populations from which they were isolated.
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Similar to calf 693, the greatest diversity of genotypes isolated from calf 694, is
observed from the sample taken within 48h of birth (26.09.01). In this sample,
isolates were obtained from unselective, ampicillin, apramycin and nalidixic acid
plates. In contrast to calf 693, the unselected isolates from the week 0 sample of calf
694 were all unique genotypes (genotypes only ever detected once).
The genotype diversity of calf 694 appears to decrease with increasing calf age in
both the selected and unselected populations. On the three dates when isolates were
obtained from both these populations, the resistant genotypes were never present in
the unselected population. This is in contrast to the detection of resistant genotypes
in the unselected populations of calves 687 and 693, and indicates that calf 694 has
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Calf age Number of isolates (Genotypes detected)
Date (weeks) Total unselected
R
amp aprR nalR
18. 09. 01 0 33 10 (24,18,19,AD,M) 23 (AA,J,H,3)
26. 09 01 1 14 2 (L) 12 (Q,J,H,11)
01.10. 01 2 28 5 (V.Q.W) 9 (Q,5) 2(A) 12(D)
09. 10. 01 3 31 6 (AC.W) 20 (0,D,G,J) 5(D)
17. 10. 01 4 19 4 (Z) 3 (0,D) 12(D)
24. 10. 01 5 13 9(D) 4(D)
29. 10. 01 6 4 4 (4,J)
12. 11. 01 7 1 1 (B)
19. 11. 01 8 1 1 (J)
Figure 4.9 and Table 4.8 Figure 4.9 shows the genotype prevalence with calf age of
unselected (U) and selected (ampR, aprR and nalR) (S) isolates obtained from calf
690. Table 4.8 lists the dates of detection, exact numbers of each genotype, and
populations from which they were isolated.
Examination of the unselected population of calf 690 revealed that the greatest
number of different genotypes is found in the first sample (18.09.01). There appears
to be a general trend towards decreasing diversity by week four (17.10.01). This
trend of decreasing diversity with increasing calf age was observed in samples
obtained from calf 693. The ampR population also appears to decrease in diversity
with increasing age of calf 690.
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Similar to calf 687, some genotypes appear on at least two consecutive sampling
dates and then disappear below the detection threshold (< lOOOcfu/mL) (e.g. H, D, O,
W and Z). Genotype J is found within the ampR population on six different sampling
dates. J is never detected within the unselected population suggesting that it is
present at a lower prevalence in calf 690 than in calf 693, where it was detected in
the unselected population. In contrast to calves 693 and 687, resistant genotypes are
only found in the unselected population on one occasion (01.10.01).
Overall, three genotypes (F, A and D) were found to persist for at least three
consecutive weeks in a particular calf. Eight PFGE types persisted for two weeks (L,
J, S, E, W, H, Q, and O). Forty-one genotypes (including unique types) were only
found on one sampling date in a given calf. To determine which genotypes were
detected in more than one calf, and which were unique to a calf, the presence or
absence of each genotype was listed in a table (Table 4.9). Blue shading indicates the
presence of a genotype, and no shading, the absence of a genotype. The unique
isolates were not included in this table because they were only found on one occasion
each, and so are by nature unique to each calf that they were isolated from (at the
detection level of the method, < 1000 cfu/mL).
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Table 4.9 Presence (blue shading) or absence (no shading) of genotypes detected in





































687 693 694 690
Table 4.9 shows that genotypes D, J and L were detected in all four calves, but the
majority of genotypes (18/25) were unique to the calf from which they were isolated.
To summarise the data presented in this section ofwork, the following observations
of the data were made:
1. The most genotypic diversity was observed in calves 693, 694 and 690 in the
first sample, and appeared to decrease with increasing calf age.
2. Only calf 687 did not harbour resistant isolates on the first sample.
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3. Genotypes isolated from antibiotic containing plates were detected in the
unseiected populations of calves 693 and 687 (and 690 on one occasion)
indicating a high prevalence of resistance in these calves.
4. Genotypes isolated from antibiotic containing plates were not detected in the
unseiected population of calf 694, indicating a lower prevalence of resistance
than in calves 693 and 687.
5. The majority of genotypes were unique to the calf from which they were
isolated, but genotypes D, J and L were detected in all four calves.
6. Genotypes F, A and D persisted for at least three weeks in at least one calf.
From the data presented in Figures and Tables 4.7 to 4.10, it was hypothesised that
genotypic richness (number of types detected) decreases with calf age, and that the
level of diversity was specific to a particular calf. When these hypotheses were tested
with the data from all 11 calves, genotypic richness was found to decrease with
increasing calf age (Fi,62 = 9.13, P = 0.004), but was not associated with specific
calves (Fio,52 = 1 -59, P = 0.14), sampling dates (Fj.6i - 2.63, P = 0.11), or population
(i.e. unseiected or selected populations) (Ft,6i = 0.024, P = 0.877). The rate of
decrease in genotype richness detected with increasing calf age was dependant on the
calf (Fh.43 = 3.20, P = 0.007), but not the sampling date (Fi,m - 0.55, P = 0.463), or
population (unseiected versus selected) (Fi,42= 0.46, P = 0.50).
4.3e Genotype diversity as afunction ofsampling dale
To explore the diversity amongst genotypes as a function of sampling date,
genotypes that were detected on more than one sampling date (not necessarily the
most abundant genotypes shown in Figure 4.4) were plotted against sampling date
for the unseiected, ampR and nalR populations (Figure 4.11, 4.12 and 4.13
respectively). The aprR population is excluded from this analysis as it is discussed in















































Figure 4.10 Genotype prevalence within the unselected population. Arrows indicate
sampling dates.
The most prevalent genotype (L) on 17.09.01 is not detected the following day
(18.09.01), instead AD is the most prevalent genotype (Figure 4.10). The samples
obtained from 17.09.01 and 18.09.01 are from different calves, therefore are likely to
reflect the differences in genotypes between these calves. Unfortunately, consecutive
samples from these two dates from the same calf were not available. After 18.09.01,
genotype L shows an overall increase in prevalence over the following 11 days. In
contrast, genotypes W and J peak on 26.09.01 and then tend to decrease to
undetectable levels on 17.10.01. These dynamics suggest that these more common
genotypes prevail for a few days but do not seem to appear and disappear below
detection threshold over the sampling period shown. The lack of samples between
the dates when samples were obtained means that any trends observed in this graph










Figure 4.11 Genotype prevalence's within the ampR population. Arrows indicate
sampling dates.
The overall impression of the genotypes within the ampR population is one of
dramatic fluctuations (Figure 4.11). Gradual increases or decreases in genotype
prevalence are rarely observed with this sampling protocol. Genotypes that appear to
vary between being present and absent on different sampling dates are likely to be
present at a prevalence that fluctuates around the detection threshold of the sampling
and detection methods.
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Figure 4.12 Genotype prevalence's within the nalR population. Arrows indicate
sampling dates.
The most common genotype in the nalR population is D. On one sampling date
(19.10.01) it was not detected, and type E is the only nalR genotype found (Figure
4.12). There appears to be a switching of the most prevalent genotype between
29.10.01 and 19.11.01. To prove this hypothesis, further sampling would be required.
4.4 Discussion
The majority of studies ofE. coli diversity have focused on pathogenic strains
(Hartman et al., 2003; Kerrn et al., 2002; Noller et al., 2003; 0rskov et al., 1990;
Shen et al., 1999; Whittam et al., 1993), but comparatively little is known about the
population structure of commensal E. coli. It is essential to determine the background
level of population diversity if valid conclusions are to be drawn as to the genetic
relatedness of groups of isolates within the E. coli genus (for example outbreak
strains, pathogenic strains or antibiotic resistant strains). This chapter aimed to study
different aspects of the population diversity of commensal E. coli isolated from
calves. Firstly, the genotype diversity within unselected populations and amp , apr
and nalR subpopulations was compared. Next, the diversity within genotype groups
(subtypes of a genotype) and diversity of genotypes within a faecal sample was
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examined. Finally, changes in the diversity of genotypes with calf age or with
sampling date were explored.
Before each of these sections ofwork is discussed, it is important to ascertain exactly
what is meant by the term diversity. Diversity may be expressed in three different
ways; the number of types of an organism (i.e. species richness), the evenness or
relative abundance of each type of organism, and the relatedness between groups of
organisms. There is no single measure capable of expressing each of these aspects of
diversity within a population. In this chapter, a combination of different approaches
was used to compare the genotype diversity of the unselected, ampR, aprR and nalR
populations.
4.4a Population diversity
Counting the number of genotypes detected within the unselected, ampR, aprR and
nalR populations revealed the unselected population to have the most number of
genotypes, and the nalR population to have the least. Only four more genotypes were
found in the unselected population compared to the ampR population, indicating a
high degree of diversity between strains resistant to the (3-lactam ampicillin.
Although plots of the number of lineages versus percentage similarity demonstrated
the genetic relatedness (or dissimilarity) between genotypes within these two
populations to be very similar, the spread of genotype abundance within the
unselected population was less even, therefore showed less diversity than the ampR
population. This emphasises the need to use different measures of diversity in any
assessment of diversity between two populations. Each measure on its own does not
provide all the information required to assess the three aspects ofdiversity described
at the start of this discussion. In agreement with this, Bohannan & Hughes (2003)
also recommend the use of a combination of different approaches to analyse diversity
in microbial communities.
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Similar to the high level of diversity found within the ampR population, Shen et al.
(1999) describe a wide genetic diversity amongst clinical isolates ofE. colt
producing extended-spectrum (3-lactamases (eight different PFGE patterns were
obtained from only 23 isolates). In the comparison of the four populations described
in this chapter, the nalR population was the least diverse. Similarly, fluoroquinolone
resistant E.coli from cancer patients were clonal within each patient (Oethinger et al.,
1998).
The reason for the different degrees of diversity within the resistant populations
studied is likely to be because of the mechanism of resistance harboured. Resistance
to P-lactam antibiotics is commonly plasmid-mediated (Datta & Kontomichalou,
1965; Heritage et al., 1999; Philippon et al., 2002). In addition to the ability to
develop resistance individually by mutations in genes controlling AmpC production,
resistance may be acquired by the acceptance of a resistance plasmid. A detailed
analysis of the diversity of the plasmids conferring ampR would confirm this. In
contrast, until recently resistance to the quinolones was never considered to be
plasmid mediated (Amyes et al., 1996), however evidence of a plasmid vector has
been found in isolates from China (Wang et al., 2003). Therefore, the most likely
way for a strain to acquire resistance is by mutation of the quinolone resistance
determining region of the DNA gyrase and topoisomerase II genes.
Although apramycin resistance is also plasmid-mediated, the genotypic diversity
within the aprR population is not as great as in the ampR population. It is likely that
ampR plasmids are more common because p-lactams are used more frequently on the
farm than aminoglycosides (see Chapter 2). Another factor affecting the spread of
plasmid-mediated resistance is plasmid host range. Are the ampR plasmids broad host
range plasmids and the aprR plasmids of a narrow host range? Some results on the
acceptance of aprR plasmids are presented in Chapter 5.
Various diversity estimates have been used previously to compare bacterial diversity
between different environments (Dunbar et al., 1999; McCaig et al., 1999; Sigler &
Zeyer, 2002). Simpson's diversity index measures the probability that two
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individuals from a population will be the same if the isolates are drawn at random.
This was considered an appropriate measure because it expresses the dominance of
one or two of the commonest species (or genotypes). The sampling protocol used in
this work was suitable for determining the commonest genotypes. In contrast, the
commonly used Shannon-Weaver diversity index is strongly affected by the
abundance of the genotypes present in the middle of a range of genotype abundances.
Although this measure has been applied to microbial populations (Dunbar et al.,
1999; McCaig et al., 1999; Sigler & Zeyer, 2002) it was considered inappropriate for
the bacterial populations described in this chapter because they contained a few
common genotypes and many rare ones (as demonstrated by the rank abundance
curves). The Shannon-Weaver diversity index assumes that the random sample taken
from the population represents all of the species in the population. This assumption
could not be even partly satisfied with this data set because of the extreme diversity
of the commensal E. coli population (see Figure 4.3) and the sampling protocol
adopted in this study.
Simpson's diversity index (D) ranges from 0 to 1. Values around 0 reflect the
dominance of a few genotypes, and values nearer 1 reflect a population containing
many different genotypes. The low D observed with the nalR resistant population
(D = 0.241) demonstrates the high dominance of a few genotypes. In contrast the
diversity of the ampR population was high (D = 0.899). This level of diversity is
comparable to that found amongst E. coli strains in piglets within the first week of
birth (mean D = 0.848) (Katouli et al., 1995).
Qualitatively, diversity as estimated by Simpson's was similar to the diversity
(defined as species richness) estimated by Chaol. Of 139 unselected E. coli
comprising 30 different genotypes, total genotype richness was estimated at 46
genotypes. This is substantially lower than the number ofE. coli predicted (predicted
n = 128) with the same richness estimate amongst 280 E. coli from a bovine feedlot
(Yang et al., 2004). However, the number of types detected will depend on the
typing method, the definition of a type, and the sampling effort. In the study of
bovine feedlot E. coli, PCR-based typing was performed and operational taxonomic
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units (OTUs) were defined with a cut-off of 85% similarity. Differences in
methodology and analysis mean it is difficult to compare diversity between studies.
Interestingly, Seurinck et al. (2003) conclude that generally 32 isolates per faecal
source were sufficient to characterise the richness of the E. coli within that source. In
the present study, a maximum of 24 isolates were obtained from any one faecal
sample, and so this hypothesis could not be challenged. However, bacterial
population dynamics are based on the ability to persist at low levels and then
increase when the selective environment favours the particular strain. It is possible
that there could be a dominant strain that is 100-fold more abundant than any of the
others, particularly if the environment favoured it. The other strains at lower
concentrations would remain undetected by Seurinck et aV s criteria.
There are two important problems associated with the use of statistical approaches to
estimate bacterial diversity. Firstly, they rely on estimates of relative abundances of
OTUs, which may be inaccurate because of sampling biases. In the present study, the
different numbers of isolates analysed from each sample may have introduced some
bias into the data. Bias may also occur because of differences in survival during
storage at 4°C between E. coli genotypes, prior to analysis. Secondly, the statistical
methods used in this chapter rely only on the information from the genotypes
observed and therefore cannot account for very rare genotypes. Although this will
result in an underestimate of the actual number of genotypes present within a sample,
they do provide a lower boundary of genotype diversity.
4.4b Genotype diversity
Subtypes within a genotype were identified in six of the 55 genotypes detected in the
commensal E .coli. The presence of subtypes within a genotype depends on the
interpretive criteria used to define a genotype. Commonly, criteria outlined by
Tenover et al. (1995) are used in defining PFGE types. The usefulness of these
definitions depend on the type of bacteria studied (more genotypic diversity may be
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expected between Streptococcus milleri group (Bartie et al., 2000) than between
enterococci isolates (Perlada et al., 1997)), the size ofgeographical area from which
isolates were obtained (isolates from different countries are likely to be less similar
than isolates from the same town unless they are related) and the diversity expected
between the isolates (diversity between E. coli 0157 is less than between commensal
E. coli isolates comprising many serogroups (Vali et al., 2004)).
In this chapter, a high degree of diversity was expected between the commensal
isolates because there was no (known) selection for specific serogroups. The
genotypes detected were highly diverse, with an uncountable number of band
differences between genotypes. Because the isolates were found to be so diverse, the
presence of types that differed from a genotype by up to two bands were considered
related to that genotype. Only by taking into account the background level of
diversity within the commensal population could this judgment be made. Similarly,
Foxman et al. (2002) established a high degree of diversity between E. coli from
pairs of heterosexual partners, which meant that finding the same genotype within a
couple was of significance. In this chapter, the criteria devised by Tenover et al.
adequately distinguished between different genotypes, which were highly dissimilar,
and subtypes within a genotype. The same interpretive criteria have been used to
characterise extended-spectrum (3-lactamase producing clinical E. coli (Shen et al.,
1999) and enterohaemorrhagic E. coli (Rios et al., 1999).
4.4c Within sample diversity
Increasing the numbers of colonies taken from a sample did not necessarily increase
the number of genotypes detected. In the ampR population increases in genotype
numbers appeared to level off at 12 picks (where a maximum of four genotypes were
detected in samples from which 12 to 23 isolates were obtained). The maximum
genotype richness in the unselected population was found when six isolates were
obtained, and increasing the number of isolates from a sample did not increase the
richness detected (up to 23 isolates per sample). Based on the shape of the rank
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abundance curve in Figure 4.4a it is hypothesised that a far greater number of rarer
genotypes would be detected were log fold increases in isolates examined. This
hypothesis is supported by the fact that when selection is applied to the commensal
population (i.e. plating onto ampicillin plates) almost as many different genotypes
are observed as in the unselected population (Figure 4.1c and d).
There appears to be no published data describing genotypic diversity of commensal
organisms within samples (faecal or other), although phenotypic diversity has been
described with 12 E. coli isolates from piglet faeces (Katouli et al., 1995). The
detection ofmore than one genotype in over half of the samples from the unselected
population (11/21) and in 19 of the 63 samples from the selected population has
important implications for the design of experiments intended to study genotypic
diversity in either antibiotic resistant or unselected bacterial populations.
4.4d Population diversity as a function ofcalfage
The genotypic diversity (number of types) was found to decrease significantly with
calf age (irrespective of whether the selected or unselected population was studied).
This result contrasts with that of Katouli et al. (1995), where the mean number of
faecal E. coli biochemical phenotypes found in piglets increased as the animals aged.
Similar to Katouli et al, most types were found to be transient and were replaced by
new types in the following samples. Genotypes F, A and D were found to persist for
at least three weeks. These genotypes may have been better able to colonise and
maintain their populations in the calf intestine than the majority of genotypes (n =
44), which were not detected on consecutive sampling dates. Colicin resistance has
been found in established strains of E. coli (Ofek et al., 1977), which was thought to
aid persistence in the lower intestine.
Alternatively, genotypes F, A and D, may simply have been the first to colonise the
calves. Freter et al. (1983) describe difficulties in implanting E. coli in the mouse
intestine when established intestinal flora are present. In contrast, when the E. coli
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are inoculated first, then the caecal flora, stable E. coli populations persist
indefinitely.
4.4e Population diversity as a function ofsampling date
The changes in PFGE types (detected on more than one occasion) did not show any
general trends during the sampling period. The sampling protocol of approximately
weekly sampling was not frequent enough to determine how genotype prevalences
changed with time. A general impression of dramatic fluctuations of genotype
prevalence was observed with both the unselected and ampR populations. Similarly
successive waves of phenotypically different E. coli have been found to colonise the
intestine of piglets (Katouli et al., 1995), although the sampling protocol of this study
was less frequent than that described in this chapter.
The most prevalent nalR genotype (D) appeared to be succeeded by a different
genotype (E), but because 14 days had elapsed between the sampling dates when D
was detected at a high prevalence, and the sampling date when a high prevalence of
E was found, the dynamics of this switching of types are not clear.
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4.5 Concluding remarks
Problems arose in analysing the diversity based on genotype prevalence, because the
numbers of isolates obtained form each sample ranged from one to 24. A better
protocol would be to spread diluted samples evenly over each agar plate, and to pick
equal numbers of colonies from each plate showing growth. In addition, weekly
sampling was found to be inadequate for studying the fluctuations of different
genotypes with time. More frequent sampling (at least daily) is suggested for future
analyses.
In this chapter a high degree of diversity amongst calf faecal commensal E. coli, in
terms of the total number of different genotypes detected, the evenness of spread of
types, and the genetic relatedness of genotypes was detected. Referring back to the
original aims of the chapter, this work demonstrated the following:
1. Different genotypes were hypothesised to be present within one faecal
sample. This was shown to be true in many but not all samples (11/21
unselected samples, 19/63 selected samples).
2. The statistical predictions of diversity produced qualitatively reasonable
estimates, although the predicted numbers of genotypes are likely to be
underestimates of the actual numbers present because they rely only on the
number of genotypes observed. In this way, very rare classes are ignored
because they are present below the detection threshold of the method. Rare
classes may only be "rare" at the time of sampling because genotypes were
found to fluctuate dramatically with time. On another sampling date, or
following a change in feed, environment, housing or treatment, rarer types
may be selected into becoming dominant types.
3. It was hypothesised that population diversity would differ between the
resistant populations because the mechanisms by which bacteria may acquire
resistance is different. The diversity observed differed between the four
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populations, but the diversity between the unselected and amp populations
were surprisingly similar. This was thought to be because ampicillin
resistance is commonly plasmid mediated. The greater number of ampR
genotypes compared to the aprR genotypes may reflect differences in the
number and host range of these two types of resistance plasmid. In addition,
the number of resistance genes that confer ampicillin resistance are numerous
(Amyes et al., 1996), in contrast to the single gene found to confer apramycin
resistance (Shaw et al., 1993).
4. The E. coli population diversity was hypothesised to decrease with calf age
because the first colonisers, which did not have to compete for space and
nutrients, would be out competed by genotypes better able to adapt to a more
crowded and resource limited environment. Diversity (number of genotypes)
was found to decrease significantly with increasing calf age, but was not
significantly associated with sampling date.
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Chapter 5. Molecular mechanism of apramycin resistance
5.1 Introduction
In 1978 the aminoglycoside apramycin was licensed for veterinary use in the United
Kingdom, and has since been used extensively in animal husbandry (Hunter et al.,
1992). Although this antibiotic has not been used in human medicine, apramycin
resistance has been detected in human isolates of Salmonella typhimurium (Chaslus-
Dancla et al., 1989), Klebsiella pneumoniae (Johnson et al., 1995) and E. coli
(Johnson et al., 1995; Hunter et al., 1993). Resistance to apramycin is conferred by
the production of the aminoglycoside-modifying enzyme, 3-jV-aminoglycoside
acetyltransferase type IV (AAC(3)IV) (Davies & O'Connor, 1978) which has been
found on diverse conjugative plasmids (Piatt & Smith, 1991; Pohl et al., 1993). A
high degree of genetic homology has been detected between plasmids harbouring
AAC(3)IV isolated from bacteria of human and animal origin (Chaslus-Dancla et al.,
1991). In addition to the acetylation of apramycin, AAC(3)IV also acetylates
tobramycin and gentamicin, which are used to treat serious infections in humans
(Amyes et al., 1996). Recently, 7% ofE. coli isolated from calf enteritidis faecal
samples in Scotland were found to be resistant to apramycin (Gunn & Low, 2003).
The aim of this study was firstly to determine whether calves that had not been
treated with aminoglycosides harboured apramycin resistant (aprR) commensal E.
coli, and secondly to study the molecular epidemiology of the resistance genes to this
antibiotic.
5.2 Materials and Methods
5.2a Bacterial isolates
Apramycin resistant E. coli isolates (n = 45) obtained as described in chapter 2 were
examined in this study.
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5.2b Antibiotic sensitivity
Minimum inhibitory concentrations (MICs) of ampicillin, apramycin, gentamicin,
streptomycin, sulphamethoxazole, tetracycline (Sigma, Poole, UK) and tobramycin
(Faulding Pharmaceuticals, Warwickshire, UK) were determined using a multipoint
inoculator to replicate test cultures onto antibiotic-containing Isosensitest agar plates
(Oxoid CM471) at 104-105 cfu/spot, following BSAC guidelines (Andrews, 2001).
The MIC was defined as the lowest concentration of antibiotic to give complete
inhibition of bacterial growth after incubation at 37°C for 18 hours.
Control organisms (NCTC10418, NCTC10662 and NCTC6571) were included to
detect any errors in the preparation of antibiotics or plates, and all isolates were
inoculated onto agar plates containing no antibiotic to ensure that any inhibition of
growth on test plates was due to the presence of the antibiotic.
5.2c Pulsed-field gel electrophoresis
PFGE typing as described in Chapter 4 was used in this study.
5.2d Conjugation experiments
Apramycin resistance plasmids were transferred by conjugation into a rifampicin
resistant E. coli J62-2 (pro" his" trp") (Bachmann, 1972) by incubating a 1:100 ratio of
donor to recipient, in nutrient broth (Oxoid) at 37°C for 7 hours (method adapted
from Provence & Curtiss, 1994). Transconjugants were isolated and purified on
MacConkey plates (Oxoid) incorporating 20mg/L rifampicin and 16mg/L apramycin.
Transfer frequencies, completed in triplicate, were defined as the proportion of
transconjugants over total number of donors (D) at the start ofmating (Provence &
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Curtiss, 1994) and were measured between J62-2 (D) and the related auxotroph J53
(pro" met") (Bachmann, 1972). Overnight nutrient broth (NB) (Oxoid) cultures of
donor and recipient were incubated in NB at 37°C in a 1:100 ratio respectively, for 7
hours (Provence & Curtiss, 1994). Transconjugants were selected on Davis Mingioli
plates (DM) supplemented with 16mg/L apramycin, 50mg/L proline and 50mg/L
methionine. Average transfer frequencies were compared to those of the well-
characterised plasmids RP4 (Datta et al., 1971) and R46 (Brown & Willetts, 1981)
using the same mating protocol.
The recipient ability of 28 different genotypes of commensal E. coli from the
unselected population was measured by repeat conjugation experiments with J62-2
harbouring plasmid pUK2001. The same 7 hr mating protocol was used as that
described above. Transconjugants were selected on DM plates containing no amino
acids and 16mg/L apramycin.
5.2e Plasmid analysis
Plasmid DNA was extracted from J53 transconjugants using a Maxiprep kit (Qiagen)
and restricted with £coRI and Apal (Promega) according to the manufacturer's
instructions. Gels were stained with ethidium bromide as described earlier.
Plasmid size estimates were determined by comparison to the standard plasmids
harboured by E. coli 39R861 and E. coli V517.
5.2fAmplification ofthe aac(3)IVgene
Primers 5'-GTCGTCCAATACGAATGGCG-3' and 5'-
CAGCAATCAGCGCGACCTTG-3' were used to amplify the region between base
pairs 241 to 1076 of the published aac(3)IV gene (GenBank X01385) (Brau et al,
1984) from purified plasmid DNA. DNA was denatured for 5 min at 94°C, followed
by 30 cycles of 1 min denaturation (94°C), 1 min anneal (55°C), and 1 min extension
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(72°C). Sequencing was performed by chain termination (Sanger et al., 1977) in both
directions and compared to the published sequence (Brau et al., 1984).
5.2g Statistical analysis
Statistical analysis was performed with S-Plus (Insightful, Seattle). Analyses of the
carriage of apramycin resistant E. coli (presence/absence) by the 11 calves was
performed using generalised linear mixed effects models, with binomial errors. Calf
identity was entered as a random effect to account for both inherent differences
between calves and the lack of independence between samples. Time and calf age
were entered into separate models as fixed effects.
5.3 Results
5.3a Detection ofaprR E. coli PFGE types
Although no aminoglycoside antibiotics were used on the 11 calves sampled in this
study, six calves harboured aprR E. coli (>1000 cfu/mL) during the four months
sampling period. Detection dates, calf identities, antibiotic treatment records and
genotypes of aprR E. coli are listed in Table 5.1.
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Table 5.1 Calves from which aprR E. coli were isolated, calf antibiotic treatments
and age, dates of aprR E. coli detection, and number and genotype of aprR isolates.
Calf Treatment (date) Sampling dates of AprR E. coli PFGE types
aprR E.coli detection isolates (number of each type)
690 None 01/10/2001 2 A (2)
12/11/2001 1 B (1)
687 None 17/10/2001 10 A (10)
24/10/2001 10 A (10)




26/09/2001 4 B (3), E (1)
694 None 26/09/2001 8 C (8)
696 None 12/11/2001 6 A (1), B(4), D (1)
698 enrofloxacin (01/10/2001) 10/12/2001 1 A (1)
From four calves (693, 694, 696 and 698), aprR E. coli were found on only one
occasion (Table 5.1). The analysis of carriage of aprR E. coli by the 11 calves
revealed that the detection of aprR E. coli was not related to calf age (F i=139 = 1.26, P
= 0.26), or sample date (Fi,i39= 1.22, P = 0.27). To ensure that those calves for
which aprR E. coli were never detected were not biasing the analysis, models were
repeated with only calves that were found to harbour aprR E. coli during the sampling
period. These repeat tests yielded similar F and P values for the effect of age (F1J3 =
0.74, P = 0.39), or sample date (F1J3 = 1.33, P = 0.25) on the presence of aprR E.
coli.
Forty-five aprR E. coli were isolated. Genotyping of the isolates by PFGE revealed
that the aprR population was not clonal, and comprised five distinct genotypes
(Chapter 4, Figure 4.1a).
The majority (7/9) of samples contained only one genotype (Table 5.1). Two calves
(690 and 687) were found to harbour aprR E. coli on more than one occasion. Calf
690 carried different genotypes on the two dates where aprR E. coli were detected,
whereas calf 687 harboured the same genotype on all dates of detection. PFGE type
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A was the most common genotype and was found in four of the calves. Genotypes C,
D and E were only found on one sampling date each. To determine if genotypes were
associated with specific sampling dates, the prevalence of each genotype was plotted















Figure 5.1 Dates of detection and prevalence's of the five different aprR E. coli
genotypes.
On four of the six dates on which aprR E. coli were detected, the only genotype
present was PFGE type A. All isolates of this genotype (n = 27) were found to have
the same resistance phenotype (resistant to tetracycline, sulphamethoxazole,
apramycin, tobramycin and gentamicin). On two sampling dates (26/09/01 and
12/11/01) more genotypic diversity (three different genotypes) was present. These
are the only two dates on which aprR E. coli were isolated from more than one calf.
P. 3b Plasmid analysis
Plasmid profiling with EcoK\ revealed three different plasmids, designated
pUK2001, pUK2002, and pUK2003, of size 91Kb, 115Kb and 181Kb respectively.
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The EcoRl restriction profiles of these plasmids are shown in Figure 5.2. Plasmid
types were confirmed with Apal restriction (results not shown). pUK2002 and
pUK2003 were found in only one genotype each, but pUK2001 was found in three
different genotypes indicating horizontal spread. It was not possible to restrict
plasmid pUK2003 despite repeated attempts, but the different sizes and transfer
frequencies (described below) indicate that pUK2003 and pUK.2002 are different
plasmids.
Plasmid restriction Calf Plasmid Host genotype
Figure 5.2 EcoRl plasmid types and the host genotypes from which they were
isolated.
5.3c Transferfrequencies
All three apramycin resistance plasmids were conjugative. Transfer frequencies were
measured between the E. coli K12 derivatives J62-2 and J53, using the different
auxotrophisms of these strains as a selective mechanism. The transfer frequencies of





LEOI .0696 pUK2002 Unique
LE01.0690 pUK2003 B
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Table 5.2 Plasmid transfer frequencies of pUK2001, pUK2002 and pUK2003,
measured on different antibiotic containing selective plates.
Plasmid Selective plate Transfer frequency
pUK2001 16mg/L apramycin 4.19 x 10~2
pUK2002 16mg/L apramycin 1.73 x 10"3
lOmg/L tetracycline 1.57 x 10"3
16mg/L apramycin + lOmg/L tetracycline 1.37 x 10"3
8mg/L streptomycin 1.87 x 10"3
16mg/L apramycin + 8mg/L streptomycin 2.02 x 10"3
pUK2003 16mg/L apramycin 4.64 x 10"6
1 Omg/L tetracycline 4.27 x 10"6
16mg/L apramycin + 1 Omg/L tetracycline 5.18 x 10"6
8mg/L streptomycin 4.41 x 10"6
16mg/L apramycin + 8mg/L streptomycin 4.27 x 10*
RP4 1Omg/L tetracycline 1.0 x 10"4
R46 1Omg/L tetracycline 2.1 x 10'5
Plasmid pUK2001 transferred at the highest frequency (4.19 x 10"), which was
substantially greater than that of the standard plasmids RP4 and R46 (Table 5.2).
Plasmid pUK2002 also transferred at a frequency faster than the standard plasmids
(Table 5.2). The similar transfer frequencies observed when pUK2002 or pUK2003
were selected on tetracycline, streptomycin or these antibiotics in combination with
apramycin, indicate that tetracycline and streptomycin resistance determinants are
also carried by these two plasmids. This was supported by measuring the MICs of the
donor strains, recipient J53, and transconjugants.
Table 5.3 shows the MICs of the recipient strain J53, the original donor strains
(WF006555Y17 to WF007225Y01), and the transconjugants. The plasmid harboured
by each of the donors is listed in the second column.
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Table 5.3 MICs ofwild type aprR E. coli donor isolates and the transconjugants
formed after the conjugation of the aprR plasmids into J53.
Isolate / strain Plasmid MIC (mg/L)
APR TOB GNT STP AMP TET SUL
J53 2 0.25 0.25 2 4 1 8
WF006555 Y17 pUK2001 >128 64 16 2 4 2 8
WF006562 Y14 pUK2001 >128 32 8 2 4 2 8
WF006716 Y17 pUK2001 >128 32 8 16 4 128 >128
WF007204 Y15 pUK2002 >128 16 8 32 4 >128 8
WF007225 Y01 pUK2003 >128 16 8 32 >128 >128 >128
pUK2001 in J53 pUK2001 >128 16 8 2 4 1 8
pUK2002 in J53 pUK2002 >128 16 8 16 2 >128 8
pUK2003 in J53 pUK2003 >128 16 8 16 2 >128 8
APR, apramycin; TOB, tobramycin; GNT, gentamicin; STP, streptomycin; AMP, ampicillin; TET,
tetracycline; SUL, sulphamethoxazole.
In addition to apramycin resistance (MIC >128 mg/L) all three plasmids conferred
resistance to tobramycin and gentamicin (MICs of 16 and 8 mg/L respectively).
Plasmids pUK2002 and pUK2003 also conferred resistance to streptomycin (MIC of
16 mg/L) and tetracycline (MIC >128 mg/L).
The ability of other commensal E. coli from the unselected population to accept
plasmid pUK2001 was studied in 28 different genotypes. Of these, 14 were able to
receive pUK2001. The frequencies at which this plasmid was transferred to these 14
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Figure 5.3 Mean transfer frequencies of pUK2001 into 14 different recipients from
the unselected E. coli commensal population. Error bars show + 2x the standard
deviation.
The transfer frequencies of pUK2001 into different commensal E. coli from the
"3 o
unselected population ranged from 2.03 x 10" to 3.43 x 10" (Figure 5.3). Fourteen
strains were unable to accept the plasmid. Of the 14 strains able to accept pUK2001
in vitro, seven were isolated from samples that also contained genotypes carrying
pUK2001. Two genotypes (6947-1 and 6947-3) were isolated from a sample from
which genotypes presumed to carry pUK2001 were present. This presumption is
based on the fact that the presumptive aprR carriers had identical PFGE patterns to
isolates from which pUK2001 was actually extracted, although a plasmid extraction
was not carried out on an aprR isolate from this sample.
5.3dAmplification ofthe aac(3)IV gene
PCR with primers based on the published aac(3)IV sequence (Brau et al., 1984)
yielded a product of the expected size (836bp). A comparison of the sequenced
104
products with the published aac(3)TV gene revealed that all three plasmids harboured
this gene. The sequence of each product was identical to that of the published
nucleotide sequence.
5.4 Discussion
Although the detection of aprR bacteria isolated from food-producing animals and
humans has been reported previously (Chaslus-Dancla et al., 1989; Hunter et al.,
1992; 1993; 1994; Johnson et al., 1994; 1995) these reports have concentrated on
organisms that are pathogenic either to humans or animals. Little is known about the
epidemiology of resistant commensal bacteria, which constitute a huge reservoir of
resistance genes (Schwarz et al., 2001). In this study, PFGE and detailed molecular
typing of the resistance mechanism were combined to give a better understanding of
the epidemiology of apramycin resistance.
A cohort of calves that had not been treated with any aminoglycosides was selected
for this work, to avoid any direct selection of aprR E. coll during the study. During
the four months sampling period, six of the 11 calves sampled were found to carry
aprR E. coli on one or more sampling dates. The presence of aprR E. coli was found
to be unrelated to calf age or sampling date. This is in contrast to the detection of
ampicillin resistant E. coli, which are significantly more prevalent in new-born and
young calves (Hoyle et al., 2004). Similarly, other workers report a higher incidence
of antibiotic resistance amongst bacteria isolated from calves than from older animals
(Hinton et al., 1985; Linton, 1977a).
The farm, from which the isolates in this study came, had not used apramycin since
at least July 2000 (the date from which records of drug usage on the farm were kept).
During this time only one calf (not sampled in this study) was treated with Penstrep
(see Chapter 2), a combination drug containing penicillin and streptomycin.
Although streptomycin resistance is conferred by a different resistance mechanism
(enzymatic phosphorylation or adenylation of the antibiotic) to that conferring
105
apramycin resistance (antibiotic acetylation) (Shaw et al., 1993), plasmids pUK2002
and pUK2003 also carry streptomycin resistance, which may indicate cross-
contamination of either strains or antibiotics between calves.
The presence of aprR plasmids in the calves in this study demonstrates the persistence
of apramycin resistance without recent selection by apramycin. A similar result has
been reported in E. coli from disease outbreaks in pigs (Hunter et al, 1994).
Antibiotic usage in cattle is dramatically less than the quantities used in pigs
(Veterinary Medicines Directorate, 2001), and so the detection of APR resistance in
the commensal flora of calves is of significance.
A total of 45 aprR E. coli were obtained from the six calves. The genotypic diversity
amongst these isolates was examined using PFGE, which has previously only been
applied to pathogenic aprR organisms. Amongst the 45 isolates, five distinct
genotypes were found. Because APR resistance is commonly found to be mediated
by transferable plasmids (Hunter etal., 1992; 1994; Johnson et a/., 1994; 1995)
(although the putative presence of the aac(3)IV gene on the chromosome has been
reported by Johnson et al., 1994) genotypic diversity amongst aprR E. coli was
expected to be high (compared to a non plasmid-mediated resistance mechanism
such as quinolone resistance). Johnson et al. (1994) reported different serogroups
amongst clinical isolates of aprR E. coli, which is consistent with our findings of
genotypic diversity within the aprR E. coli population. Similarly, aminoglycoside
resistance amongst different salmonella serotypes (Wray et al., 1986) and
genotypically diverse enterococci isolates has been described (Donabedian et al.,
2003b; Papaparaskevas et al., 2000). Further PFGE studies on a greater number of
isolates would be required to determine the extent to which apramycin resistance
plasmids have spread to different E. coli genotypes.
The most prevalent apramycin resistant genotype (type A) was detected on five of
the six dates where aprR E. coli were recovered. This genotype was also resistant to
tetracycline and sulphamethoxazole in addition to the aminoglycosides tested. The
high prevalence of this strain in calves that have never been treated with tetracycline,
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sulphamethoxazole or aminoglycosides shows the signature of antibiotics used
previously or the cross-contamination of resistant strains within the farm.
The sampling dates where more genotypic diversity was detected were those in
which aprR E. coli were recovered from different calves. This would suggest that the
intestinal flora of each calf differs in the prevalence and range of genotypes present.
This hypothesis is supported by Howe et al. (1976a; 1976b), where a total of 103
different O-antigen serotypes of commensal E. coli were found colonising the
intestines of calves. Different selective forces may be exerted on each ecosystem,
such as the use of antibiotics, disinfectants, initial colonisation of the gut by different
micro-organisms, and the production of bacteriocins by other flora colonising the
intestine. Any aprR E. coli present will be subject to these selective pressures and are
therefore likely to differ between calves. The study of the predominate genotypes in
cattle, and any associations between genotype and animal, would require the
genotyping of aprR E. coli from a larger cohort of animals. Work is currently
underway to address this issue.
Restriction analysis of the apramycin resistance plasmids from the five aprR
genotypes demonstrated that the gene conferring resistance was carried on diverse
plasmids. Similar findings have been reported in pathogenic bacteria, based on
incompatibility groups (Wray et al., 1986) and restriction endonuclease
fragmentation pattern (Piatt & Smith, 1991; Pohl et al., 1993). Sequencing analysis
of the aac(3)IV gene revealed identical genes in all aprR plasmids. This degree of
plasmid diversity and gene homology suggests that the aac(3)IV gene is carried on a
transposable element. Previously, the aac(3)IV gene has been found to be associated
with insertion sequences (Brau et al., 1984; Salauze et al., 1990) which is compatible
with this hypothesis. This would greatly increase the potential for dissemination of
the gene to different replicons.
The aprR plasmids were all conjugative. The frequency at which the transfer of aprR
plasmids occurs is rarely measured, but one study has measured transfer frequencies
of aprR plasmids isolated from E. coli and salmonellae isolated from disease
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outbreaks of cattle, pigs, sheep and poultry (Wray et al., 1986). Two AprR E. coli
isolates from diseased cattle were found to transfer apramycin resistance at
frequencies of <10"8 and <10"10 transconjugants per donor overnight. Higher transfer
frequencies were detected in three aprR E. coli isolated from pigs, where frequencies
of 10" and 10" per donor were detected when the plasmids were transferred to
secondary recipients during a one hour mating (Wray et al., 1986). A seven-hour
mating was required to give the similar transfer frequencies detected for plasmids
pUK2001 and pUK2002 in this work. In the following chapter, mating times of one
hour were studied, which are directly comparable with those described by Wray et al.
(1986). In addition to these high transfer frequencies, the use of PFGE to genotype
each isolate allowed the detection of one plasmid (pUK2001) in three different
genotypes. To the best ofmy knowledge, this is the first report of horizontal spread
of apramycin resistance in commensal organisms.
The ability of wild type isolates to accept aprR plasmids has not been studied
previously, and there are very few publications in which the recipient ability ofwild-
type strains is assessed. Of 28 different genotypes of commensal E. coli from the
unselected population, 14 were able to accept pUK2001. Of interest is the fact that
nine of these recipients were isolated from samples in which isolates containing (or
presumed to contain for two isolates) pUK2001 were present. The donor and
recipient genotypes are likely to be at similar cell densities within the calves because
they were isolated from the same diluted sample. These results indicate that there are
barriers to in vivo conjugation that may not be present in vitro. Resource limitation
and conditions of stress have been found to decrease the rate of plasmid transfer
(Arana et al., 1997; Curtiss et al., 1969; Muela et al., 1994), and the use of rich
media has been shown to increase the probability ofmating pair formation compared
to minimal media (Curtiss et al., 1969). Some kind of selective pressure may be
required in order for the donor bacterium to expend energy and resources in
transferring its plasmid. This may have been the use of apramycin many years ago,
or resistance to disinfectants or feed supplements, resulting in the spread of
pUK2001 into three different genotypes. The calfmay have acquired other genotypes
capable of accepting the plasmid at a later date, but without any selective pressure
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the plasmid may just remain in these three genotypes only. Alternatively, the trigger
for transfer may be related to growth phase, and other workers have shown that
donor ability is greatest during exponential phase growth (Curtiss et al., 1969). The
dynamics of plasmid transfer are discussed in more detail in Chapter 6.
The selective pressures maintaining these large conjugative resistance plasmids in
the commensal flora are not clear. The calves sampled were not treated with
aminoglycosides or tetracyclines. The presence of pUK2002 and pUK2003 suggests
that the spread of plasmids or resistant strains resulted from previous tetracycline or
streptomycin use. pUK2001 only carried apramycin resistance. The selective force
driving the spread of this plasmid may be previous farm usage of apramycin, or the
employment of disinfectants or feed supplements on the farm. Sequencing of the
plasmids, which is currently underway, may reveal the presence of such resistance
determinants. Unfortunately, it was not possible to determine when in the
evolutionary history of the strains acquisition of pUK2001 occurred.
The presence and spread of aprR plasmids in commensal E. coli, under unknown
selective pressures, poses important implications for the transmission of this
resistance determinant into clinical bacteria.
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Chapter 6. The study of plasmid dynamics
6.1 Introduction
In the previous chapter, the transfer frequencies of each apramycin resistance
plasmid found in the calf faecal commensal E. coli population were defined as the
number of transconjugants divided by the number of donors at the start ofmating
(Provence & Curtiss, 1994). The initial density of the donors and recipients, and the
time permitted for mating, were kept constant to allow an accurate comparison of
transfer frequencies between the aprR plasmids, and with the well-characterised
plasmids RP4 and R46.
In this chapter, a second method of quantifying plasmid transfers originally described
by Simonsen et al. (1990), was used. The method, designated the end-point method,
is described by the authors as one which "overcomes the shortcomings of previous
techniques because it is not affected by cell density, donor: recipient ratio and mating
time".
There are three reasons for calculating the plasmid transfer frequencies by two
different methods. Firstly, this allows a comparison of the methods to determine the
advantages and disadvantages of each. Secondly, different researchers have used a
variety ofmethods to calculate plasmid transfer frequencies, and so the use of two
methods allows a comparison of transfer frequencies with a greater number of
published results than if only one method was used. Lastly, the results from the end-
point calculation may be incorporated into a mathematical model, originally
presented by Levin et al. (1979). The model describes bacterial cell growth and
plasmid transfer in batch culture, and may be used to explore the dynamics of
plasmid transfer by altering input variables and observing their effects.
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This chapter aims to address the following questions:
1. In what manner do plasmid transfer frequency estimates vary as a function of
mating time?
2. What are the advantages and disadvantages of each technique?
3. How do the transfer frequencies/rates measured by each of the methods
compare?
4. Does the published model of bacterial cell growth and plasmid transfer fit the
experimental data of pUK2002 transfer in batch culture?
5. If the model does not fit, what biological processes are occurring which are
not taken into account by the model?
6. Can the model be used to address questions of plasmid persistence in natural
populations?
6.2 Materials and Methods
6.2a Bacterial strains andplasmids
The plasmids used in this comparative study were the aprR plasmids identified in
Chapter 5 (pUK2001, pUK2002 and pUK2003). The plasmid pUK2002 was chosen
for the more detailed study of variation within and between the two methods of
calculating plasmid transfer frequencies. This plasmid was chosen because it had an
intermediate transfer frequency in relation to the other aprR plasmids, and the transfer
frequency measured in Chapter 5 indicated that this plasmid was unlikely to be
derepressed for transfer. To determine plasmid transfer rates by the end-point
method, plasmids were maintained in E. coli K12 strain J53 (pro' met') (Bachmann,
1972). The E. coli K12 strains J62-2 (lac-, pro' trp' hist') (Bachmann, 1972) and
MG1655kan (A lac, KmR) were used as recipients.
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6.2b Conjugations
To explore the effect ofmating time on the estimates of plasmid transfer frequency,
transfer frequencies were determined as described in Chapter 5, but over mating
times of 1, 7, 10 and 16 hours. To determine rates of plasmid transfer as estimated by
the end-point method, matings were carried out in 50 ml Erlenmeyer flasks
containing 10 ml LB (Lennox L broth) (Invitrogen). Overnight cultures of donor and
recipient were diluted 1:10 in saline and used to inoculate the flasks, to give an initial
density of approximately 1 x 106 cfu/ml and a 1:1 ratio of donors to recipients. The
cultures were incubated at 37°C with shaking at 150 rpm, and sampled at 30 min
intervals after initial inoculation (t = 0) for six hours. Donor, recipient and
transconjugant cell densities were estimated by serial dilution in saline and selective
plating. In matings between J53 and J62-2, donors were selected on Davis Mingioli
(DM) plates supplemented with 50mg/L proline and 50mg/L methionine. Recipients
were selected on DM plates with 50mg/L proline, 50mg/L tryptophan and 50mg/L
histadine, and transconjugants selected on MacConkey plates containing 16mg/L
apramycin and 20mg/L rifampicin. When plasmids were transferred between J53 and
MG1655kan, donors and recipients were distinguished by colony colour on the same
plate. Here S-gal plates (Sigma) were used, which contain a chromogenic B-
galactosidase substrate. Cleavage of this substrate results in the black coloration of
colonies. Recipient cells MG1655kan have a deletion of the lacZ gene, resulting in
the presence ofwhite colonies. Transconjugants were selected on S-gal plates
containing 40mg/L apramycin and 32mg/L kanamycin. Growth rate estimates were
based on the average of three replicates. The exponential phase population growth
rate was assumed to be the average of the individual growth rates of the donor and
recipient, again based on three replicate experiments.
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6.2c Estimates ofplasmid transfer frequencies and rates
Plasmid transfer rates were estimated as a function of the cell densities of donors (D),
recipients (R) and transconjugants (7), during exponential growth, in accordance









Where vj/ is the average growth rate per hour of the two strains (.D and R) involved in
the mating during exponential growth, N, the total cell density at the time of
sampling, and No, the total cell density at the start ofmating.
Plasmid transfer frequencies were also determined as the number of transconjugants
to donors at the start ofmating, as described in chapter 5. Although this method is
often quoted as the T/D ratio, mathematically this is not strictly a ratio because T and
D are measured at different time points during the experiment (T is measured at the
end of the mating and D, at the start). To make clear this distinction, the transfer
frequency as estimated by this method will be referred to as T/D0.
6.2d Model theory
The model used to explore this system was that presented by Levin et al. (1979) to
describe cell growth and plasmid transfer in a batch mating culture. Here, changes in
the densities of donors, recipients and transconjugants due to cell growth and plasmid







^ = y(c)-T + r(c)R(D + T)
Equation 5.
= -i//(c)(r + D + T)e
Where D, R and T are the densities (cfu/ml) of the donors, recipients and
transconjugants respectively. vKC) is the growth rate per hour, y/, at a given
concentration, C, of resource (mg/L), and e (pg) the amount of resource required to
make a new cell. The exact concentration of resource in 10ml LB could not be
calculated, so an estimated concentration of 500 pg/mL was used in the model, based
on trial and error against experimental results. The plasmid transfer rate constant, y,
(ml per cell h'1) is calculated as described above. Growth rates and plasmid transfer
rates are assumed to be Monod functions (Monod, 1949) of resource concentration





Here, y/max and ymAX are the maximum growth and plasmid transfer rates respectively,
and 0, the half saturation constant (mg L"1).
There are four basic assumptions of the model, which are summarised as follows:
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1. Mating occurs randomly with a frequency that is jointly proportional to the donor
and recipient densities, and independent of bacterial growth rates.
2. Plasmids are not lost by segregation.
3. Transconjugants are immediately able to transfer the plasmid at the same rate as
donor cells.
4. All clones grow at the same rate.
Model simulations were produced with Berkley Madonna1 M differential equation
solving package (www.berkleymadonna.com).
6.2e Growth curves
Growth curves were measured in 50 ml Erlenmeyer flasks containing 10 ml LB
(Lennox L broth) (Invitrogen). Overnight cultures of plasmid-harbouring J53
(J53pUK2002) were diluted 1:10 in saline and used to inoculate the flasks, to give an
initial density of approximately 1 x 106 cfu/ml. Cultures were incubated at 37°C with
shaking at 150 rpm, and sampled at 30 min intervals since initial inoculation (t = 0)
for 5.5 hours. Cell densities were estimated by serial dilution in saline and selective
plating onto MacConkey plates supplemented with 16mg/L apramycin.
6.2fStatistics
To analyse the variation in plasmid transfer frequencies as a function of time and
plasmid, analysis of variance and multiple linear regressions were performed. In all
tests, the number of degrees of freedom is written as a subscript of the test statistic
and a significant result was recorded ifP < 0.05. Linear mixed effects models were
used to test whether log-transformed transfer rates differed significantly with mating




6.3a Effect ofmating time on estimates ofplasmid transfer frequency
Mean transfer frequencies, determined as T/Do, were calculated from replicate
matings of 1, 7, 10 and 16 hours. Transfer frequencies of pUK2003 could not be
determined within a one-hour mating period, as this plasmid required longer than one
hour for its transfer. The transfer frequencies of each of the plasmids during the four
different mating times are shown in Figure 6.1. Table 6.1 shows the mean transfer

















Figure 6.1 The effect of mating time on estimates of plasmid transfer frequency as
determined by the number of transconjugants to donors at the start of mating.
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Table 6.1 Mean transfer frequencies (T/Do) and number of replicates used in
estimates.
Mating time (no. of replicates)
Plasmid 1 7 10 16
pUK2001 1.14 x 10"4 (8) 4.19x102 (3) 1.84 x10"2 (2) 3.07 x10'1 (2)
PUK2002 9.46 x 10^(35) 1.73 x 10"3 (5) 3.41 x 10"3 (5) 3.03 x 10~2 (3)
pUK2003 ND 4.65 x 10"6 (5) 4.84 X10"6 (5) 4.43 x 10"6 (3)
As can be seen in Figure 6.1, the estimate of plasmid transfer frequency varies
according to the time allowed for mating. Transfer frequencies of pUK2003 appeared
least affected by mating time, whilst pUK2002 and pUK2001 showed general trends
towards increased frequencies during longer mating times. The analysis of variance
performed on this data confirmed these trends; a significant increase in transfer
frequencies was present with increasing length ofmating time (F 1,70 = 255.3, P <
0.001). The plasmid transfer frequencies were significantly different (F2,7o= 214.6, P
< 0.001), and the relationship between time and transfer frequency was found to be
plasmid dependant (F2,7o = 25.47, P < 0.001), with pUK2001 and pUK2002 transfer
frequency estimates increasing with mating time (tn = 9.9, P < 0.001; and t46 =
17.85, P < 0.001 respectively). pUK2003 transfer frequencies did not change
significantly with mating time (tn = -0.23, P = 0.82) (Figure 6.1).
6.3b Transfer rates estimated by the end-point method
The end-point method has been described as being independent ofmating time
because transfer rates and growth rates during exponential growth are assumed to be
related in accordance with equation 1 (Simonsen et al., 1990). To determine when
during the course of the experiment, the exponential growth phase is reached, growth
curves of the donor strain (J53) harbouring pUK2002 were plotted. The growth
curves were determined in eight replicate experiments carried out in the same type
and volume of broth, and under the same experimental conditions, as would be used
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for determining plasmid transfer rates. The individual growth curves of the replicate
experiments are shown in Figures 6.2, and the geometric mean growth curve of all
replicates is shown in Figure 6.3.
Lag Exponential Fbst-exponential
Time (hours)
Figure 6.2 Eight replicate growth curves of J53 harbouring plasmid pUK2002 in
10ml LB.
Figure 6.3. Geometric mean growth curve of J53 harbouring pUK2002 10ml of LB.
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Figure 6.2 shows that a lag phase occurs during approximately the first hour of
incubation. This is followed by an approximately exponential growth phase spanning
from one to approximately four hours, after which the growth rate of this strain
declines. Figure 6.3 shows the geometric mean of these growth curves. In this graph,
the start of the exponential phase is distinct, but the end of this phase is less well
defined. To determine if plasmid transfer rates as measured by the end-point method
were independent of time of sampling, transfer rates of pUK2002 were determined
on the proportion of donors, recipients and transconjugants at each time point. For
each transfer rate estimate, the growth rate specific to that time point was used. Here,
average growth rates for each of the time points were calculated by performing linear
regression of the slope between pairs of consecutive time points for each replicate
growth curve, and taking the mean of these rates. Transfer rates at 0-0.5 and 0.5-1
hours were excluded from the analysis because although the mean growth rates of the
eight replicate growth curves were very low, some replicates were not growing.
Additionally, in two of four replicate mating experiments, the transconjugant
population was below the detection threshold of the method (< 100 cfu/mL).
The results of this analysis are presented in Table 6.2, where each transfer rate (with
the exception of t = 3.5 and t = 4, where the number of replicates < 2) has been
calculated from the geometric means of the cell densities (Z), R and T) of replicate
experiments. Figure 6.4 shows the transfer rate estimates of all replicates. The
numerical values at each time point are listed in 1 able 6.2.
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Table 6.2 Mean transfer rates and confidence intervals for the transfer of pUK2002
from J53 into J62-2 measured after different mating times by the end-point method.
Transfer rate (mL per cell h"1) Mean transfer rate
(Hours) replicates Replicate 1 Replicate 2 Replicate 3 Replicate 4 (mL per cell h"1)
1.5 3 2.91 x 10"11 3.23 x 10 "11 9.42 x 10 "11 ND 5.18 x 10 "11
2 4 1.32 x 10 "10 5.36 x 10 "11 8.70x 10 "11 1.61 x 10 "10 1.08 x 10 "10
2.5 4 5.78 x 10 11 2.32 x 10 "11 4.88 x 10'11 2.00 x 10'11 3.74 x 10 11
3 4 1.51 x 10 11 5.21 x 10 "12 7.88 x 10 "12 6.80 x 10 "12 8.75 x 10 "12
3.5 1 ND 2.10 x 10 12 ND ND 2.10 x 10 ~12
4 2 ND 9.24 x 10 "13 ND 1.22 x 10 "12 1.07 x 10 "12
4.5 3 ND 1.71 x 10"13 1.42 x 10 12 1.07 x 10 "12 8.88 x 10 13
5 3 ND 4.73x10 14 6.00 x 10 "13 3.58 x 10 "13 3.35 x 10 "13
Time
-■— rep 1 —•— rep 2 —a— rep 3 rep 4
Figure 6.4 Four replicate experiments showing the effect ofmating time on
estimates of plasmid transfer rate of pUK.2002 from J53 into J62-2, as measured by
the end-point method.
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As can be seen in Figure 6.4, estimates of transfer rate tend to be lower when
calculated from cell densities of samples taken later in the mating time. The decrease
in transfer rate with mating time was significant (ftg = -5.08, P < 0.001).
The transfer rate appeared to be fastest during the lag phase and slowest after the
exponential growth phase when the growth rate is also decreasing. To ensure that the
plasmid transfer rate estimates for the three aprR plasmids were as comparable as
possible, and would not be affected by variations in the length of lag phase, they
were estimated from cell densities of samples taken at approximately the middle of
the exponential growth phase. This will be a conservative estimate, as plasmid
transfer rates are thought to be fastest during the lag phase (Simonsen et al., 1990).
The plasmid transfer frequencies were then calculated from the cell densities of a
sample removed after 2.5 hours of mating. Growth rates were calculated as the rate
of growth during exponential phase (1-4 hours). These results are listed in Table 6.3.
Table 6.3 Mean plasmid transfer rates as measured by the end-point method, and
mean transfer frequencies as measured by T/Do.
Plasmid Plasmid transfer rate Plasmid transfer frequency




2.83 x 10 9
3 74 x 10 "11
1.15 x 10 "15
4.19 x 10 2
1.73 x 10 "3
4.65 x 10 "6
The transfer rates listed in table 6.3 demonstrate that plasmid pUK2001 has the
fastest rate of transfer, and pUK2003 has the slowest. Qualitatively, these results
correlate well with the transfer frequencies obtained by calculating T/Dq.
In Table 6.3, different E. coli K12 recipient strains were used tor the end point
matings (MG1655kan) compared to the T/D(l matings (J62-2). This was to minimise
pipetting errors when determining D and R densities with the end-point method. To
determine whether the choice of recipient strain used in the mating experiment
affected the plasmid transfer frequency obtained, pUK2002 was mated with
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MG1655kan and with J62-2, and the transfer rates compared. Conjugations were
repeated four times with each recipient. Cell densities were estimated from samples
removed after 2.5 hours ofmating. The growth rates used in each calculation were
the average growth rates of each mating pair during exponential growth (1-4 hours).
The results of this analysis are shown in Table 6.4.
Table 6.4 Mean transfer rates of pUK2002 into J62-2 and MG1655kan.
Mating pair Average transfer rate Lower 95% Upper 95%
(ml per cell h"1)
J53 + pUK2002 into J62-2 3.74 x 10 "11 7.62 x 10"12 6.72 x 10 -11
J53 + pUK2002 into MG1655 3.53 x 10 "11 9.18 x 10 "12 6.14 x 10"11
The mean transfer frequencies of pUK.2002 into J62-2 and MG1655kan were very
similar, and the upper and lower 95% confidence intervals indicate similar variation
with the two recipients. A standard two sample t-test revealed that the two transfer
systems (into J62-2 or into MG1655kan) did not give significantly different estimates
of transfer frequency (ts = 2.57, P = 0.87).
6.3c Variation in transferfrequency/rate with different methodology
To explore the variation over a range of mating times, when the plasmid transfer
frequency or rate was measured by each of the two different methods, the results of
the mating experiment described in Figure 6.4 were plotted with the T/Do frequencies




































Figure 6.5 A comparison of four replicate experiments to study plasmid transfer.
EP1-4; transfer rates measured by the end-point method (mL per cell h"1), T/D 1-4;
transfer frequencies measured as the density of transconjugants over donors at the
start ofmating (T/Do).
Figure 6.5 shows that neither measure of plasmid transfer is independent of mating
time. The frequency of transfer as measured by T/D0 increases with mating time,
whereas the transfer rate, measured by the end-point method, decreases as mating
time increases. A significant decrease in transfer rate with mating time
(t 19 = -5.08, P < 0.001) was described earlier for the end-point method (Figure 6.4).
This analysis was repeated for the T/Do data, and revealed a significant increase in
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transfer frequency with mating time (t33 = 4.82, P < 0.001). The replicate points of
the end-point method appear more closely clustered than those of the T/Do measure
(Figure 5.5), indicating less variation within this method.
6.3d Modelling plasmid transfer in batch culture
A model describing bacterial cell growth and plasmid transfer in batch cultures (see
section 6.2d in materials and methods) was used to describe mathematically the
experimental results obtained during the calculations of plasmid transfer frequencies
by the end-point method, and to predict the effect of altering various parameters
where this could not be achieved practically. The plasmid transfer results selected for
this section ofwork were those of plasmid pUK2002. To ensure the model accurately
describes the experimental data, the cell densities, plasmid transfer rate, and average
growth rates from the mean results of four replicate pUK2002 conjugation
experiments were incorporated into the model. The model was then run using
Berkley-Madonna™ software and the output compared to the experimental results.
When the model was run using the maximal cell growth rates for each population it
did not represent the experimental data. The T, D and R populations were
overestimated throughout the five hours mating time (results not shown). The model
predicted resource limitation at 2.5 hours, but this was not observed in the
experimental data. The results shown in Figure 6.2 demonstrate that growth rates
vary during the experiment, and so the model was repeated with the average growth
rates over the five-hour experiment for each population. This gave a better
representation of the experimental data than when the maximal growth rates were
used, but the transconjugant population was still greatly overestimated by the model
(results not shown). Table 6.2 and Figure 6.4 indicate that the plasmid transfer rate
varies during different growth phases. It was hypothesised that the model would fit
the real data better if the average transfer rate during the five-hour experiment was
used. This hypothesis was tested and the comparison of real and model data is



















Figure 6.6 Population dynamics during pUK2002 transfer from J53 to J62-2, using
the average plasmid transfer frequency over each of the time points.
Figure 6.6 shows that the model-generated data follows the general trend of each of
the populations, but it does not capture the sigmoid shape of the D and R
experimental curves. Although the slope of the modelled T population is similar to
that of the real data, the main discrepancy between the model and real data is that it
overestimates the T population throughout the five hours. In an attempt to enhance
the fit of the model to the real data, two further models were run in which cell
densities, growth rates, and plasmid transfer rates from the lag phase and secondly
from the post-exponential phase were used. The use of data from these specific
growth phases only, resulted in very inaccurate modelling of all populations, even
during the particular growth phases from which the data came (results not shown).
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The model shown in Figure 6.6 was also repeated with a range of transconjugant
growth rates (vT) from 0 to 2.5, to determine whether the overestimation of T density
was because of transconjugant growth. The numerical solutions and the resulting
graph for all these vT values were almost identical to those for Figure 6.6 (results not
shown), indicating that the transconjugant population plotted in Figure 6.6 is a direct
result of conjugation events and that transconjugant growth has an undetectable
effect on population density.
A sensitivity analysis was performed to determine how each parameter influences the
output of the model. The graphs of this analysis may be found in appendix 1. The
key findings of this analysis are as follows:
1. Reducing the donor or recipient growth rates (vD and vR respectively) enhanced
the fit of the model to the T population, but resulted in very inaccurate modelling of
the D and R populations.
2. When vD > vR, donors constituted a greater proportion of the total population at
resource limitation. Conversely, when vR > vD, recipients occupied a greater
proportion of the broth than D. The reduction in D as a function of increasing vR,
was less than the reduction in R due to increasing vD. This is likely to be because D
only acts in competition with the other strains present, whereas R is affected by
conversion to T, in addition to competition with both D and T.
3. Lowering the initial densities ofD or R to 1 x 105 lowered the T curve to fit the
experimental T data much better, but this also caused a lowering of the D and R
curves, which was a very poor representation of the experimental data for these
populations.
4. There was a trade off between an increase in resource concentration increasing the
fit of the D and R populations, but resulting in a reduced fit to the T population.
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5. The parameter changes that did enhance the fit of the model to the experimental
data were the introduction of a lag in conjugation, increased resources, a lag in
growth of all D and R, and a reduction in plasmid transfer frequency. A more
detailed discussion of these parameter changes now follows.
A lag in plasmid transfer was introduced by offsetting the model-generated results of
the transconjugant population from the corresponding time points by 30, 60 and 90






Figure 6.7 The effect of a lag in conjugation on the dynamics of pUK.2002 transfer
between E. coli J53 and J62-2.
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The model more accurately represents the experimental data when a 30 minute (0.5
hours) lag in transfer is introduced (Figure 6.7), but after 3 hours the increase in T
density is less than is predicted by the model. A lag in growth of approximately one
hour also needs to be introduced before D and R growth begins. This is illustrated in
Figure 6.8.
-exp D
— — exp R
i—— model D









Figure 6.8 The effect of 0.5, 1 and 1.5hrs lag in growth on the D and R populations.
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To compensate for the one hour lag before cell growth, the growth rates of the D and
R populations needs to be increased. A growth rate of 2.4h"' was found to be most
suitable.
Next, the effect of varying transfer rate (y) was explored. This analysis is shown in
Figure 6.9, where for simplicity, only the effects on the R and T populations are
shown. The D population is only affected by direct competition between the other






















Figure 6.9 The effect of plasmid transfer rate on the R and T populations.
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Figure 6.9 shows that a plasmid transfer rate of between le"10 and le"15 does not
affect the R population (shown as just a turquoise dashed line; the other colours
cannot be seen, as they are directly under this line). At y > le'9, the R population is
reduced, and dies out when y > le"7 because all the R's are converted into T's during
the course of the experiment. From this figure it appears that the best plasmid
transfer rates to fit the experimental data is between 1 x 10"12 mL per cell h"1 and
1 x 10"u mL per cell h"1.
Different combinations of the three parameters found to enhance the fit of the model
(lag in transfer, lag in D and R growth, and increased resource concentration) were
studied in combination. The results of this analysis may be found in Appendix 2, in
graphs 1 to 27.
Figure 6.10 shows the results of the best fit of the model (selected by eye), which
includes a 30min lag before plasmid transfer, a 1.5 hour lag before D and R cell
growth, D and R growth rates of 2.4h"!, a plasmid transfer rate of 1 x 10"11 mL per
cell h"1 and a resource concentration of 500pg/mL. Here it is important to note that
the concentrations of resource input into the model are arbitrary. LB contains both
tryptone peptide and yeast extract, both ofwhich may be used as a C source. This
meant that it was not possible to calculate exactly how much of each different carbon
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Figure 6.10 Best fit of the model to the experimental data, using measured plasmid
transfer rate (1.98 x 10"" mL per cell h"1).
In Figure 6.10, the density of transconjugants throughout the experiment are
overestimated. With a resource concentration of 500pg/mL, the culture reaches
resource limitation at 4 hours. Experimentally, resource limitation is not reached
until at least 5 hours. However, increasing resources further also affects the T
population (see Figure A1 in appendix 1) by increasing the number of transconjugant
cells formed. To reduce this, a lower plasmid transfer rate may be used, but this is
not logical because the transfer rate is measured during the experiment based on the
densities and growth rates of the cells involved. Therefore, either the measurement of
transfer rates with the end-point method is not accurate, or the use of the transfer rate
in the model requires a further variable to reduce the transfer rate with increasing
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mating time. Biologically, the reason for this is likely to be because of a reduction in
donor ability during exponential phase growth compared to lag phase.
The final section of this chapter intended to explore which parameters are influential
in allowing persistence of the plasmid in a population. The use of an accurate model
is critical for this analysis, as it allows the alteration of different parameters in a
thorough and stepwise manner, which is not possible experimentally. Although only
a crude exploration ofparameter space was completed due to time limitations, it is
clear from the results above (Figures 6.6 to 6.10) that the model is not able to capture
all of the behaviour of the experimental data. The model needs to allow the input of
transfer rates that change throughout the experiment, depending on the growth phase
of the donor and recipient strains. The application of a mathematical model to the
phenomenon of conjugative plasmid transfer has however highlighted processes and
dynamics of aprR plasmid transfer that would not have been observed by simply
measuring transfer frequencies or rates.
6.4 Discussion
This chapter is concerned with gaining a better understanding of the biology of the
aprR plasmids described in chapter 5. Two different methods of determining plasmid
transfer frequencies were examined to allow a comparison of these two published
methods, in addition to a comparison of plasmid transfer frequencies with other
worker's results. The use of the end-point method enabled experimental data to be
compared with data generated using a mathematical model describing cell growth
and plasmid transfer in batch culture. Testing the model against experimental data
highlighted limitations of the model and identified biological processes likely to be
involved in plasmid transfer. The discussion of the results described earlier will be
organised according to the original aims set out in the introduction.
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6.4a In what manner do plasmid transfer frequency estimates vary as a function of
mating time?
When plasmid transfer frequencies were measured as T/Do (where T = cfu/ml of
transconjugants, and Do = cfu/ml of donors at the start ofmating), overall there was a
significant increase in transfer frequency estimate with increasing mating time. This
is because transconjugants are formed by plasmid transfer to a recipient (horizontal
spread) as well as by clonal replication (vertical spread) of a transconjugant cell. The
number of transconjugants formed by both modes of plasmid transmission will
increase as the mating time is increased. The longer the mating time the greater the
effect of transconjugant growth on the number T/Do, because of the logarithmic
nature of bacterial cell growth.
In contrast, the transfer rates measured by the end point method decreased with
mating time. The fastest transfer rates occurred during the early exponential growth
phase, and a significant decrease in the rate of plasmid transfer occurred during 2.5
to 5 hours ofmating. Similarly, Smets et al. (1993) found that the highest rates of
plasmid transfer were observed when donor cultures were in the exponential growth
phase. The decrease in plasmid transfer between 2.5 and 5 hours is because with
increasing mating times Ln(l+T/R • N/D) increases, but at a slower rate than the
decrease in l/(N-No). This indicates that in order to compare results between
different labs, the same growth phase should be used in the estimate of transfer rate.
This result is in contrast to the results of Simonsen et al. (1990) where constant
transfer rates were found throughout the exponential, post-exponential and stationary
phases of growth.
The correlation ofmaximum transfer rates with early exponential growth phase
contrasts strongly with the results of other workers, where minimum transfer
frequencies (measured as the frequency of T/D0) were measured during the donor
exponential growth phase (Muela et al., 1994).
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6.4b What are the advantages and disadvantages ofeach technique?
The measure T/D0 does not take into account the growth of the transconjugant
population. This, as outlined above, may lead to inaccurate transfer frequency
estimates with longer mating times. In the determination of transfer frequencies of
the three aprR plasmids identified in chapter 5, a mating time of one hour would have
been less affected by transconjugant growth than the seven hours used. However, the
minimum mating time that could be used was seven hours, as pUK2003 transfer
could only be detected after this time.
Additionally, transfer frequencies obtained by T/D0 are likely to vary if different
donor: recipient ratios are used. A lower initial density of donors to recipients is
likely to have more of an effect than a reduction in the initial density of recipients.
This is because the expression of genes required for the transfer ofmost conjugative
plasmids occurs in only a small proportion of the cells that harbour them (Hardy,
1984), and so the rate-limiting step would be donor ability. In Enterobacteriacae, the
conjugative ability of F-like R plasmids is only expressed in approximately 0.1% of
cells containing the plasmid (Hardy, 1984). Walmsley (1976) describes the limiting
step in the formation of mating pairs under normal physiological conditions, as the
production of F pili by donor cells. Considering both these observations, one would
expect that a reduction in donor numbers would be likely to reduce transfer
frequencies more dramatically than a reduction in the number of recipients. To test
whether this hypothesis is true for the strains, plasmids and media used in these
conjugation experiments would require repeat mating experiments with a variety of
donor: recipient ratios.
Fernandez-Astorga et al. (1992) report constant transfer frequencies in tryptone soya
broth, as measured by T/D0 when the density of recipient cells is higher than that of
donor cells. With ratios of 30:1 (D: R) or higher donor densities, a significant
decrease in transfer frequency was detected. A ratio of 1:10 (D: R) was used in the
measurements of transfer frequencies by T/D0 in this and the previous chapter,
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therefore any variation in inocula (introduced by pipetting errors) were expected to
have a minimal effect of the transfer frequency obtained.
In summary, this method of calculating plasmid transfer frequencies allowed an
accurate comparison between the three aprR plasmids and the two reference plasmids
(RP4 and R46). In addition, a comparison of the transfer frequencies obtained
following the detection of transconjugants on different selective plates, enabled
inferences to be made as to whether other resistance genes were present on the same
plasmid or different but mobilisable plasmids. The main disadvantage of the T/D0
measure is that comparisons with other researchers are not possible if slightly
different methodologies have been used (for example, initial donor and recipient
inoculums and ratios, different mating times and different culture conditions).
The rate of plasmid transfer was next measured by the end-point method. According
to Simonsen et al. (1990), plasmid transfer and cell growth are thought to remain
proportional to each other and to vary little during exponential growth. The period
during which exponential growth occurred for the cells and culture conditions used
was determined by plotting growth curves. This is an important first step, as the
different phases of bacterial cell growth vary in both their presence and duration
(Monod, 1949), depending on the media, strain, amount of aeration, and starting
temperature.
Transfer rates could not be determined until after one hour ofmating, because some
replicates were not growing at all, and two of the four replicates did not yield
transconjugants at that time. To give an average transfer rate of these replicates
would not be an accurate representation of the data. At this early stage in the
experiment, the formation of some transconjugants were expected, but their numbers
may have been below the detection threshold of the method (<100 cfu/mL), giving
the appearance of an absence of plasmid transfer. According to Simonsen et al.
(1990), plasmid transfer rates are at their maximum during the lag phase, so we
would expect the highest rates to occur during the first hour ofmating. In agreement
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with this statement, Muela et al. (1994) demonstrate high transfer frequencies during
donor cell lag phase compared to the exponential growth phase.
To sum up, the end-point method is more complicated and labour intensive than the
T/D0 measure, but is less affected by mating time, and demonstrated less variation in
replicate experiments. A disadvantage of the end-point method is that the calculation
of transfer rates during lag phase may be inaccurate or impossible because of very
low or negative growth rates.
6.4c How do the transfer frequencies/rates measured by each ofthe methods
compare?
Two different recipients, J62-2 and MG1655kan were used in the measurement of
transfer frequencies/rates by the two methods. The use of a second recipient in the
end-point method was to minimise pipetting errors introduced by plating samples
onto different agar plates. Before the transfer frequencies/rates could be compared, it
was necessary to ensure that the use of different recipients would not affect the
results.
The ability of different E. coli strains to receive plasmids is likely to vary if the
recipient strain has a different restriction modification system to that of the donor cell
(Murray, 2002). Gordon (1992) found the variation in transfer rate between E. coli
isolated from a variety of natural populations to be mainly due to recipient effects.
Both the genetic relatedness of the two strains involved, and the native plasmid
burden of the isolate influenced its ability to receive plasmid R1 (Gordon, 1992).
Mutations affecting the inner core of lipopolysaccharide (LPS) and the porin OmpA
have also been found to result in poor recipient ability in broth matings, and are
thought to reduce mating pair stabilisation (Klimke & Frost, 1998).
It was expected that MG1655kan would have a very similar if not identical ability to
receive plasmids from J53. The main reason for this hypothesis is that it is also a K12
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derivative strain, and so is genetically related to both J53 and J62-2. Additionally,
MG1655kan does not contain any other plasmids. Transfer rates obtained with the
same plasmid and each recipient were not significantly different, and so the
frequencies of T/D0 and the plasmid transfer rates measured by the end-point method
could be compared.
Qualitatively, the transfer rates of plasmids pUK2001, pUK2002 and pUK2003
estimated by the end-point method, were found to correlate well with those obtained
by measuring T/D0. Plasmid pUK2001 transferred at the fastest rate (2.83 x 10"9 ml
per cell h"1). Plasmids pUK2002 and pUK2003 transferred at slower rates
(3.74 x 10~H and 1.15 x 10"'5 ml per cell h"1 respectively). A study of the transfer
rates ofR1 between different E. coli strains from natural populations revealed that
the fastest rate of transfer for this plasmid was 5.2 x 10"11 ml per cell If1 (Gordon,
1992). Transfer rates varied according to the donor and recipient strains used, and
averaged at 1.3 x 10"15ml per cell h"\ This rate is several log-fold slower than the
rate of pUK2001 transfer.
However, the rates estimated in this chapter are likely to be faster than those obtained
by mating experiments with the natural host strain. This is because the E. coli K12
strains used in this work are well-adapted to culture conditions in the laboratory, and
perhaps more importantly, they are isogenic and so there is likely to be no restriction
on the transfer of plasmids between them (Murray, 2002). In support of this
hypothesis, Gordon (1992) found that the transfer of R1 into the lab strain CSH50
was on average 100 times faster than when wild-type strains served as both donors
and recipients.
The transfer rates and frequencies obtained in this and the previous chapter are likely
to be the maximum possible for each plasmid. Nutrient rich media was used, the
broths were well aerated and constantly mixed, and no other competing bacteria were
present. These conditions do not represent the conditions likely to occur in the
intestine of a calf. The use of a rich medium has been shown to increase the mean
number and length of donor pili and increase the probability ofmating pair formation
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(Curtiss et al., 1969) compared to minimal media. Starvation prior to mating, or
conditions of stress have also been found to inhibit plasmid transfer (Muela et al.,
1994; Curtiss et al., 1969; Arana et al., 1997).
6.4dDoes the published model of bacterial cell growth andplasmid transferfit the
experimental data ofpUK2002 transfer in batch culture?
The transfer rates determined by the end-point method, may be readily incorporated
into a mathematical model (Levin et al., 1979) describing bacterial cell growth and
plasmid transfer in batch culture. The reason for wishing to use a model in this work
was to enable an exploration of the dynamics of plasmid transfer by altering input
variables which were not achievable experimentally, and subsequently observing
their effects. The model was found to fit the growth curves of the donor and recipient
population much better than it did the transconjugant population, although it did not
capture all of the behaviour of the data. The rate of plasmid transfer was found to
vary depending on the growth phase, a result that has been reported by others (Smets
et al., 1993; Muela et al., 1994; Curtiss et al., 1969) as well as demonstrated in this
work. Although repeat runs of the model with the average transfer rate over the
whole experiment fitted the data better, it was still overestimating the number of
transconjugants throughout the mating time. The introduction of a 30 minute lag
before plasmid transfer did appear to improve the fit to the T population. This
illustrates that the dynamics of transfer of plasmid pUK2002 between J53 and J62-2
are not as simple as predicted by the model, and highlights the need to identify
biological processes occurring during the transfer of pUK2002 that are not
considered by the model.
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6.4e Ifthe model does notfit, what biologicalprocesses are occurring which are not
taken into account by the model?
Firstly, a lag in growth was detected (Figure 6.2) at the start of the experiment
despite the fact that the LB broth was warmed to 37°C prior to inoculation. The
presence of a lag phase in bacterial growth has been found to depend on the specific
conditions and the properties of the organism (Monod, 1949). Additionally, an
apparent lag may be caused if the inoculate contains a large proportion of non-viable
cells (Monod, 1949). In the end-point mating experiments described in this chapter,
an overnight culture was diluted in total 1 in 1000 into the LB. Although it is not
clear what proportion of the total cells present in this inoculum were viable, all of the
viable cells would be in stationary phase (after 16-18hrs incubation in 5mls LB) at
the moment of inoculation. Here, there will be a delay in growth (the duration of
which will depend on the bacteria and the media) while the necessary genes for
growth are transcribed and translated into protein products. The model requires a
function to allow for this lag in growth, the duration ofwhich in vivo is unknown.
Secondly, plasmid transfer has been found to be more frequent during the lag and
early stationary phase of donor cells than during the exponential phase (Muela et al.,
1994). The results of this chapter suggest that the plasmid transfer rate varies as a
function of growth phase, not necessarily growth rate. The model does not take into
account any variation in ability to donate or receive plasmids by the strains involved,
which has also been found to vary with growth phase (Smets et al., 1993; Fernandez-
Astorga et al., 1992).
6.4f Can the model be used to address questions ofplasmidpersistence in natural
populations?
Models simplify observed phenomenon into mathematical terms to determine
whether the data can be explained in terms of apparently few parameters and
variables, and by doing so have to make assumptions. By studying the assumptions
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made, one can determine whether the model is likely to be a realistic representation
of plasmid transfer in vivo.
The model assumes that the frequency ofmatings increases at a rate proportional to
the increase in donor and recipient populations. A consequence of this assumption is
that the mating culture must be subjected to continuous mixing, which increases the
likelihood that donor cells will encounter recipient cells. In vivo studies have
indicated that the majority of plasmid transfers occur in the mucus layer of the
intestine (Poulsen et al., 1994). Here the bacteria are thought to retain fixed spatial
positions despite peristalsis and the fluidity of the mucus (Licht et al., 1999). These
conditions permit little mixing of the population, which is thought to account for the
observation of a brief period of rapid conjugation after inoculation in mouse
colonisation experiments, followed by no further plasmid transfer (Licht et al.,
1999). Additionally, the density of cells able to receive the plasmid is likely to be far
lower in vivo than in these broth matings, because of differences in restriction
modification systems present in other bacteria and even within different E. coli
strains (Murray, 2002).
A second assumption of the model is that mating frequency is independent of
bacterial growth phase. The results described in this chapter demonstrate that the rate
of plasmid transfer is affected by the growth phase of the donor and recipient
population, because significantly different transfer rates were measured at different
mating times, and different growth rates were demonstrated at each of these mating
times. Here the fastest rate of transfer occurred during exponential growth of the
donors and recipients, and the slowest rates were measured in the lag and post-
exponential growth phases. Although other workers have found different
relationships between growth rates and plasmid transfer frequencies (Smets et al.,
1993; Muela et al., 1994; Curtiss et al., 1969), these studies support the hypothesis
that plasmid transfer is not independent of bacterial growth phase.
The model also assumes that transconjugants are immediately able to transfer the
plasmid at the same rate as donor cells. Cullum et al. (1978) report that most newly
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formed transconjugants are only able to mate after approximately 90 minutes.
Similarly, Andrup & Anderson (1999) report a "recovery period" of about 40-80
minutes, following acceptance of the F plasmid in E. coli or plasmid pCFlO in
Enterococcusfaecalis before tranconjugants mature into proficient donors. These
reports indicate that this assumption may introduce inaccuracy into the model.
The are a number of studies which report that the growth rates of plasmid carrying
cells are slower than those of plasmid free cells (Gillespie, 2001; Goodwin & Slater,
1979; Helling et al., 1981; Inselberg, 1978; Kayama & Yara, 1975). In contrast, other
workers have identified plasmids for which carriage does not impart a fitness cost on
the host bacterium (Bouma & Lenski, 1988; Lenski et al., 1994; Enne et al., 2004b).
The model used in this chapter assumes that the growth rate of all clones is identical.
This is tested in the next chapter, where plasmid-carrying and plasmid-free isogenic
strains are grown in competition with each other.
The growth rates of all strains involved is likely to be much lower in vivo than in a
nutrient rich broth like LB. Generation times of 20mins have been observed in broth
cultures compared to a mean generation time of 12h in the alimentary canal (Hardy,
1984). Cell growth and plasmid transfer are energy requiring processes, and so are
both likely to be slower when nutrients are more limited than in LB. A comparative
study on the transfer rates of the derepressed plasmid K\drd\9 in batch culture
demonstrated transfer rates in mouse caecal contents or mouse caecal mucus were 4-
and 50-fold lower than those obtained in L-broth (Licht et al., 1999). In vivo, plasmid
transfer was only detected during a brief period following inoculation, after which no
further transfer occurred, even though rapid division of donors and recipients was
observed (Licht et al., 1999). Similarly, Thomas et al. (2001) report a reduced
plasmid transfer frequency between Bacillus spp. in mosquito larvae compared to
broth culture. These results support the hypothesis that the transfer rates obtained in
the broth mating experiments described in this chapter, are likely to be over¬
estimates of the rates achievable in vivo.
141
Finally, the model predicts that plasmids with faster transfer rates will transfer to a
greater number of recipients, resulting in a greater prevalence than plasmids with
lower transfer rates. Of the three aprR plasmids identified in the calf faecal E. coli
population, pUK2003 transferred at the slowest rate (Chapter 5), yet it is the second
most prevalent plasmid. This demonstrates that the factors responsible for plasmid
persistence in vivo are more complicated than can be explained simply in terms of
growth rates and plasmid transfer rates of the two strains involved in a mating. Other
factors that may influence plasmid persistence include the presence of other genes on
the plasmids (e.g. bacterial attachment pili, metabolic genes), which may not be
expressed in vitro, as yet unknown selective pressures (e.g. bacteriocin production by
other gut flora), and costs associated with high transmission rates that may be
undetectable in the closed in vitro system used. More information about the
immediate environment in which these aprR plasmids reside is required before
questions about plasmid persistence in vivo can begin to be addressed.
In summary, two methods were used to measure the transfer rate or frequency of the
aprR plasmids described in Chapter 5. The measurement of T/D0 allowed an accurate
comparison of transfer frequencies within a study, but was more affected by mating
time and showed a greater degree of variation than the end-point method. The end-
point method is likely to be more comparable with other workers results because it
takes into account the densities of all cells involved in a mating, but problems may
arise when attempting to measure transfer rates during lag phase.
Secondly, a model was applied to the experimental data. It proved difficult to get a
very close fit of the model with the experimental data, but exploring the effects of
altering the parameters enabled the identification of biological processes occurring
during the transfer of the aprR plasmid pUK2002 that may not otherwise have been
questioned. For example, the presence of a lag phase prior to conjugation, and the
non-linear (sigmoid) shape of transconjugant density demonstrating the different
rates of plasmid transfer with growth phase. The study of the underlying assumptions
of the model prompts many questions about the process of conjugation both in batch
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cultures and in vivo. It is this prompting of questions, more than any attempts to use
the model in addressing hypotheses on plasmid persistence, which has been useful in
the study of the transfer of pUK2002.
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Chapter 7. Competitive fitness costs of aprR plasmids
7.1 Introduction
The three aprR plasmids identified in chapter 5 were all of high molecular size
(>90kb). The carriage of large conjugative resistance plasmids is generally thought to
engender a competitive fitness cost on the host bacterium in the absence of selection
for the resistance phenotype (Gillespie, 2001; Goodwin & Slater, 1979; Helling et
al., 1981). Lower growth rates of plasmid-containing cells compared with plasmid-
free cells have been observed in both closed-culture experiments (Inselburg, 1978;
Kayama & Yara, 1975) and chemostat systems (Goodwin & Slater, 1979; Noack et
al., 1981). Plasmid-carrying strains are thought to display decreased growth rates
because of the energy expended and the carbon sources needed for both maintenance
and replication of the plasmid, and its functions (Goodwin & Slater, 1979).
Previous studies of the competitive fitness cost engendered by plasmid carriage have
focused on common laboratory plasmids or cloning vectors (Dahlberg & Chao, 2003;
Bjorkman & Andersson, 2000). There appears to be no studies to date that have
determined fitness costs associated with plasmids from veterinary isolates.
The aim of this chapter is to determine whether the carriage of plasmids pUK2001,
pUK2002 and pUK2003 confer detectable competitive fitness costs on a host
bacterium, either in single culture experiments (5hr growth rate comparisons) or
during direct competition (for 5hr and for 5 days).
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7.2 Materials and Methods
7.2a Bacterial strains andplasmids
The competitive fitness costs of the aprR plasmids pUK2001, pUK2002 and
pUK2003, identified in Chapter 5 were studied. Plasmid pUK2002 was selected for a
more detailed analysis of growth rates of plasmid-carrying and plasmid-free strains.
This plasmid was chosen because its size and transfer frequency was intermediate
among the three plasmids isolated. Plasmids were maintained in E. coli MG1655 and
E. coli J53. The E. coli K12 strains J62-2 (lac', pro' trp' his') and MG1655kan (A lac,
Km) were used as isogenic competitors in J53 competitions and in MG1655
competitions, respectively.
5.2b Five hour growth rate comparisons
Cultures of each strain (plasmid-harbouring J53 or MG1655 and plasmid-free J53 or
MG1655) were grown in 5ml Lennox L broth (LB) (Invitrogen) or Davis Mingioli
broth supplemented with 0.4% glucose (designated MM for minimal media), for 16-
18h at 37°C with shaking at 150 rpm. Starter cultures were diluted 1:10 in saline and
used to inoculate lOmL LB or MM to give an initial density of approximately
1 x 106 cfu/mL. During incubation at 37°C with shaking at 150 rpm, samples were
taken at 30 min intervals since initial inoculation for five hours. Cell densities were
estimated by serial dilution in saline and selective plating. To determine whether
plasmid segregation was occurring during the course of the experiment, viable counts
ofplasmid-harbouring strains were plated onto MacConkey plates, with or without
16mg/L apramycin.
145
7.2c Five hour competition study
The same protocol as that described for the five hour growth rate comparison was
used to study plasmid-carrying and plasmid-ffee strains in direct competition, except
that MG1655kan and J62-2 were used as the plasmid-ffee competitors. This was to
enable the identification of plasmid-carrying, plasmid-ffee and transconjugant strains
during the experiment. Starter monocultures were diluted 1:10 in saline and used to
inoculate 10ml LB orMM at a ratio of 1:1 and an initial density of 1 x 106 cfu/mL of
each strain. The formation of any transconjugants was measured by serial dilution
and plating onto selective MacConkey plates. Supplementation with 40pg/mL
apramycin and 32pg/mL kanamycin was used for MG1655 competitions, and
32pg/mL apramycin and 32pg/mL rifampicin for J53 and J62-2 competitions.
7.2d Five day competition experiments
Five-day competition experiments between plasmid-carrying MG1655 and plasmid-
ffee MG1655kan were performed in MM to limit the ffequency ofplasmid transfer.
Overnight cultures of the competing strains were grown up in separate bijoux
containing 5mL MM. The two cultures were mixed in a 1:1 ratio (mixO) and used to
inoculate 250pL of broth in each of six wells of a microtitre plate, to give an initial
inoculum of approximately 1 x 106 cfu/mL. Initial counts of plasmid-carrying
MG1655 and plasmid-free MG1655kan were determined by serial dilution and
plating onto S-gal plates (Sigma). The presence of any transconjugants was detected
by plating lOOpL mixO onto MacConkey plates supplemented with 40pg/mL
apramycin and 32pg/mL kanamycin. Microtitre plates were incubated at 37°C with
gentle shaking (150 rpm.). After 24 hours of growth, cultures were diluted 1:100 into
fresh media. This dilution step was repeated daily for a total of five transfers. The
densities ofplasmid-ffee, plasmid-harbouring and transconjugant cells were
estimated every 24 hours by serial dilution and selective plating. S-gal was used for
the estimates of plasmid-carrying (black) and plasmid-ffee cells (white), and
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MacConkey plates supplemented with 40mg/L apramycin and 32mg/L kanamycin
for the quantification of transconjugants.
Relative fitness (5) was estimated as described by Lenski et al (1991)
S U^0)/^(0)/^(2)]]iJ [l«[jV7(l)/JV/0)/I»i(2)Jj
Where N/0) and N/0) are the initial densities of the tested clone and the common
competitor (MG1655kan) respectively, and N/l) andN/l) are their corresponding
final densities.
Fitness was estimated after 24 hours of direct competition and also after five days of
direct competition (with a 1:100 dilution of each culture into fresh broth after each
24 hour period). Some workers have calculated fitness only after 24 hours (Dahlberg
& Chao, 2003). The reason for estimating fitness after 24 hours and after five days of
competition was to determine if the estimates differed with longer competition times.
In all assays, the relative fitness was calculated as the growth ofMG1655 relative to
MG1655kan. In this way a positive relative fitness calculated as described by Lenski
et al. (1991) demonstrates a growth advantage ofMG1655 compared to MG1655kan.
The selection rate constant, r (day"1) was calculated by regressing the natural log-
transformed ratio of plasmid-bearing to plasmid-free cell densities against time
(Lenski et al., 1994), over the five day time period.
7.2e Reproducibility ofviable count method
It was hypothesised that the differences between growth rates of plasmid-carrying
and plasmid-free strains may be slight, if detectable. It was important therefore, to
determine the level of variation introduced by the viable count method used to
quantify the numbers of bacteria present. Four colonies ofE. coli 10418 were
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inoculated into 5mL LB and grown for 8 hours at 37°C with shaking at 150 rpm.
The culture was then diluted 100,000 fold in saline. To study the variation with
repeat dilutions, thirty lOOpL aliquots were diluted 10-fold in saline and plated onto
MacConkey plates for quantification (method A). To study variation within one
dilution (method B), a lmL aliquot was diluted 10-fold in 9mL saline, and 30
aliquots of this dilution were subsequently plated out onto MacConkeys plates.
7.2fStatistical analyses
The effects ofplasmid, host, media (LB or MM) and detection plate (MacConkeys or
MacConkeys supplemented with 16mg/L apramycin) on the number of cfu/mL
during the five-hour growth experiments and five-day competition assays were
analysed with generalised linearmixed effects models. Data that were not normally
distributed were log-transformed before the analysis was performed. Different flasks
or wells were entered as a random effect to account for both the variation between
replicate experiments and the lack of independence between samples. Type of
detection plate was included in the model as a fixed effect to determine whether
plasmid segregation was occurring in any of the experiments.
A second linear mixed effects model was run to study the effect ofplasmid carriage
during the five-hour growth experiments. Non-significant interactions were removed
from the previous models, and time, host (J53 or MG1655), media (LB or MM) and




7.3a Variation introduced by the viable count method
Thirty replicate dilutions of E. coli 10418 (method A) and 30 replicate aliquots of the
same diluted E. coli 10418 culture (method B) were plated onto MacConkeys plates
for quantification by the viable count method. Figure 7.1 shows the spread of counts















Figure 7.1 Spread of counts obtained when repeat dilutions of the same bacterial
culture was diluted and plated out 30 times (blue bars; method A), and when 30
repeat aliquots of the same culture were plated out (pink bars; method B).
Figure 7.1 shows that although all replicate counts were performed on dilutions of
the same 8-hour bacterial culture, a variety of counts are obtained. The counts were
not significantly different between the two methods (Tx = 0.54, P = 0.591), but
ranged from 21 to 81. If the colony counts of two samples differed by less than 60
colonies, it would be difficult to state whether the two samples contained
significantly different cfu/mL. This is because the variation observed may be a result
I I—
A B
21 23 25 27 29 31 33 35 37 39 41 43 45 47 49 51 53 55 57 59
No. of colonies
61 63 65 67 69 71 73 75 77 79 81
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of variation introduced by the methodology. Table 7.1 lists the descriptive statistics
of the data sets from each method.
Statistic Method
A B
No. of replicates 30 30
Mean 46.6 45
Standard Error 2.2 1.9
Standard Deviation 12 10.4
Coefficient of variation 0.26 0.23
Range 60 (21-81) 48(22-70)
Table 7.1 Descriptive statistics of data from method A and method B.
The range of counts, standard error and standard deviation indicate that method A
(multiple dilutions of the same culture) generates slightly more diversity in the
colony counts than multiple aliquots of a diluted culture (method B). The variation
between the two methods was insignificant (F = 1.55, P = 0.248). From the results
described in Figure and Table 7.1, it was decided that a difference of at least 60
colonies should be present between identical dilutions of two given cultures, to be
certain that they had different cfu/mL of bacteria.
7.3b Five-hour growth rate comparisons
Firstly, the growth curves of each strain (MG1655pUK2002, MG1655kan,
J53pUK2002 and J53) in LB and MM was plotted (at least five replicates) to
determine the phases of growth exhibited under these conditions. The growth curves
of replicate cultures in LB are shown in Figure 7.2. and the geometric means of each
of these, in Figure 7.3. Similarly, the growth curves of replicate cultures in MM and
the geometric means of these results are shown in Figures 7.4 and 7.5 respectively.
The missing data points on the graph occur when the number of cfu on a plate was of
an uncountable number (>300cfu). The exclusion of these data points does not affect
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the ability of the linear mixed effects model to determine the significance of any
observed trends.
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Figure 7.2 Replicate growth curves of a, MG1655pUK2002; b, J53pUK2002; c,
MG1655kan; and d. J53 in lOmL LB.
In Figure 7.2 it can be seen that the replicate experiments show similar trends
overall, but there are times during the experiment where more variation is present.
During the first hour, more variation between the five replicates ofMG1655kan is
observed than at 1.5 and 2 hours. This may result in inaccurate estimates of growth
rates if they are measured from the moment of initial inoculation (t = 0), as the slopes
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of each replicate ofMG1655kan during the first hour are quite different. In the
graphs of J53pUK2002 and J53 (b and d respectively) replicate cultures, the slopes
of each replicate appear very similar except at 4 and 5 hours. Here, the viable counts
of some replicates continue to increase where in other replicates they either decrease
or reach a stationary phase with no overall increases in viable cell numbers. Overall,
it appears that variation between replicate growth curves is most evident during the
first hour and after the fourth hour of growth.
Lag Exponential Rost-exponential
Time (hours)
Figure 7,3 Geometric mean growth curves of MG1655pUK2002, MG1655kan,
J53pUK2002 and J53 in lOmL LB.
In the comparison of the geometric mean growth curves of MG1655pUK2002,
MG1655kan, J53pUK2002 and J53 (Figure 7.3), all four cultures demonstrate a one
152
hour period of reduced growth in comparison to the exponential phase occurring
between one and four hours. The decreased growth rate is more evident with cultures
ofMG1655pUK2002 and J53. After four hours, the cultures enter a post-exponential
growth phase, where J53pUK2002 and J53 cultures show a more dramatic decrease
in growth rate than MG1655pUK2002 and MG1655kan. In this way, after four hours
the growth curve varied in a manner dependent on the host strain (J53 or MG1655).
With respect to determining differences in growth rates between plasmid carrying
and plasmid free strains, it is important to define periods of growth that are most
comparable. From Figure 7.2, it is clear that less variation between replicate growth
curves is present during one and four hours. Between the four different strains,
obvious variation was present during the lag and post-exponential growth phases. In
the post-exponential phase, the pattern of growth appeared dependent on host strain.
Therefore, only data from the exponential phase (between one and four hours) was
used to compare growth rates between plasmid-free and plasmid-carrying strains.
The increase in cfu/mL over time was host specific, with MG1655 cultures
(irrespective of plasmid carriage) containing significantly less cfu/mL with time
(slower growth) than J53 strains, t50 - -4.17, P =0.0001. Plasmid segregation was
discounted as changes in cell numbers over time revealed no significant difference in
the recovery of plasmid-carrying cells on MacConkey plates or on MacConkey plates
supplemented with 16mg/L apramycin, fto ~ 0.59, P = 0.56
In MM more variation between replicate experiments was apparent (Figure 7.4) than
between replicates in LB (Figure 7.2). This is likely to be because of variation
introduced when making the MM, as each flask was made up separately from double
concentrate DM, distilled water and glucose. Slower growth was predicted in MM
than in LB. and this is what is observed, with the presence of <18 Ln cfu/mL after
five hours compared to around 21 Ln cfu/mL in LB. The J53pUK2002 starter culture
may have contained more cells than the other starter cultures, because the cultures at
time Ohr contain more cfu/mL than the other three growth curve experiments.
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The geometric mean growth curves in MM (Figure 7.5) show less well-defined
growth phases compared to those in LB (Figure 7.3). The growth curves of
MG1655kan and J53 have much more distinct lag phases than those of the plasmid-
carrying strains (MG1655pUK2002 and J53pUK2002). None of these curves reach a
post-exponential phase, which was observed in LB.
To keep the two data sets (LB growth and MM growth) as comparable as possible,
again only data between one and four hours were used in the statistical analysis
Figure 7.4 Replicate growth curves of a, MG1655pUK2002; b, J53pUK2002; c,







Figure 7.5 Geometric mean growth curves ofMG1655pUK2002, MG1655kan,
J53pUK2002 and J53 in lOmL MM.
In MM, cultures of J53 (with or without plasmid) contained significantly more
cfu/mL overall, during the course of the experiment than cultures ofMG1655 (with
or without plasmid) tg = -2.41, P = 0.039. The increase in cfu/mL with time was host
specific, with J53 cultures growing significantly faster than MG1655 cultures, t6i = -
2.16, P = 0.035. Plasmid segregation was again discounted as changes in cell
numbers over time revealed no significant difference in the recovery of plasmid-
carrying cells on MacConkey plates or on MacConkey plates supplemented with
16mg/L apramycin, ts7 = -92, P = 0.36.
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In the final model the growth of J53, J53pUK2002, MG1655kan and
MG1655pUK2002 were compared. The number of cfu/mL in each culture of
plasmid-carrying strains (J53pUK2002 and MG1655pUK2002) throughout the
course of the experiment did not differ significantly from those of plasmid-free
cultures, t3i = 1.35, P - 0.19. Plasmid carriage did not affect the changes in cfu/mL
over time (i.e. cell growth), tni = 0.363, P = 0.7172. The increase in cfu/mL over
time was host-dependant, with MG1655 cultures growing significantly slower than
J53 cultures, tm, P - < 0.0001.
7.3c Five-hour growth in direct competition
When plasmid-carrying (J53pUK2002 and MG1655pUK2002) and plasmid-free (J53
and MG1655kan) strains were grown in direct competition, the mean colony counts
of competing strains did not differ by > 60 colonies. This suggests that plasmid
carriage did not affect growth because this level of variation could occur on account
of the methodology. When tested statistically, overall fewer cfu/mL were present in
MG1655 cultures (either plasmid-carrying or plasmid-ffee MG1655) than J53
cultures, Xn = -3.86, P = 0.002, but the growth rates ofMG1655 strains and J53
strains were not significantly different, t245 = 0.94, P = 0.35.
Plasmid carriage did not affect the numbers of cfu/mL over the course of the
experiments, t243 = -0.14, P = 0.89, and did not affect the growth rates of the host
strain (increase in cfu/mL with time), t243 = 1 -06, P = 0.29. Plasmid segregation was
discounted in both LB and MM, as changes in cfu/mL with time were not
significantly different when measured on MacConkey plates and MacConkey plates
supplemented with 16mg/L apramycin, t46 = -0.2, P = 0.85 (LB data), and t7o = -1.19,
P = 0.24 (MM data).
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7.3d Five-day growth in direct competition
Relative fitness estimates and selection rate constants of plasmid-carrying MG1655
in direct competition with MG1655kan are listed in Table 7.2. The control for this 5-
day competition assay was the direct competition ofMG1655 and MG1655kan.
Relative fitness estimates ofSy = 0.005 + 0.005 after 24 hours revealed that the
insertion of the kanamycin resistance gene into MG1655 marginally reduced the
competitive fitness of the strain (Table 7.2). The relative fitness cost of the
kanamycin resistance gene is more evident after five days of competition.
If there is no difference in the growth rate of two competing cultures but one has a
higher inoculum, the difference in competing cell densities may be amplified with
each repeat passage. To ensure that variation the number of bacteria present in the
initial cultures did not influence the outcome of the competition, control experiments
were repeated with an initial ratio of 1:2 and of 2:1 MG1655 to MG1655kan. The
selection rate constants of six replicate competitions did not differ significantly when
initial ratios of 1:2 or 2:1 were used (t6 = -0.386, P = 0.712).
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Table 7.2 Relative fitness estimates and selection rate constants ofMG165 5
harbouring plasmid pUK2001, pUK2002 or pUK2003, in direct competition with
MG1655kan.
Plasmid
Selection rate constant (r) Relative fitness Sijb
Replicate (day1)3 24h 5 day
1 0.253 0.145 0.290
2 0.219 0.149 0.236
3 0.293 0.295 0.405
4 0.330 0.188 0.593
5 0.107 0.144 0.263
6 0.136 0.211 0.319
mean 0.223 + 0.088 0.189 + 0.024 0.351 +0.054
1 0.358 0.140 0.638
2 0.378 0.182 0.361
3 0.190 0.350 0.332
4 0.215 0.143 0.301
5 0.351 0.199 0.405
6 0.511 0.124 0.437
mean 0.334 + 0.117 0.190 + 0.034 0.412 + 0.049
1 -0.0839 0.003 -0.071
2 -0.0915 0.015 -0.043
3 -0.1261 0.029 -0.072
4 -0.0361 0.016 -0.056
5 0.0065 ND -0.041
6 -0.0601 ND -0.057
mean -0.069 + 0.044 0.016 + 0.01 -0.057 + 0.01
1 0.0567 0.016 0.077
2 0.0047 0.008 0.059
3 0.0295 -0.009 0.014
4 0.0704 0.004 0.052
5 0.0682 ND 0.058
6 0.0051 ND 0.000





a Standard deviation is given for each mean estimate, b standard error is given for each mean estimate.
Table 7.2 shows that pUK2001 and pUK2002 confer fitness advantages on MG1655
that are far greater than the advantage of this strain over its kanamycin resistant
counterpart. The fitness advantages conferred by carriage of these plasmids are more
evident after five days of competition. The mean colony counts of the raw data
showed a difference of> 60 colonies after day three and day one for pUK2001 and
pUK2002 respectively. The selection rate constants for MG1655 carrying these
plasmids were significantly different from the control (pUK2001; tio = -4.87, P =
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0.0006, pUK2002; tio = -5.96, P = 0.0001). Plasmid segregation of pUK2001 or
pUK2002 was discounted, as changes in cfu/mL with time did not differ significantly
when measured on S-gal plates or MacConkey plates supplemented with 16mg/L
apramycin (Us = 0.96, P = 0.342, tn2 = 1.18, P = 0.24 respectively). Over the five
days of competition, cfu/mL ofMG1655pUK2001 differed significantly from those
ofMG1655kan (t5i - -1.24, P < 0.0001). Cfu/mL ofMG1655pUK2001 increased
significantly with time (t23 = 4.67, P - 0.0001).
The increase over time of cfu/mL ofMG1655pUK2002, compared to MG1655kan
was significant, tug = -11.133, P = <0.0001. When separate models ofthe
MG1655pUK2002 or the MG1655kan data were run, the cfu/mL ofMG1655kan
decreased significantly over time, ts7 = -12.89, P <0.0001.
In contrast, pUK2003 appeared to confer a fitness cost which was detectable after
five days of competition (Table 7.2). After only 24 hours of competition, the
difference in relative fitness was not significant (t9 = -1.533, P = 0.176). Fewer
cfu/mL ofMG1655pUK2003 compared to cfu/mL ofMG1655kan were detected
during the course of the assay, but the difference was not significant (t33 - -0.92, P =
0.36). Cfu/mL ofMG1655pUK2003 decreased with time, but this decrease was not
significant (ti4 = -0.72, P = 0.48). Consistent with these statistical findings, the
colony counts of competing strains throughout the five-day competition did not differ
by > 60 colonies.
7.4 Discussion
Resistance plasmids are threatening the successful management of both human and
animal bacterial infections. Traditionally, the carriage of resistance plasmids is
thought to engender a competitive fitness disadvantage on the host bacterium, in the
absence of selective pressure by antibiotics (Goodwin & Slater, 1979; Lee & Edlin,
1985; Noack et al., 1981; Zund & Lebeck, 1980). In this way, the presence of
plasmid-mediated resistance may be limited by restricting the use of the selective
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antibiotics, allowing sensitive strains to outcompete the resistant bacteria. A few
reports have documented the amelioration of a fitness disadvantage conferred by the
presence of chromosomal mutations (Bjorkman et al., 1998; Reynolds, 2000),
transposable elements (Hartl et al., 1983; Modi et al., 1992) conjugative and non-
conjugative plasmids (Bouma & Lenski, 1988; Enne et al., 2004b; Negri et al.,
2000). Very few of these reports have studied naturally occurring plasmids,
focussing mainly on cloning vectors and common laboratory plasmids (Bjorkman &
Andersson, 2000). There appears to be no studies of fitness costs associated with
plasmids isolated from veterinary isolates. The aprR plasmids identified in the
commensal E. coli of the calves sampled in this study were large (> 90kb), and so the
presence of a fitness disadvantage associated with the carriage of these plasmids was
expected.
Previously, the biological cost of resistance has been measured experimentally by
estimating growth rates of sensitive and resistant bacteria in monocultures (Bjorkman
et al., 1998), or by pairwise competition studies in batch cultures (Dahlberg & Chao,
2003; Enne et al., 2004b; Lenski et al., 1994), chemostats (Helling et al., 1981, Modi
et al., 1992) or experimental animals (Bjorkman et al., 1998; Enne et al., 2004a;
Negri et al., 2000). In this chapter growth rate comparisons ofmonocultures and
competing cultures were compared, in addition to pairwise competition studies in
batch culture.
The growth of isogenic strains with and without pUK2002, in single culture
experiments and during direct competition, did not reveal any significant differences
in growth rates. Similarly, Enne et al. (2004b) did not find significantly shorter
generation times of plasmid-carrying strains compared to their isogenic plasmid-free
counterparts. The use of linear mixed effects models to analyse the data, enabled
more information to be gleaned than by comparing growth rates by paired t-tests, in
that interactions between factors such as media and host strain could be analysed.
This meant it was possible to account for any differences for example, between the
host strain used, when studying the effect of plasmid carriage. The growth of
isogenic plasmid-carrying and plasmid-free strains for five hours, either in direct
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competition or in single cultures may be too short a period for any slight differences
in growth rate to be detected. A five-day pairwise competition was performed to test
this hypothesis.
Different fitness cost estimates have been used to quantify the difference in
competitive fitness between two strains (Lenski et al., 1991). These include estimates
of relative fitness (Helling et al., 1981; Reynolds, 2000), per generation fitness
impact (Enne et al., 2004a, 2004b), generation times (Bjorkman et al., 1998) and
selection rates or coefficients (Dahlberg & Chao, 2003; Lenski et al., 1994; Modi et
al., 1992; Negri et al., 2000). The lack of a standard estimate to quantify fitness costs
leads to difficulties in comparing results between studies. In this chapter, both the
selection coefficient and the relative fitness (as described by Lenski et al., 1991)
were used to allow the results to be compared with those of similar published studies.
During five days of pairwise competition, the average selection coefficient of
pUK2002 was found to be r — 0.334 day+ 0.117. Similar selection coefficients
(r = 0.216 day"1 + 0.043) have been described by Lenski et al. (1994) for a 2.9kb
plasmid conferring tetracycline resistance. The authors suggest that the tetracycline
resistance gene (tetC) was the factor responsible for the enhanced fitness with
plasmid carriage in the co-evolved host. Interestingly, plasmids pUK2002 and
pUK2003 also carry a tetracycline resistance determinant (tetB). Plasmid pUK2003
did not confer a fitness advantage, and demonstrated a potential fitness cost
(r = -0.069 + 0.044 day _1) although more replicate experiments and longer
competition times would be required to improve the significance of this result, so this
gene may be unrelated to the fitness advantage of pUK2002.
The competitive fitness advantage ofpUK2001 and pUK2002 was observed in hosts
that had no evolutionary history of association. This is a surprising result because the
competitive fitness advantage described by Lenski et al. (1994) was only present
when the plasmids and hosts had coevolved for 500 generations. In contrast, Enne et
al. (2004b) report a fitness advantage in both naive and adapted hosts, of a 6.2kb
plasmid conferring sulphamethoxazole and streptomycin.
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The relative fitness of pUK2001 and pUK2002 (S= 0.189 ± 0.024 and 0.190 ± 0.034
respectively) after 24 hours of competition are within the range ofmean fitness
estimates ofRl- or RP4-bearing J53 after 24h following approximately 1100
generations of growth in an antibiotic-free environment (range of 0.16 to 0.35)
(Dahlberg & Chao, 2003).
The five-day pairwise competition study described in this chapter has an advantage
over the five-hour competition study in that more components of bacterial growth are
compared. For example, differences in initial lag phase, speed of growth in
exponential phase, and efficiency of resource utilisation. Over 24 hours, all available
resources are used up and the cells enter stationary phase. Upon subculture into fresh
broth, this complete cycle of growth is repeated. A substantial amount of variation
occurred between the replicate competition experiments described in this chapter,
demonstrating the necessity for repeat estimates of fitness.
The results of this chapter indicate that pUK2001 and pUK2002 confer a competitive
fitness advantage on the naive host strain MG1655, under the conditions tested
(minimal media, incubation at 37°C with shaking at 150 rpm.). At present the nature
of this advantage is unknown. The plasmids may carry a metabolic function aiding
growth of the host strain under the conditions tested. To determine whether a gene
present on the plasmid is responsible for conferring a competitive advantage will
require sequencing of the plasmids.
It is also unclear at this stage whether the competitive advantage observed in vitro
will also occur in vivo. Although an attempt was made to stress the cells by growing
them under nutrient limited conditions, this is unlikely to be as stressful as conditions
in vivo. Intestinal E. coli must compete for nutrients against many other intestinal
micro-organisms (bacteria; Bacteroides spp. Klebsiella, Proteus, Streptococcus
faecalis; the yeasts Candida and Torulopsis; and protozoa; Entamoeba) (Stanier et
al., 1983), some ofwhich may produce bacteriocins (Avelar et al., 1999). Gut
bacteria are likely to be exposed to cycles of nutrient starvation and abundance in
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vivo (Hardy, 1984). The carriage and maintenance of a large accessory genetic
element is likely to require more of the cells available energy, than to not carry it.
During periods of starvation, when the cell must reduce its metabolic activity in
order to survive, strains without the plasmid are likely to overgrow those with a
plasmid unless there is direct selection for its presence. Other conditions may arise
when it is more advantageous to carry such a plasmid. However, on consideration of
the occurrence of these aprR plasmids (which required selective isolation for their
detection), they are rare in the commensal population studied, and so it is likely that a
selective pressure not yet identified is responsible for their presence. This may be co-
selection by tetracycline or streptomycin farm usage for pUK2002, or the use of
disinfectants or feed supplements, as is discussed in Chapter 5.
Although the fitness advantage described in this chapter should be interpreted with
caution until in vivo studies have been performed, this work demonstrates an in vitro
competitive fitness advantage associated with the carriage of pUK2001 and
pUK2002 that is comparable to other published studies.
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Chapter 8. The search for extended-spectrum beta-lactamases
8.1 Introduction
In 1965 the first plasmid-mediated P-lactamase in a gram-negative organism, was
described (Datta& Kontomichalou, 1965). This enzyme was designated TEM-1 after
the Greek patient, Temoniera, from whom it was isolated. TEM-1 efficiently
hydrolyses amoxycillin, and is commonly found on transposons (Yamamoto et al.,
1982) and plasmids (Gulay et al., 2000; Simpson et al., 1980). Because of the
mobility of these genetic elements, the enzyme TEM-1 has been able to spread to
other species of bacteria, such as Klebsiella (Jeong et a!., 2004a), Proteus (Chanal et
al., 2000), Salmonella (Rivera et al., 1991), Pseudomonas (Calderwood et al., 1982)
and Acinetobacter (Vila el al., 1993). TEM-1 has since spread worldwide, and is
currently the most common plasmid-mediated P-lactamase (Amyes et al., 1996). A
sulphydryl variable of this enzyme (SHV-1), originally isolated from Klebsiella
pneumoniae is also commonly found amongst Enterobacteriacae (Heritage et al.,
1999). This enzyme is usually plasmid mediated in E. coli isolates (Bradford, 2001).
Extended-spectrum p-lactams were developed to combat organisms harbouring P-
lactamases. These are based on the original p-lactam structure but with additional
side-chains intended to prevent their hydrolysis. However, each new extended-
spectrum p-lactam used therapeutically has been met with the discovery of a new P-
lactamase (designated extended-spectrum P-lactamases or ESBLs) capable of its
hydrolysis. Most ESBLs are derived from TEM or SHV enzymes, by the presence of
between one and five point mutations enabling the extended-spectrum P-lactams
antibiotics to fit into the active site of the enzyme for subsequent hydrolytic
inactivation (Bush et al., 1995). Other classes ofESBL include those that are based
on CTX-M and OXA enzymes. The latter is commonly found in Pseudomonas
isolates (Danel et al., 1999; Hall et al., 1993; Mugnier etal., 1998), but CTX-M
enzymes have been isolated mainly from salmonella (Edelstein et al., 2004;
Tzouvelekis et al., 2000) and E. coli strains (Brinas et al., 2003b; Jeong et al.,
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2004b). CTX-M enzymes preferentially hydrolyse cefotaxime and are becoming a
huge problem (Pitout et al., 2004; Poumaras et al., 2004). ESBLs are commonly
encoded by self-transmissible or mobilisable plasmids, which further exacerbate the
therapeutic challenges posed by these enzymes.
The presence ofESBLs in organisms causing infections is now a global problem.
The prevalence ofESBLs amongst clinical isolates varies between countries and
even within a country (Winkur et al., 2001). In France 3.2% of 2506
Enterobacteriacae isolated in 1998 produced an ESBL (De Champs et al., 2000). In
contrast, a recent survey in Japan estimated that less than 0.1% ofE. coli and 0.3% of
K. pneumoniae strains isolated possessed an ESBL (Yagi et al., 2000). The type of
ESBL most commonly identified is also often country or region specific. In the
United States TEM-10 producing organisms have caused several unrelated outbreaks
(Bradford et al., 1994; Schiappa et al., 1996; Wiener et al., 1999), but in Europe this
enzyme is much less common (De Champs et al., 2000; Perilli et al., 2002). In
Chicago, a common plasmid harbouring TEM-10 was found in 17 isolates from 20
hospitals or nursing homes (Wiener et al., 1999). PFGE demonstrated that seven
different Klebsiellapneumoniae and E. coli strains were carrying the plasmid,
leading the authors to presume that the plasmid was present in the commensal flora
of the patients. This interesting and alarming speculation is substantiated by other
studies on (3-lactam resistance in commensal organisms (Thomson et al., 1993). In
Turkey, a high incidence of ampicillin resistance has been found in commensal
faecal E. coli from healthy volunteers (Gulay et al., 2000). In South Africa, 94.3% of
ampicillin resistant commensal faecal gram-negatives from healthy volunteers were
found to harbour TEM-1 (Shanahan et al., 1995).
Although extended-spectrum (3-lactams are used in animal husbandry, there have
been very few studies on the characterisation of P-lactamases from healthy food-
producing animals (Brinas et al., 2002; 2003b; Zhao et al., 2001). ESBLs have been
identified in pathogenic organisms from veterinary isolates (Brinas et al., 2003a) but
not yet in commensal isolates. This may be because therapeutic failures have not
occurred or not been detected, and so the presence ofESBLs has not been sought.
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Alternatively, the use of cephalosporins in animal husbandry may have not yet lead
to the selection and development of resistant isolates. The aim of this chapter was to
determine whether any of the commensal E. coli collected from the calf cohort,
demonstrating reduced susceptibility to 3 rd generation cephalosporins, harboured an
ESBL. In addition, a Salmonella enterica serotype Enteritidis isolate (S. Enteritidis),
identified by the Scottish Salmonella Reference Laboratory (SSRL) in Glasgow was
included in the study because it was implicated in a Salmonellosis outbreak during
which therapeutic failures with 3rd generation cephalosporins were reported. Because
antibiotic resistance in relatively uncommon in S. Enteritidis (Vahaboglu el al.,
2001), the mechanism of resistance was of interest.
The two aims of this chapter are described as follows:
1. To determine if the cephalosporin resistant commensal E. coli isolated from the
calves in this study harbour ESBLs.
2. To establish the mechanism of resistance of the S. Enteritidis isolate to 3rd
generation cephalosporins.
8.2 Materials and Methods
8.2a Bacterial isolates
This study was carried out on 52 isolates of the ampR population identified by work
described in Chapter 3 as having reduced susceptibility to 3 rd generation
cephalosporins (cefotaxime MIC > 2mg/L, ceftazidime MIC > 4mg/L).
The S. Enteritidis isolate was collected from an outbreak of salmonellosis in a
general hospital in Glasgow, Scotland. The epidemiology of this outbreak and the




The Salmonella outbreak occurred from the 20th December 2001 to the 21st January
2002, during which nine isolates were obtained from five patients with salmonella
gastroenteritis, and two asymptomatic members of staff. The SSRL identified the
isolates as Salmonella enterica serovar Enteritidis PT21, by agglutination to
polyvalent antisera and phage typing. Isolates ofS. Enteritidis from two patients and
one member of staffwere sensitive to fourteen common antibiotics. The isolates
from the remaining patients and one member of staffwere resistant to ampicillin and
cefotaxime. Plasmid profiling and PFGE were used by the SSRL to demonstrate that
these isolates were clonal and carried a plasmid of 95 kb. One isolate (020003) was
used to determine the mechanism of resistance of the isolates.
8.2c Antibiotic sensitivity
Initial antibiotic susceptibility testing of 183 ampR isolates was performed with a
panel of 25 commonly used antibiotics (Chapter 3). The susceptibility of
S. Enteritidis 020003 to ampicillin and cefotaxime was determined by the SSRL by
disc diffusion.
MICs of the ampR E. coli to amoxycillin, cefotaxime, ceftazidime, and these
antibiotics in combination with clavulanic acid (in a ratio of 2:1 antibiotic to P-
lactamase inhibitor), were determined following BSAC guidelines (Andrews, 2001).
NCTC strains E. coli 10418, S. aureus 6571 and E. coli 11560 were used as controls.
Susceptibility testing of S. Enteritidis 020003 to ampicillin, cefaclor, cefotaxime and
ceftazidime was performed using Etest strips (AB Biodisc, Sweden) following the
manufacturer's instructions.
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8.2d Determination ofthe presence ofan ESBL
The presence or absence of an ESBL was determined by Etest strips specific for the
detection ofESBLs, containing cefotaxime or ceftazidime, with and without
clavulanic acid, and by double disc synergy tests (Livermore & Brown, 2001). Discs
containing lOpg cefpodoxime, 30pg ceftazidime or 30pg cefotaxime with and
without clavulanic acid (lpg with cefpodoxime and 1 Ojxg with ceftazidime or
cefotaxime) (Oxoid, Basingstoke, UK) were placed on 1ST agar plates (Oxoid)
inoculated with 0.5 McFarland standard of test organism. Plates were incubated for
12-18 hours at 37°C. A positive result for the presence of an ESBL was recorded if
the inhibition zone around the disc containing cephalosporin and clavulanic acid was
>5mm larger than that around the disc containing only the cephalosporin.
NCTC organisms E. coli 11560 (TEM-1 +ve) and E. coli 10418 (ESBL -ve) were
used as positive and negative controls respectively, for both the double disc synergy
tests and Etest strips.
8.2e Amplification ofbla-xEM-i and hlasnv-i
The B-lactamase genes blaTEM.{ and blaSw-\ were sought by PCR using a Taq
polymerase kit (Promega) and the following oligonucleotide primer pairs: Watem-i,
5'ATGAGTATTCAACATTTCCG-3\ 5' -CCAATGCTTAATCAGTGAGG-3'; and
blasm-u 5'-GCCCGGGTTATTCTTATTTGTCGC-3', 5'-
CTTTCCGATGCCGCCGCCAGTCA-3'. DNA was initially denatured for 5 min at
95°C, followed by 30 cycles ofamplification, and a final 10 min extension at 72°C.
The amplification of 6/aTEM-i comprised a 30 sec denaturation at 95°C, 1 min of
annealing at 53.3°C, and 1 min extension at 70°C. For 6/asHV-i cycles of 30 sec
denaturation at 95°C, 30 sec of annealing at 68°C, and 50 sec extension at 72°C, were
used. Sequencing was performed by the chain termination method (Sanger et al.,
1977) in forward and reverse directions, and the sequences were compared with




Initial breakpoint susceptibility testing revealed that 52 of 183 ampK commensal
E. coli tested, demonstrated reduced susceptibility to the 3rtt generation
cephalosporins cefotaxime (> 2mg/L) or ceftazidime (> 4mg/L). The MIC values of
these isolates to amoxycillin, cefotaxime, ceftazidime, and these antibiotics in
combination with clavulanic acid are shown in Figure 8.1 To display the MICs of
the 52 isolates in a graph, isolates were sorted in ascending order according to firstly
their amoxycillin MIC, then cefotaxime MIC, and final by their ceftazidime MIC.
This was to aid the identification of isolates for further study. The isolates selected
(n = 16) are highlighted on Figure 8.1 by black squares. These isolates were chosen
to give a range of isolates representative of a group with similar sensitivity profiles,
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Figure 8.1 MICs of 52 isolates to amoxycillin, cefotaxime, ceftazidime, and these
antibiotics in combination with clavulanic acid. Sixteen isolates were selected for
further study. These are highlighted with black squares.
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The susceptibilities of these 16 isolates to a range of cephalosporins and (3-lactams
are listed in Table 8.1. The breakpoint susceptibilities were determined as described
in Chapter 3. The actual MIC values of amoxycillin, ceftazidime, cefotaxime, and
these antibiotics in combination with clavulanic acid, are given in brackets next to
the phenotype.
Table 8.1 Susceptibilities of 16 ampR isolates selected for further study to (3-lactams
and cephalopsorins.
Antibiotic (low and high breakpoints listed below)
AMP AZL PEN AZT THN DNE URX FOX TIZ AMX AMX/C TAX TAX/C TAZ TAZ/C
4 6 0.12 2 4 8 8 8 2 4 2 2 2 4 4
32 64 32 8 16 32 32 32 16 32 8 16 16 16 16
Isolate
WF006962-4 R R R I R R I I S R (128) R (32) S (0.5) S (0.5) I (8) S (2)
WF006986-4 R R R S R R R R I R(256) R (32) I (2) I (2) R (16) I (8)
WF007204-4 R R R I R R I I s R(256) R (32) I (2) I (2) I (4) I (4)
WF007013-1 R R R I R R I I s R(>256) R (32) S(1) S (1) I (4) I (4)
WF006996-3 R R I R R R I R I R(>256) R (32) I (2) S(1) R (16) I 64)
WF007104-4 R R R R R R I R I R(>256) R (32) I (2) S (1) I (8) l(>4)
WF0G7104-9 R R R R R R S R I R(>256) R (32) I (2) s (1) R (16) I (>4)
WF006720-3 R R R R R R I R s R(>256) R (32) 1(2) I (2) R (16) I (8)
WF006720-4 R R R R R R R R I R(>256) R (32) 1(2) I (2) R (16) I (8)
WF006831-5 R R R I R R I R s R(>256) R (32) 1(2) I (2) I (8) I (8)
WF006831-6 R R R R R R R R I R(>256) R (32) 1(2) I (2) R (16) I (8)
WF006959-1 R R R S R R R R I R(>256) R (32) 1(2) I (2) R (16) R (16)
WF007490-3 R R R R R R I R I R(>256) R (>128) 1(2) I (2) I (8) K>4)
WF007490-7 R R R R R R R R I R(>256) R (>128) 1(2) I (2) R (16) I (>4)
WF007558-1 R R R I R R R R s R(>256) R (>128) 1(2) I (2) R (16) I 64)
WF007766-1 R R R R R R R R I R(>256) R (>128) 1(2) I (2) R (16) I 64)
AMP: ampicillin, AZL; azlocillin, PEN: penicillin, AZT: aztreonam, THN; cephalolhin, DNE;
cephradine, URX; cefuroxime. FOX; cefoxitin. T1Z; ceftizoxime. AMX: amoxycillin, AMX/C;
amoxyclavulanic acid. TAX; cefotaxime, TAX/C; cefotaxime + clavulanic acid, TAZ; ceftazidime.
TAZ/C; ceftazidime + clavulanic acid. Yellow highlighting demonstrates isolates found to harbour
blaTEM-i- Breakpoints concentrations given in pg/mL
Table 8.1 shows that all 16 isolates are resistant to the lsl generation cephalosporins;
cephalothin and cephradine. More variation in resistance phenotype is present with
the 2nd generation cephalosporins; cefuroxime (URX) and cefoxitin (FOX). No
resistance to the 3ld generation cephalosporin ceftizoxime (TIZ) is observed, in
contrast to ceftazidime (TAZ) to which 10/16 are resistant. The presence of an ESBL
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is indicated, but not proven by an eight-fold difference in the MIC of a 3rd generation
cephalosporin and the MIC obtained when this antibiotic is used in combination with
a P-lactamase inhibitor (e.g. clavulanic acid). According to these criteria, none of the
isolates were thought to possess an ESBL.
Screening for blctiEu-i revealed that the following isolates (isolate number is given
after the sample number separated by a dash) (WF00-) 6720-3, 6720-4, 6831-5,
6831-6, 6996-3, 7104-4, 7104-9, 7490-3, 7490-7 and 7558-1 harboured this gene.
These are highlighted in yellow in Table 8.1. The resistance profiles of isolates
(WF00-) 6986-4, 7204-4, 7013-1, 6959-1, and 7766-1 are suggestive ofAmpC-type
(3-lactamases. These enzymes are usually resistance to ampicillin, amoxycillin,
ceftazidime (MIC > 4mg/L), cefotaxime (MIC > lmg/L), cefoxitin (MIC > 16mg/L),
and often (but not always) resistant to monobactams such as aztreonam. AmpC-type
P-lactamase MICs are usually higher for ceftazidime than for cefotaxime, a result
that is observed for all 16 isolates (Table 8.1).
The salmonella isolate S. Enteritidis 020003 was resistant to ampicillin (>128mg/L),
cefaclor (>128mg/L), cefotaxime (8mg/L) and ceftazidime (>32mg/L).
8.3b Determination of the presence ofan ESBL
E-test strips and double disc diffusion tests confirmed that none of the 16 commensal
E. coli isolates harboured an ESBL. S. Enteritidis 020003 did have an ESBL
according to these tests.
8.3c Amplification ofA/atem-/ and b/ashv-i in S. Enteritidis 020003
PCR with b/aSHv.\ primers failed to detect a gene encoding an SHV-1 derivative in
S. Enteritidis 020003. Amplification of bla^u-i in this isolate yielded a product of
the expected size (858bp). The comparison of the DNA sequence of this product with
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blajem-i (Lefon-Guilbout et al., 2000) and bla-xEu-si (Lee et al., 2003; Poyart et al.,
1998) showed that this gene encoded blajem-52- 5/atem-52 differs from blajEu-i by
amino acid substitutions at positions Glu-104-»Lys (GAG-»AAG), Met-182->Thr
(ATG—> ACG) and Gly-238—» Ser (GGT—»AGT). The changes identified in addition
to a silent mutation identified at codon 134 are listed in Table 8.2.
Table 8.2 Comparison of £/«tem from S. Enteritidis 020003 and published blatem-i,
and blaTEu-52 sequences
Amino acid (codon) at position
p-lactamase 104 134 182 238 Reference
TEM-l Glu(GAG) Ala(GCG) Met (ATG) Gly (GGT) Leflon-Guibout etal., 2000
TEM-52 (S. Enteritidis 02003) Lys(AAG) Ala(GCG) Thr (ACG) Ser(AGT) This work
TEM-52 (5. Saint Paul) Lys(AAG) Ala(GCT) Thr (ACG) Ser (AGT) Lee etal. ,2003
TEM-52 (K. pneumoniae) Lys(AAG) Ala(GCG) Thr (ACG) Ser (AGT) Poyart etal., 1998
8.4 Discussion
Although the 52 isolates identified in this work had reduced susceptibility to 3rd
generation cephalosporins, they did not harbour any ESBLs. Similarly, Brinas et al.
(2002) did not find any ESBLs in ampicillin resistant E. coli from food, humans and
healthy animals. Based on susceptibility profiles, the isolates were thought to harbour
either 6/gttem-i (conferring high level resistance to amoxycillin), an AmpC-type P-
lactamase, or both. In E. coli, the chromosomal ampC gene is normally expressed at
low levels, but production of this enzyme can be increased by gene duplication or by
mutation in the ampC promoter or attenuator (Caroff et al., 2000; Nelson & Elisha,
1999). More recently, plasmid-mediated AmpC-type P-lactamases have also been
found in E. coli from food-producing animals (Zhao et al., 2001) and Salmonella
spp. (Allen & Poppe, 2002).
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The primary aim of this section of the chapter was to determine if the calf faecal E.
coli harboured any ESBLs. Reduced susceptibility to the cephalosporins was
demonstrated in 16 isolates, and Wcttem-i was detected in ten of these. Unfortunately
due to time restrictions, it was not possible to determine the exact mechanism of this
reduced susceptibility in the other six isolates. The hypothesis that some of these
isolates harboured AmpC P-lactamases, may be tested by isoelectric focusing and
PCR to amplify and sequence the 6/aAmpC gene implicated by the pi value (Allen &
Poppe, 2002; Brinas et al., 2003b; Zhao et al., 2001. It would also be of interest to
determine if the resistance gene was transferable by conjugation, as has been found
for some AmpC-type P-lactamases (Alvarez et al., 2004; Knox, 1995; Zhao et al.,
2001).
The S. Enteritidis isolate was of interest because antibiotic resistance is not common
in this serovar (Vahaboglu et al., 2001). The isolate was implicated in a
Salmonellosis outbreak during which therapeutic failures with 3rd generation
cephalosporins were reported. In the treatment of extraintestinal salmonella infection
the antibiotics of choice are extended-spectrum cephalosporins and fluoroquinolones.
Recently, Salmonella isolates harbouring extended-spectrum B-lactamases (ESBLs)
capable of hydrolysing third-generation cephalosporins have been reported (Lee et
al., 2003; Vahaboglu et al., 2001). This is of particular concern for the treatment of
salmonellosis in children, because fluoroquinolones cannot be used in this age group.
The resistance detected to the 3rd generation cephalosporins ceftazidime and
cefotaxime was mediated by blajem-52 (mutations at codons 104, 182 and 238,
compared to 6/axEM-i)-
A change in residue 104 from either glutamic or aspartic acid to lysine, is the second
most common substitution of the TEM-type ESBLs (Knox, 1995). Here, a negatively
charged residue is replaced by a positively charged residue with a long basic side
chain, which may interact with the carboxylic acid group in ceftazidime, ceftibuten
or aztreonam, increasing initial binding (Knox, 1995). In TEM-type ESBLs, the
substitution from methionine to threonine at position 182 adds an extra hydrogen
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bond between the hydroxyl group of threonine and the carbonyl group of the
glutamic acid in position 64. This may increase the stability of the protein where
multiple mutations are present (Poyart et al., 1998). The substitution Gly-238-» Ser,
occurs in 27 TEM variants and in all SHV mutants. Position 238 is in a key beta-
strand of the catalytic site of class A beta-lactamases, and this mutation has been
found to be critical in increasing resistance to cefotaxime (Blazquez et al., 1995). A
mutation at position 238 has been hypothesised to slightly expand the lower portion
of the P-lactam binding site, allowing larger cephalosporins such as cefotaxime to
form hydrogen bonds with residue 237 in the binding site (Huletsky et al., 1993). A
silent mutation was present in the blajEU-si allele of isolate 020003 at position Ala-
134 (GCT—► GCG) that is not present in other published salmonella TEM-52
sequences (GenBank no. AF126444, AY220520), but which has been reported in a
Klebsiella pneumoniae TEM-52 sequence (GenBank no. Y13612).
In conclusion, reduced susceptibility to cephalosporins was found in 52/183 ampR
commensal E. coli, but no ESBLs were detected amongst a subset (n = 16) of these
isolates. The outbreak strain S. Enteritidis 020003 was found to harbour an ESBL,
and because antibiotic resistance is not common in this serovar the detection of an
ESBL is significant. The enzyme was identified as TEM-52, which has not
previously been reported in Salmonellae in the UK. The TEM-52 gene described




Resistance to antibiotics arises from the use of these agents in human and animal
medicine, and in animal husbandry. The advent of antibiotics into animal husbandry
for treatment, but especially for prophylaxis and growth promotion, has precipitated
concern that this usage poses risks to human health (Swann Committee, 1969;
Salyers, 1999b; Khachatourians, 1998; van den Bogaard & Stobberingh, 2000). The
debate over whether or not human health is being compromised (or will be in the
future) by antibiotic use in animal husbandry is ongoing, with several working
groups and independent scientists stressing the need for more surveillance of
antibiotic resistance not only in pathogens but also in commensal organisms
(Caprioli et al., 2000; Jones et al., 2000; Masterton, 2000; O'Brien, 1997). It is
within this context that the key findings from this thesis are most relevant.
Chapters 3 to 8 contain detailed discussions of the specific results therein, and so this
final chapter aims to address some of the wider issues emerging from these results.
To date there are many reports documenting antibiotic resistance in both human and
animal pathogens, but comparatively little is known about levels of resistance in
commensal organisms in food animals (Salisbury et al., 2002). Notwithstanding this
imbalance in the data available, the hypothesis that antibiotic uses in animals pose a
risk to human health is supported by claims that commensal organisms constitute a
huge reservoir of resistance genes (Salyers, 1999a; Schwarz et al., 2001). On
inspection of the results presented in Chapter 3, it is clear that the commensal E. coli
of calves do harbour resistance genes to a range of antibiotics. In the unselected
population these include ampicillin, amoxyclavulanic acid, cephalosporins (1st, 2nd
and 3rd generation), tetracycline, streptomycin, chloramphenicol, trimethoprim and
sulphamethoxazole.
The fact that isolates harbouring resistance mechanisms to these antibiotics were
identified without selection to amplify their numbers indicates that they constitute a
significant proportion of the population (Chapter 3). However, the relative
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abundance of a particular resistance mechanism is not as important as the fact that it
is present in the population. When the bacterial population is exposed to sufficient
concentrations of an antibiotic, susceptible strains are suppressed and any resistant
strains are amplified (Amyes et al., 1996). Reduced susceptibility within the
commensal E. coli was also found to nalidixic acid, apramycin, gentamicin and
tobramycin. With the exception of apramycin, all of the antibiotics to which reduced
susceptibility was demonstrated are used in human medicine. From this, the
commensal E. coli of calves is concluded to constitute a substantial reservoir of
resistance genes.
After the demonstration of numerous resistance phenotypes, the genotypes of
members of the unselected and the three selected (antibiotic resistant) populations
were examined. Knowledge of the background level of population diversity is
essential if studies on the genetic relatedness ofpathogenic or antibiotic resistant E.
coli are to be put into context. In chapter 4, genotyping by PFGE was found to be
highly discriminatory, enabling the distinction of 55 different genotypes within the
commensal population, in addition to subtypes within six of these genotypes. Fewer
antibiotic resistant genotypes and less diversity of genotypes correlated with
increasing calf age. In the context of the current debate, these results suggest that
meat from older animals is less likely to contain antibiotic resistant E. coli than that
from calves, and so poses less of a risk to human health.
So far, the results from this research have demonstrated that the commensal E. coli of
calves constitute a large reservoir of resistant genes, and that resistant commensal
E. coli comprise many diverse genotypes. For human health to be compromised by
the presence of these resistant commensals, meat or other foodstuff contaminated
with these organisms must be ingested, or the resistance genes transferred to
organisms pathogenic to humans (Piddock, 1996).
In Chapter 5, the horizontal conjugative transfer of a high frequency apramycin
resistance plasmid (pUK2001) into three different genotypes was demonstrated. This
transfer may have occurred in vivo, or in the environment before the strains colonised
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the calves. Two other apramycin resistance plasmids were identified, both ofwhich
had lower transfer frequencies and were not found in multiple genotypes.
Interestingly, the ability ofpUK2001 to transfer into other commensal E. coli
genotypes, isolated from the same sample as that from which pUK2001 was isolated,
was demonstrated in vitro. Therefore, pUK2001 was capable of transfer into these
genotypes, which were present in similar abundances, but had not transferred into
these strains in vivo. This suggests that there are barriers to the spread of resistance
plasmids that are present in vivo, but which may not be evident in in vitro
experiments.
The nature of these barriers include the presence of restriction modification systems
(Murray, 2002), the presence of other plasmids of different incompatibility groups in
a potential recipient (Gordon, 1992), and spatial and temporal barriers such as the in
vivo proximity of donors and recipients (Licht et al., 1999). The application of a
mathematical model to the phenomenon ofplasmid transfer within a population
(Chapter 6) revealed a further inhibition to the spread of plasmids. This is the growth
phase of the mating pair. Experimental data of the population dynamics of plasmid
transfer (chapter 6) did not fit the outcome predicted by the model. The model
overestimated the numbers of transconjugants formed in the later stages of the
mating experiment (from around 2.5 hours) because plasmid transfer varied with
growth phase, not growth rate. In this way, the growth phase of possible donors and
recipients is concluded to be a potential barrier to plasmid spread in a mixed
population.
The results of chapter 6 also demonstrate that the dynamics ofplasmid transfer
cannot be simply explained in terms of cell densities, growth rates and plasmid
transfer rates. The model predicts that plasmids with high transfer rates will be
present at a greater prevalence than plasmids with lower transfer rates. These
comparative prevalences are not observed in vivo, demonstrating that many more
factors influence the dynamics ofplasmid transfer than may be incorporated into an
in vitro experiment (see chapter 6 for details).
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A fitness advantage was observed in E. coli hosts harbouring pUK2001 or pUK2002,
compared to their isogenic counterparts. This is the first demonstration of an in vitro
fitness advantage ofplasmids obtained from commensal isolates. The fitness
advantages measured were comparable to fitness advantages described by other
studies of cloning vectors and common laboratory plasmids. However, the fact that
these plasmids required selection in order to be isolated from the commensal E. coli
population shows that within this population they are rare, and so the in vivo
advantage must be slight, if present at all.
The results from chapters 6 and 7 are very interesting in themselves, but their full
interpretation requires a comparison with the situation in vivo. This comparison
phase has been omitted in some earlier studies (Dahlberg & Chao, 2003; Lenski et
al., 1994; Modi et al., 1992). The results of such in vitro experiments have been used
to support the hypothesis that resistant bacteria in food animals are potential risks to
human health (McGeer, 1998; Salyers & Amabile-Cuevas, 1997). Chapters 6 and 7
demonstrate that although apramycin resistance plasmids may transfer horizontally to
other E. coli, and may not confer a competitive disadvantage on the host bacterium,
in vivo, there are barriers to the spread of these plasmids. The low prevalences of
these plasmids suggest that the cost of carriage is also likely to be greater in vivo.
As mentioned earlier in this discussion, one potential hazard posed by the presence
of resistant bacteria in the flora of food animals is the contamination of foodstuff for
human consumption. This is most easily tracked with zoonotic organisms such as
Salmonella spp. Salmonella is a common resident of the calf intestinal flora, and
causes infections and outbreaks in humans following ingestion (Threlfall, 2002). One
such outbreak is described in chapter 8. Here the mechanism of resistance was found
to be an ESBL. To the best ofmy knowledge ESBLs have not yet been found within
the commensal organisms of calves, and were not harboured by the E. coli isolates
characterised in this thesis. Based on this evidence, and the fact that cephalosporins
are commonly used in the treatment of extraintestinal salmonella infections and other
serious infections (Amyes et al., 1996), the most likely way in which the salmonella
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strain causing the outbreak acquired its plasmid-mediated resistance was from human
usage of cephalosporins.
There are a few reports where resistance mechanisms present in human isolates are
thought to have been acquired from animal isolates (Fey el al., 2000; Spika el al.,
1987; van den Bogaard et al., 1997), but the majority of resistance in human isolates
does not appear to have arisen from the use of antibiotics in animals, but from their
use in human medicine (Cook, 1997; Phillips et al., 2004). Although antibiotic
resistant bacteria are present within the flora of food animals, the way to reduce the
potential hazard this poses is to minimise the spread of organisms between animals
and humans. This can be achieved by better food hygiene practices, such as reducing
cross contamination of raw animal products and cooked foods, washing fruit and
vegetables (as manure is often used in their cultivation), and adequate cooking of
meat based products.
In conclusion, the work presented in this thesis demonstrates that commensal E. coli
of calves do represent a substantial reservoir of resistance genes, ofwhich resistance
to apramycin has been demonstrated to have spread horizontally. For resistant
organisms to pose a threat to human health, they must either contaminate foodstuffs
or transfer their resistance mechanisms to pathogenic organisms. Although the
transfer of apramycin resistance plasmids has been demonstrated, in vivo barriers
exist that are capable of preventing extensive spread throughout a population. The
risk posed by the contamination of foodstuffs can be minimised by good food
hygiene practices. From the evidence provided by this thesis, it is suggested that the
use of antibiotics in animal husbandry poses far less of a risk to human health than
the use of these agents in human medicine. All antibiotic usage provides a selective
pressure for the emergence of resistance, and efforts now need to be concentrated on




Aarestrup, F.M., Kruse, H., Tast, E., Hammerum, A.M., and Jensen, L.B. (2000).
Associations between the use of antimicrobial agents for growth promotion and
the occurrence of resistance among Enterococcus faecium from broilers and
pigs in Denmark, Finland, and Norway. Microbial Drug Resistance 6, 63-70.
Abraham, E.P., and Chain, E. (1940). An enzyme from bacteria able to destroy
penicillin. Nature 146, 837.
Allen, K.J., and Poppe, C. (2002). Occurrence and characterisation of resistance to
extended-spectrum cephalosporins mediated by beta-lactamase CMY-2 in
Salmonella isolated from food-producing animals in Canada. Canadian Journal
ofVeterinary Research 66, 137-144.
Alvarez, M., Tran, J.H., Chow, N., and Jacoby, G.A. (2004). Epidemiology of
conjugative plasmid-mediated AmpC beta-lactamases in the United States.
Antimicrobial Agents and Chemotherapy 48, 533-537.
Amyes, S.G.B. and Smith, J.T. (1974). R-factor trimethoprim resistance mechanism:
an insusceptible target site. Biochemical and Biophysical Research
Communications 58, 412-418.
Amyes, S.G.B., Thomson, C.J., Miles, R.S., and Tillotson, G. (1996). Antimicrobial
chemotherapy. Publishers: Martin Dunitz, London, UK.
Anadon, A., Martinez-Larranga, M.R., Diaz, M. J., Fernandez-Cruz, M.L., Martinez,
M.A., Frejo, M.T., Martinez, M., Fernandez, R., Anton, R.M., Morales, M.E.,
and Tafur, M. (1999). Pharmacokinetic variables and tissue residues of
enrofloxacin and ciprofloxacin in healthy pigs. American Journal ofVeterinary
Research 60, 1377-1382.
Andrews, J.H., and Hall, R.F. (1986). r- and K selection and microbial ecology.
Advances in Microbial Ecology 9, 99-147.
Andrews, J.M. (2001). Determination ofminimum inhibitory concentrations. Journal
ofAntimicrobial Chemotherapy 48, Supplement SI, 5-16.
Andrews, J.M., Walker, R., and King, A. (2002). Evaluation of media for testing the
susceptibility ofPseudomonas aeruginosa by BSAC methodology. Journal of
Antimicrobial Chemotherapy 50,479-486.
Andrup, L. and Anderson, K. (1999). A comparison of the kinetics of plasmid
transfer in the conjugative systems encoded by the F plasmid from Escherichia
coli and plasmid pCFlO from Enterococcus faecalis. Microbiology 145, 2001-
2009.
180
Antunes, P., Machado, J., Sousa, J.C., and Peixe, L. (2004). Dissemination amongst
humans and food products of animal origin of a Salmonella typhimurium clone
expressing an integron-borne OXA-30 beta-lactamase. Journal of
Antimicrobial Chemotherapy 54, 429-434.
Arana, I.I., Justo, J.I., Muela, A., Pocino, M., Iriberri, J., and Barcina, I.I. (1997).
Influence of a survival process in a freshwater system upon plasmid transfer
between Escherichia coli strains. Microbial Ecology 33, 41-49.
Arcangioli, M.A., Leroy-Setrin, S., Martel, J.L., and Chaslus-Dancla, E. (1999). A
new chloramphenicol and florfenicol resistance gene flanked by two integron
structures in Salmonella typhimurium DTI04. FEMSMicrobiology Letters 174,
327-332.
Aslam, M., Nattress, F., Greer, G., Yost, C., Gill, C. and McMullen, L. (2003).
Origin of contamination and genetic diversity ofEscherichia coli in beef cattle.
Applied and Environmental Microbiology 69, 2794-2799.
Atlas, R.M. and Bartha, R. (1998). Development of microbial communities. In:
Microbial Ecology - fundamentals and applications. Addison Wesley
Longman, California. Chapter 6, p. 174-217.
Avelar, K.E., Pinto, L.J., Antunes, L.C., Lobo, L.A., Bastos, M.C., Domingues,
R.M., and Ferreira, M.C. (1999). Production of bacteriocin by Bacteriodes
fragilis and partial characterization. Letters in AppliedMicrobiology 29, 264-
268.
Bachmann, B. (1972). Pedegrees of some mutant strains ofEscherichia coli K-12.
Bacteriological Reviews 36, 525-557.
Bartie, K.L., Wilson, K.J., Williams, D.W., and Lewis. M.A.O. (2000).
Macrorestriction fingerprinting of "Streptococcus millerF group bacteria by
pulsed-field gel electrophoresis. Journal ofClinical Microbiology 38, 2141-
2149.
Bass, L., Liebert, C.A., Lee, M.D., Summers, A.O., White, D.G., Thayer, S.G., and
Maurer, J.J. (1999). The incidence and characterization of integrons, genetic
elements associated with multiple drug resistance, in avian Escherichia coli.
Amtimicrobial Agents and Chemotherapy 43, 2925-2929.
Bates, J., Jordens, J.Z., and Griffiths, D.T. (1994). Farm animals as a putative
reservoir for vancomycon-resistant enterococcal infection in man. Journal of
Antimicrobial Chemotherapy 34, 507-516.
Benveniste, R., and Davies, J. (1971). Enzymatic acetylation of aminoglycoside
antibiotics by Escherichia coli carrying an R factor. Biochemistry 10, 1787-
1796.
181
Bergeron, M.G. and Ouellette, M. (1998). Preventing antibiotic resistance through
rapid genotypic identification of bacteria and of their antibiotic resistance genes
in the clinical microbiology laboratory. Journal ofClinical Microbiology 36,
2169-2172.
Bjorkman, J., Hughes, D., and Andersson, D. (1998). Virulence of antibiotic-resistant
Salmonella typhimurium. Proceedings ofthe National Academy ofScience USA
95, 3949-3953.
Bjorkman, J., and Andersson, D.I. (2000). The cost of antibiotic resistance from a
bacterial perspective. Drug Resistance Updates 3, 237-245.
Blazquez, J., Morosini, M.I., Negri, M.C., Gonzalez-Leiza, M., and Baquero, F.
(1995). Single amino acid replacements at positions altered in naturally
occurring extended-spectrum TEM beta-lactamases. Antimicrobial Agents and
Chemotherapy 39,145-149.
Block, C., Davidson, Y., and Keller, N. (1998). Unreliability of disc diffusion test for
screening for reduced penicillin susceptibility in Neisseria meningitidis.
Journal ofClinicalMicrobiology 36, 3103-3104.
Boerlin, P., Wissing, A., Aarestrup, F.M., Frey, J., and Nicolet, J. (2001).
Antimicrobial growth promoter ban and resistance to macrolides and
vancomycin in enterococci from pigs. Journal ofClinical Microbiology 39,
4193-4195.
Bohannan, B.J.M., and Hughes, J. (2003). New approaches to analysing microbial
biodiversity data. Current Opinion in Microbiology 6, 282-287.
Bouma, J.E., and Lenski, R.E. (1988). Evolution of a bacteria/plasmid association.
Nature 335, 351-352.
Bradford, P.A., Cherubin, C.E., Idemyor, V., Rasmussen, B.A., and Bush, K. (1994).
Multiply resistant Klebsiella pneumoniae strains from two Chicago hospitals:
identification of the extended-spectrum TEM-12 and TEM-10 ceftazidime-
hydrolysing (3-lactamases in a single isolate. Antimicrobial Agents and
Chemotherapy 38, 761-766.
Bradford, P.A. (2001). Extended-spectrum P-lactamases in the 21st century:
Characterization, epidemiology, and detection of this important resistance
threat. Clinical Microbiology Reviews 14, 933-951.
Brau, B., Pilz, U., and Piepersberg, W. (1984). Genes for gentamicin-(3)-N-
acetyltransferases III and IV: I. Nucleotide sequence of the AAC(3)-IV gene
and possible involvement of an IS 140 element in its expression. Molecular and
General Genetics 193, 179-187.
Briggs, C.E., and Fratamico, P.M. (1999). Molecular characterization of an antibiotic
resistance gene cluster of Salmonella typhimurium DTI 04. Antimicrobial
Agents and Chemotherapy 43, 846-849.
182
Brinas, L., Zarazaga, M., Saenz, Y., Ruiz-Larrea, F., and Torres, C. (2002). (3 -
lactamases in ampicillin-resistant Escherichia coli isolates from foods, humans,
and healthy animals. Antimicrobial Agents and Chemotherapy 46, 3156-3163.
Brinas, L., Moreno, M.A., Teshager, T., Zarazaga, M., Saenz, Y., Porrero, C.,
Dominguez, L., and Torres, C. (2003a). Beta-lactamase characterisation in
Escherichia coli isolates with diminished susceptibility or resistance to
extended-spectrum cephalosporins recovered from sick animals in Spain.
Microbial Drug Resistance 9, 201-209.
Brinas, L., Moreno, M.A., Zarazaga, M., Porreor, C., Saenz, Y., Garcia, M.,
Dominguez, L., and Torres, C. (2003b). Detection of CMY-2, CTX-M-14, and
SHV-12 p-lactamases in Escherichia coli faecal isolates from healthy chickens.
Antimicrobial Agents and Chemotherapy 47, 2056-2058.
Bronzwaer, S., Buchholz, U., Courvalin, P., Snell, J., Cornaglia, G., de Neeling, A.,
Aubry-Damon, H., Degener, J., and EARSS participants. (2002). Comparability
of antimicrobial susceptibility tests from 22 European countries and Israel: An
external quality assurance exercise of the European Antimicrobial Resistance
Surveillance System (EARSS) in collaboration with the United Kingdom
National External Quality Assurance Scheme (UK NEQA). Journal of
Antimicrobial Chemotherapy 50, 953-964.
Brown, A.M.C., and Willetts, N.S. (1981). A physical and genetic map of the IncN
plasmid R46. Plasmid 5,188-201.
BSAC (2004). Disc diffusion method for antimicrobial susceptibility testing.
http://www.bsac.org.uk/uploads/ian%202004%20website%20version%203.pdf.
Date last accessed; 19th July 2004.
Burman, L.G., Nordstrom, K., and Bloom, G.D. (1972). Murein and the outer
penetration barrier ofEscherichia coli K-12, Proteus mirabilis, and
Pseudomonas aeruginosa. Journal ofBacteriology 112, 1364-1374.
Bush, K., Jacoby, G.A., Medeiros, A.A. (1995). A functional classification scheme
for beta-lactamases and its correlation with molecular structure. Antimicrobial
Agents and Chemotherapy 39, 1211-1233.
Calderwood, S.B., Gardella, A., Philippon, A.M., Jacoby, G.A., and Moellering,
R.C.Jr. (1982). Effects of azlocillin in combination with clavulanic acid,
sulbactam, and N-formimidoyl thienamycin against beta-lactamase-producing,
carbenicillin-resistant Pseudomonas aeruginosa. Antimicrobial Agents and
Chemotherapy 22, 266-271.
Caprioli, A., Busani, L., Martel, J.L., and Helmuth, R. (2000). Monitoring of
antibiotic resistance in bacteria of animal origin: epidemiological and
microbiological methodologies. International Journal ofAntimicrobial Agents
14,295-301.
183
Carlson, C.A., Pierson, L.S., Rosen, J.J., and Lngraham, J.L. (1983). Pseudomonas
stutzeri and related species undergo natural transformation. Journal of
Bacteriology 153, 93-99.
Caroff, N., Espaze, E., Gautreau, D., Richet, H. and Reynaud, A. (2000). Analysis of
the effects of-42 and -32 ampC promoter mutations in clinical isolates of
Escherichia coli hyperproducing AmpC. Journal ofAntimicrobial
Chemotherapy 33, 783-788.
Casewell, M., Friis, C., Marco, E., McMullin, P., and Phillips, I. (2003). The
European ban on growth-promoting antibiotics and emerging consequences for
human and animal health. Journal ofAntimicrobial Chemotherapy 52, 159-161.
Catlin, B .W. (1960). Transformation ofNeisseria meningitidis by
deoxyribonucleates from cells and from culture slime. Journal ofBacteriology
79, 579-590.
Caugant, D.A., Levin, B.R., and Selander, R.K. (1981). Genetic diversity and
temporal variation in the E. coli population of a human host. Genetics 98, 467-
490.
Chadwick, D.J., and Goode, J. (1997). Antibiotic resistance: origins, evolution,
selection, and spread. Ciba Foundation Symposium 207, 1-3.
Chanal, C., Bonnet, R., De Champs, C„ Sirot, D., Labia, R., and Sirot, J. (2000).
Prevalence of beta-lactamases among 1,072 clinical strains ofProteus
mirabilis. a 2-year survey in a French hospital. Antimicrobial Agents and
Chemotherapy 44, 1930-1935.
Chao, A. (1987). Estimating the population size for capture-recapture data with
unequal catchability. Biometrics 43, 783-791.
Chaslus-Dancla, E., Mattel, J.L., Carlier, C., Lafont, J.P., and Courvalin, P. (1986).
Emergence of aminoglycoside 3-N-acetyltransferase IV in Escherichia coli and
Salmonella typhimurium isolated from animals in France. Antimicrobial Agents
and Chemotherapy 29, 239-243.
Chaslus-Dancla, E., Glupcznski, Y., Gerbaud, G., Lagorce, M., Lafont, J.P., and
Courvalin, P. (1989). Detection of apramycin resistant Enterobacteriaceae in
hospital isolates. FEMSMicrobiology Letters 61, 261-266.
Chaslus-Dancla, E., Pohl, P., Meurisse, M., Marin, M., Lafont, J.P. (1991). High
genetic homology between plasmids of human and animal origin conferring
resistance to the aminoglycosides gentamicin and apramycin. Antimicrobial
Agents and Chemotherapy 35, 590-593.
Chen, H.Y., Yuan, M., Ibrahim-Elmagboul, I B., Livermore, D M. (1995). National
survey of susceptibility to antimicrobials amongst clinical isolates of
Pseudomonas aeruginosa. Journal ofAntimicrobial Chemotherapy 35, 521-
534.
184
Cohen, S.P., Hooper, D.C., Wolfson, J.S., Souza, K.S., McMurry, L.M., Levy, S.B.
(1988). Endogenous active efflux of norfloxacin in susceptible Escherichia
coli. Antimicrobial Agents and Chemotherapy 32, 1187-1191.
Cohen, S.P., Hachler, H., and Levy, S.B. (1993). Genetic and functional analysis of
the multiple antibiotic resistance (mar) locus in Escherichia coli. Journal of
Bacteriology 175, 1484-1492.
Collis, C.M, Grammaticopoulos, G., Briton, J., Stokes, H.W., and Hall, R.M. (1993).
Site-specific insertion of gene cassettes into integrons. Molecular Microbiology
9,41-52.
Colwell, R.K., and Coddington, J.A. (1994). Estimating terrestrial biodiversity
through extrapolation. Philosophical Transactions of the Royal Society
(London) series B 345, 101-118.
Cook, R.R. (1997). Antimicrobial resistance - use in veterinary medicine and human
medicine. Journal ofAntimicrobial Agents and Chemotherapy 39, 435.
Cooper, A.J., Shoemaker, N.B., and Salyers, A.A. (1996). Erythromycin resistance
gene from the Bacteroides conjugal transposon Tc-r Em(r) 7853 is nearly
identical to ermG from Bacillus sphaericus. Antimicrobial Agents and
Chemotherapy 40, 506-508.
Corpet, D.E (1987). Antibiotic residues and drug resistance in human intestinal flora.
Antimicrobial Agents and Chemotherapy 31, 587-593.
Cox, E.C., White, J.R., Flaks, J.G. (1964). Streptomycin action and the ribosome.
Proceedings of the National Academy ofSciences USA 51, 703-709.
Crawley, M.J. (2002). Statistical computing: an introduction to data analysis using
S-Plus. John Wiley & Sons, Chichester.
Cullum, J., Collins, J.F., and Broda, P. (1978). Factors affecting the kinetics of
progeny formation with F'/ac in Escherichia coli K12. Plasmid 1, 536-544.
Curtiss, R., Caro, L.G., Allison, D.P. and Stallions, D.R. (1969). Early stages of
conjugation in Escherichia coli. Journal ofBacteriology 100, 1091-1104.
Dahlberg, C., and Chao, L. (2003). Amelioration of the cost of conjugative plasmid
carriage in Escherichia coli K12. Genetics 165, 1641-1649.
Danel, F., Hall, L.M., Duke, B., Gur, D., and Livermore, D.M. (1999). OXA-17, a
further extended-spectrum variant ofOXA-10 beta-lactamase, isolated from
Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy 43, 1362-
1366.
185
DANMAP (1998). Consumption of antimicrobial agents and occurrence of
antimicrobial resistance in bacteria from food animals, food and humans in
Denmark. Statens Serum Institut, Danish Veterinary and Food Administration,
Danish Medicines Agency, Danish Veterinary Laboratory, Copenhagen,
Denmark. ISSN 1397-1409.
DANMAP (2002). Consumption of antimicrobial agents and occurrence of
antimicrobial resistance in bacteria from food animals, food and humans in
Denmark. Statens Serum Institut, Danish Veterinary and Food Administration,
Danish Medicines Agency, Danish Veterinary Laboratory, Copenhagen,
Denmark. ISSN 1600-2032.
Darville, J.M., and Lovering, A.M. (2003). Variation in the content of ciprofloxacin
susceptibility testing discs: Its effect on the BSAC disc method. Journal of
Antimicrobial Chemotherapy 51, 465-467.
Datta, N., and Kontomichalou, P. (1965). Penicillinase sysnthesis controlled by
infectious R factors in Enterobacteriacae. Nature 208, 239-244.
Datta, N., Hedges, R.W., Shaw, E.J., Sykes, R.B., and Richmond, M.H. (1971).
Properties of an R factor from Pseudomonas aeruginosa. Journal of
Bacteriology 108, 1244-1249.
Davies, J., and O'Connor, S. (1978). Enzymatic modification of aminoglycoside
antibiotics: 3-N-aminoacetyltransferase with broad specificity that determines
resistance to the novel aminoglycoside apramycin. Antimicrobial Agents and
Chemotherapy 14, 69-72.
Davies, J., and Webb, V. (1998). Antibiotic resistance in bacteria. In: Emerging
Infections, Academic Press, pages 239-273.
De Champs, C., Sirot, D., Chanal, C., Bonnet, R., Sirot, J., and the French Study
Group. (2000). A 1998 survey of extended-spectrum ^-lactamases in
Enterobacteriacae in France. Antimicrobial Agents and Chemotherapy 44,
3177-3179.
Delsol, A.A., Anjum, M., Woodward, M.J., Sunderland, .J, and Roe, J.M. (2003).
The effect of chlortetracycline treatment and its subsequent withdrawal on
multi-resistant Salmonella enterica serovar Typhimurium DTI04 and
commensal Escherichia coli in the pig. Journal ofApplied Microbiology 95,
1226-1234.
Dencer, H.G., Slaney, I,., Maclean, I.W., and Albritton, W.L. (1982). Mobilization of
nonconjugative antibiotic resistance plasmids in Haemophilus ducreyi. Journal
ofBacteriology 149, 726-732.
Diez-Gonzalez, F., Calloway, T.R., Kizoulis, M.G., and Russell, J.B. (1998). Grain
feeding and dissemination of acid-resistant Escherichia coli from cattle.
Science 281, 1666-1668.
186
Dijkshoorn, L., and Towner, K. (2001). An introduction to the generation and
analysis ofmicrobial typing data. In: New Approaches for the Generation and
Analysis ofMicrobial Typing Data. Editors; Dijkshoorn, L., Towner, K., and
Struelens, M. Elsevier Science, Amsterdam, The Netherlands.
Donabedian, S., Thai, L.A., Bozigar, P., Zervos, T., Hershberger, E., and Zervos, M.
(2003a). Antimicrobial resistance in swine and chickens fed virginiamycin for
growth promotion. Journal ofMicrobiological Methods 55, 739-743.
Donabedian, S.M., Thai, L.A., Hershberger, E., Perri, M.B., Chow, J.W., Bartlett, P.,
Jones, R., Joyce, K., Rossiter, S., Gay, K., Johnson, J., Mackinson, C., Debess,
E., Madden, J., Angula, F., and Zervos, M.J. (2003b). Molecular
characterization of gentamicin-resistant Enterococci in the United States:
Evidence of spread from animals to humans through food. Journal ofClinical
Microbiology 41, 1109-1113.
Doucet-Populaire, F., Trieucuot, P., Andremont, A., and Courvalin, P. (1992).
Conjugal transfer of plasmid DNA from Enterococcus-faecalis to Escherichia-
coli in digestive tracts of gnotobiotic mice. Antimicrobial Agents and
Chemotherapy 36, 502-504.
Dowson, C.G., Hutchison, A., Woodford, N., Johnson, A.P., George, R.C., and
Spratt, B.G. (1990). Penicillin-resistant viridans Streptococci have obtained
altered penicillin-binding protein genes from penicillin- resistant strains of
Streptococcus-pneumoniae. Proceedings ofthe National Academy ofSciences
of the United States ofAmerica 87, 5858-5862.
Dubnau, D. (1991). The regulation of genetic competence in Bacillus-subtilis.
Molecular Microbiology 5, 11-18.
Dunbar, J., Takala, S., Barns, S.M., Davis, J.A., and Kuske, C.R. (1999). Levels of
bacterial community diversity in four arid soils compared by cultivation and
16S rRNA gene cloning. Applied and Environmental Microbiology 65, 1662-
1669.
Dunlop, R.H., McEwen, S.A., Meek, A.H., Clarke, R.C., Black, W.D., and
Friendship, R.M. (1998). Associations among antimicrobial drug treatments
and antimicrobial resistance of fecal Escherichia coli of swine on 34 farrow-to-
finish farms in Ontario, Canada. Preventative Veterinary Medicine 34, 283-
305.
Edelstein, M., Pimkin, M., Dmitrachenko, T., Semenov, V., Kozlova, N., Gladin, D.,
Baraniak, A., and Stratchounski, L. (2004). Multiple outbreaks of nosocomial
Salmonellosis in Russia and Belarus caused by a single clone ofSalmonella
enterica Serovar Typhimurium producing an extended-spectrum beta-
lactamase. Antimicrobial Agents and Chemotherapy 48, 2808-2815.
187
Edgar, R., and Bibi, E. (1997). MdfA, an Escherichia coli multidrug resistance
protein with an extraordinarily broad spectrum of drug recognition. Journal of
Bacteriology 179, 2274-2280.
Edwards, G.F.S. (2003). Personal communication.
Eisenstein, B.I. (1990). New molecular techniques for microbial epidemiology and
the diagnosis of infectious diseases. The Journal ofInfectious Diseases 161,
595-602.
Emborg, H.D., Andersen, J.S., Seyfarth, A.M., Andersen, S.R., Boel, J., and
Wegener, H.C. (2003). Relations between the occurrence of resistance to
antimicrobial growth promoters among Enterococcus faecium isolated from
broilers and broiler meat. International Journal ofFood Microbiology 84, 273-
284.
Endtz, H.P., Ruijs, G.J., Vanklingeren, B., Jansen, W.H., van der Reyden, T., and
Mouton, R.P. (1991). Quinolone resistance in Campylobacter isolated from
man and poultry following the introduction of fluoroquinolones in veterinary-
medicine. Journal ofAntimicrobial Chemotherapy 27, 199-208.
Enne, V.I., Delsol, A.A., Roe, J.M., and Bennett, P.M. (2004a). Rifampicin
resistance and its fitness cost in Enterococcus faecium. Journal of
Antimicrobial Chemotherapy 53, 203-207.
Enne, V.I., Bennet, P.M., Livermore, D.M., and Hall, L.M.C. (2004b). Enhancement
of host fitness by the sw/2-coding plasmid p9123 in the absence of selective
pressure. Journal ofAntimicrobial Chemotherapy 53, 958-963.
Everett, M.J., Jin, Y.F., Ricci, V., and Piddock, L.J. (1996). Contributions of
individual mechanisms to fluoroquinolone resistance in 36 Escherichia coli
strains isolated from humans and animals. Antimicrobial Agents and
Chemotherapy 40, 2380-2386.
Everitt, R.S. (1989). Statistical Methodsfor Medical Investigations. Oxford
University Press, New York/Edward Arnold, London.
Feighner, S.D., and Dashkevicz, M.P. (1987). Subtherapeutic levels of antibiotics in
poultry feeds and their effects on weight gain, feed efficiency, and bacterial
cholyltaurine hydrolase activity. Applied and Environmental Microbiology 53,
331-336.
Fermer, C., Kristiansen, B.E., Skold, O., Swedberg, G. (1995). Sulfonamide
resistance in Neisseria meningitidis as defined by site-directed mutagenesis
could have its origin in other species. Journal ofBacteriology 177, 4669-4675.
Fernandez-Astorga, A., Muela, A., Cisterna, R., Iriberri, J., and Barcina, I. (1992).
Biotic and abiotic factors affecting plasmid transfer in Escherichia coli strains.
Applied and Environmental Microbiology 58, 392-398.
188
Fey, P.D., Safranek, T.J., Rupp, M.E., Dunne, E.F., Ribot, E., Iwen, P C., Bradford,
P.A., Angulo, F.J., and Hinrichs, S.H. (2000). Ceftriaxone-resistant salmonella
infection acquired by a child from cattle The New England Journal of
Medicine 342, 1242-1249.
Fischer, W., and Haas, R. (2004). The RecA protein ofHelicobacter pylori requires a
posttranslational modification for full activity. Journal ofBacteriology 186,
777-784.
Foxman, B., Manning, S.D., Tallman, P., Bauer, R., Zhang, L., Koopman, J.S.,
Gillespie, B., Sobel, J.D., and Marrs, C.F. (2002). Uropathogenic Escherichia
coli are more likely than commensal E. coli to be shared between heterosexual
sex partners. American Journal ofEpidemiology 156, 1133-1140.
Franke, A.E., and Clewell, D.B. (1981). Evidence for a chromosome-borne
resistance transposon (TN916) in Streptococcusfaecalis that is capable of
conjugal transfer in the absence of a conjugative plasmid. Journal of
Bacteriology 145, 494-502.
Freter, R. (1981). Mechanism of association of bacteria with mucosal surfaces. Ciba
Symposium Foundation 80, 36-47.
Freter, R., Brickner, H., Fekete, J., Vickerman, M M., and Carey, K.E. (1983).
Survival and implantation ofEscherichia coli in the intestinal tract. Infection
and Immunity 39, 686-703.
Frischer, M.E., Thurmond, J.M., and Paul, J.H. (1990). Natural plasmid
transformation in a high-frequency-of-transformation marine Vibrio strain.
Applied and EnvironmentalMicrobiology 56, 3439-3444.
Gaskins, H.R., Collier, C.T., and Anderson, D.B. (2002). Antibiotics as growth
promotants: mode of action. Animal Biotechnology 13, 29-42.
Gautom, R.K. (1997). Rapid pulsed-field gel electrophoresis protocol for typing of
Escherichia coli 0157:H7 and other gram-negative organisms in 1 day. Journal
ofClinical Microbiology 35, 2977-2980.
Gemmell, C.G. (1999). Where is typing going? Journal ofHospital Infection 43,
(Supplement) S89-S92.
Gillespie, S.H. (2001). Antibiotic resistance in the absence of selective pressure.
International Journal ofAntimicrobial Agents 17, 171-176.
Goldberg, I D., Gwinn, D.D., and Thorne, C.B. (1966). Interspecies transformation
between Bacillus subtilis and Bacillus licheniformis. Biochemical and
Biophysical Research Communications 23, 543-548
Goodwin, D , and Slater, J.H. (1979). The influence of the growth environment on
the stability of a drug resistant plasmid in Escherichia coli K12. Journal of
GeneralMicrobiology 111, 201-210.
189
Gordon, D M. (1992). Rate of plasmid transfer among Escherichia coli strains
isolated from natural populations. Journal ofGeneral Microbiology 138, 17-21.
Gormley, E.P., and Davies, J. (1991). Transfer of plasmid RSF1010 by conjugation
from Escherichia coli to Streptomyces lividans and Mycobacterium smegmatis.
Journal ofBacteriology 173, 6705-6708.
Goze, A., and Ehrlich, S.D. (1980). Replication of plasmids from Staphhylococcus
aureus in Escherichia coli. Proceedings of the National Academy ofSciences of
the United States ofAmerica 77, 7333-7337.
Grant, A.J., and Pittard, J. (1974). Incompatibility reactions ofR-plasmids isolated
from Escherichia coli of animal origin. Journal ofBacteriology 120, 185-190.
Gulay, Z., Biemen, M., Amyes, S.G.B., and Yulug, N. (2000). Beta-lactamase
patterns and betalactam/clavulanic acid resistance in Escherichia coli isolated
from fecal samples from healthy volunteers. Journal ofChemotherapy 12, 208-
215.
Gunn, G.J., and Low, J.C. (2003). Analysis of passive surveillance data for
antimicrobial resistance from cases ofneonatal bovine enteritis. Veterinary
Record 152, 537-539.
Haas, C.E., Nix, D.E., and Schentag, J.J. (1990). In vitro selection of resistant
Helicobacter-pylori. Antimicrobial Agents and Chemotherapy 34, 1637-1641.
Hahm, B.K., Maldonado, Y., Schreiber, E, Bhunia, A.K. and Nakatsu, C.H. (2003).
Subtyping of foodborne and environmental isolates ofEscherichia coli by
multiplex-PCR, rep-PCR, PFGE, ribotyping and AFLP. Journal of
Microbiological Methods 53, 387-399.
Hall, L.M., Livermore, D M., Gur, D., Akova, M., and Akalin, H E. (1993). OXA-
11, an extended-spectrum variant ofOXA-10 (PSE-2) beta-lactamase from
Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy 37, 1637-
1644.
Hardy, K. (1984). Bacterial plasmids. Aspects ofMicrobiology. Van Nostrand
Reinhold (UK) Co. Ltd, Wokingham, Berkshire, England.
Hartl, D.L., Dykhuizen, D.E., Miller, R.D., Green, L., and de Framond, J. (1983).
Transposable element 1S50 improves growth rates ofE. coli cells without
tranposition. Cell 35, 503-510.
Hard, D.L., and Dykhuizen, D.E. (1984). The population genetics ofEscherichia
coli. Annual Reviews in Genetics 18, 31-68.
Hartman, A.B., Essiet, 1.1., Isenbarger, D.W. and Lindler, L.E. (2003). Epidemiology
of tetracycline resistance determinants in Shigella spp. and enteroinvasive
Escherichia coli. characterization and dissemination of tet(A)-l. Journal of
ClinicalMicrobiology 41, 1023-1032.
190
Heffron, F., Sublett, R., Hedges, R.W., Jacob, A., and Falkow, S. (1975). Origin of
the TEM-beta-lactamase gene found on plasmids. Journal ofBacteriology 122,
250-256.
Heinzel, P., Werbitzky, O., Distler, J., and Piepersberg, W. (1988). A second
streptomycin resistance gene from Streptomyces griseus codes for
streptomycin-3"-phosphotransferase. Relationships between antibiotic and
protein kinases. Archives ofMicrobiology 150, 184-92.
Heir, E., Lindstedt, B.A., Leegaard, T.M., Gjernes, E., and Kapperud, G. (2004).
Prevalence and characterization of integrons in blood culture
Enterobacteriaceae and gastrointestinal Escherichia coli in Norway and
reporting of a novel class 1 integron-located lincosamide resistance gene.
Annals ofClinical Microbiology andAntimicrobials 3,12.
Helling, R.B., Kinney, T., and Adams, J. (1981). The maintenance of plasmid-
containing organisms in populations of Escherichia coli. Journal ofGeneral
Microbiology 123, 129-141.
Heritage, J., M'Zali, F.H., Gascoyne-Binzi, D., Hawkey, P.M. (1999). Evolution and
spread ofSHV extended-spectrum beta-lactamases in gram-negative bacteria.
Journal ofAntimicrobial Chemotherapy 44, 309-318.
Hinton, M., Rixson P.D., Allen V., and Linton A.H. (1984). The persistence of drug
resistant Escherichia coli in the majority faecal flora of calves. Journal of
Hygiene (London) 93, 547-557.
Hinton, M., Linton, A.H., and Hedges, A.J. (1985). The ecology of Escherichia coli
in calves reared as dairy-cow replacements. Journal ofApplied Bacteriology
58, 131-138.
Hinton, M. (1986). The ecology of Escherichia coli in animals including man with
particular reference to drug resistance. Veterinary Record 119, 420-426.
Hirai K., Aoyama, H., Irikura, T., Iyobe, S., and Mitsuhashi S. (1986a). Differences
in susceptibility to quinolones of outer membrane mutants ofSalmonella
typhimurium and Escherichia coli. Antimicrobial Agents and Chemotherapy
29, 535-538.
Hirai, K., Aoyama, H, Suzue, S., Irikura, T., Iyobe, S., and Mitsuhashi, S. (1986b).
Isolation and characterization of norfloxacin-resistant mutants of E. coli K12.
Antimicrobial Agents and Chemotherapy 30, 248-253.
Hollingshead, S., and Vapnek, D. (1985). Nucleotide sequence analysis of a gene
encoding a streptomycin/spectinomycin adenylyltransferase. Plasmid 13, 17-
30.
Hovde, C.J., Austin, P.R., Cloud, K.A., Williams, C.J., and Hunt, C.W. (1999).
Effect of cattle diet on Escherichia coli 0157:117 acid resistance. Applied and
Environmental Microbiology 65, 3233-3235.
191
Howe, K., and Linton, A.H. (1976a). The distribution ofO-antigen types of
Escherichia coli in normal calves, compared with man, and their R plasmid
carriage. Journal ofApplied Bacteriology 40, 317-330.
Howe, K., Linton, A.H., and Osborne, A.D. (1976b). A longitudinal study of
Escherichia-coli in cows and calves with special reference to the distribution of
O-antigen types and antibiotic resistance. Journal ofApplied Bacteriology 40,
331-340.
Hoyle, D.V., Knight, H.I., Shaw, D.J., Hillman, K., Pearce, M.C., Low, J.C., Gunn,
G.J., Woolhouse, M.E.J. (2004). Acquisition and epidemiology of antibiotic
resistant Escherichia coli in a cohort of new-born calves. Journal of
Antimicrobial Chemotherapy 53, 867-871.
Hughes, J.B., Hellmann, J.J., Rickets, T.H., and Bohannan, B.J. (2001). Counting the
uncountable: Statistical approaches to estimating microbial diversity. Applied
and Environmental Microbiology 67, 4399-4406.
Huletsky, A., Knox, J.R., and Levesque, R.C. (1993). Role of Ser-238 and Lys-240
in the hydrolysis of third-generation cephalosporins by SHV-type beta-
lactamases probed by site-directed mutagenesis and three-dimensional
modelling. Journal ofBiological Chemistry 268, 3690-3697.
Hunter, J.E.B., Shelley, J.C., Walton, J.R., Hart, C.A., and Bennett, M. (1992).
Apramycin resistance plasmids in Escherichia coli: possible transfer to
Salmonella typhimurium in calves. Epidemiology and Infection 108, 271-278.
Hunter, J.E.B., Hart, C.A., Shelley, J.C., Walton, J.R., and Bennett, M. (1993).
Human isolates of apramycin-resistant Escherichia coli which contain the
genes for the AAC(3)IV enzyme. Epidemiology and Infection 110, 253-259.
Hunter, J.E.B., Bennett, M., Hart, C.A., Shelley, J.C., and Walton, J.R. (1994).
Apramycin-resistant Escherichia coli isolated from pigs and a stockman.
Epidemiology and Infection 112, 473-480.
Hutchison, J.G.P. (1954). Antibiotic sensitivity tests: A rapid method suitable for
multiple cultures. Journal ofClinical Pathology 7, 350-351.
Ichige, A.S., Matsutani, S., Oishi, K., and Mizushima, S. (1989). Establishment of
gene transfer systems and construction of the genetic map of a marine Vibro
strain. Journal ofBacteriology 171, 1825-1834.
Inselburg, J. (1978). ColEl plasmid mutants affecting growth of an Escherichia coli
recB recC sbcC mutant. Journal ofBacteriology 133, 433-436.
Jeong, S.H., Bae, I.K., Kwon, S.B., Lee, J.H., Jung, H.I., Song, J.S., Jeong, B.C.,
Kim, S.J., and Lee, S.H. (2004a). Investigation of extended-spectrum beta-
lactamases produced by clinical isolates of Klebsiella pneumoniae and
Escherichia coli in Korea. Letters in AppliedMicrobiology 39, 41-47.
192
Jeong, S.H., Bae, I.K., Lee, J.H., Sohn, S.G., Kang, G.H., Jeon, G.J., Kim, Y.H.,
Jeong, B.C., and Lee, S.H. (2004b). Molecular characterization of extended-
spectrum beta-lactamases produced by clinical isolates ofKlebsiella
pneumoniae and Escherichia coli from a Korean nationwide survey. Journal of
Clinical Microbiology 42, 2902-2906.
Jiang, S.C., and Paul, J.H. (1998). Gene transfer by transduction in the marine
environment. Applied and EnvironmentalMicrobiology 64, 2780-2787.
Johnson, A.P., Burns, L., Woodford, N., Threlfall, E.J., Naidoo, J., Cooke, E.M., and
George, R.C. (1994). Gentamicin resistance in clinical isolates ofEscherichia
coli encoded by genes of veterinary origin. Journal ofMedical Microbiology
40,221-226.
Johnson, A.P., Malde, M., Woodford, N., Cunney, R.J., and Smith, E.G. (1995).
Urinary isolates of apramycin-resistant Escherichia coli and Klebsiella
pneumoniae from Dublin. Epidemiology and Infection 114, 105-112.
Johnson, J.R., and O'Bryan, T.T. (2000). Improved repetitive-element PCR
fingerprinting for resolving pathogenic and non-pathogenic phylogenetic
groups within Escherichia coli. Clinical andDiagnostic Laboratory
Immunology 7, 265-273.
Johnston, M. (1998). Use of antimicrobial drugs in veterinary practice. British
Medical Journal 317, 665-667.
Jones, I.M., Primrose, S.B., Robinson, A., and Ellwood, D.C. (1980). Maintenance of
some ColEl-type plasmids in chemostat culture. Molecular and General
Genetics 180, 579-584.
Jones, R.N. (2000). Detection of emerging resistance patterns within longitudinal
surveillance systems: data sensitivity and microbial susceptibility. Journal of
Antimicrobial Chemotherapy 46, Suppliment B, 1-8.
Juni, E., and Janik, A. (1969). Transformation ofAcinetobacter calco-aceticus
(Bacterium anitratum). Journal ofBacteriology 98, 281-288.
Katouli, M., Lund, A., Wallgren, P., Kuhn, I., Soderland, O., and Mollerby, R.
(1995). Phenotypic characterisation of intestinal Escherichia coli of pigs during
suckling, postweaning, and fattening periods. Applied and Environmental
Microbiology 61, 778-783.
Kayama, A.M., and Yara, T. (1975). Plasmid mutations affecting self-maintenance
and host growth in Escherichia coli. Journal ofBacteriology 122, 80-88.
Kerrn, M.B., Klemmensen, T., Frimodt-Moller, N., and Espersen, F. (2002).
Susceptibility ofDanish Escherichia coli strains isolated from urinary tract
infections and bacteraemia, and distribution of sul genes conferring
sulphonamide resistance. Journal ofAntimicrobial Chemotherapy 50, 513-516.
193
Khachatourians, G.G. (1998). Agricultural use of antibiotics and the evolution and
transfer of antibiotic-resistant bacteria. Canadian Medical Association Journal
159, 1129-1136.
Klimke, W.A., and Frost, L.S. (1998). Genetic analysis of the role of the transfer
gene, traN, of the F and R100-1 plasmids in mating pair stabilization during
conjugation. Journal ofBacteriology 180, 4036-4043.
Kluytmans, J., Vanleeuwen, W., Goessens, W., Hollis, R., Messer, S., Herwaldt, L.,
Bruining, H., Heck, M., Rost, J., van Leeuwen, N., van Belkum, A., and
Verbrugh, H. (1995). Food-initiated outbreak ofmethicillin-resistant
Staphylococcus aureus analyzed by phenotyping and genotyping. Journal of
ClinicalMicrobiology 33, 1121-1128.
Knox, J.R. (1995). Extended-spectrum and inhibitor-resistant TEM-type (3-
lactamases: Mutations, specificity, and three-dimensional structure.
Antimicrobial Agents and Chemotherapy 39, 2593-2601.
Koeth, L.M., King, A., Knight, H., May, J., Miller, L.A., Phillips, I., and Poupard,
J.A. (2000). Comparison of cation-adjusted Mueller-Hinton broth with Iso-
Sensitiest broth for the NCCLS broth microdilution method. Journal of
Antimicrobial Chemotherapy 46, 369-376.
Kruse, H., and Sorum, H. (1994). Transfer ofmultiple-drug resistance plasmids
between bacteria of diverse origins in natural microenvironments. Applied and
EnvironmentalMicrobiology 60, 4015-4021.
Krause, D.O., Smith, W.J.M., Conlan, L.L., Gough, J.M., Williamson, A., and
McSweeney, C.S. (2003). Diet influences the ecology of lactic acid bacteria
and Escherichia coli along the digestive tract of cattle: neural networks and
16SrDNA. Microbiology 149, 57-65.
Lacks, S., Greenberg, B., and Neuberger, M. (1975). Identification of a
deoxyribonuclease implicated in genetic transformation ofDiplococcus
pneumoniae. Journal ofBacteriology 123, 222-232.
Landis, R.J., and Koch, G.G. (1977). The measurement of observer agreement for
categorical data. Biometrics 33, 159-174.
Le Bouguenec, C., de Cespedes, G., and Horaud, T. (1990). Presence of
chromosomal elements resembling the composite structure TN3701 in
Streptococci. Journal ofBacteriology 172, 727-734.
Lee, S.W., and Edlin, G. (1985). Expression of tetracycline resistance in pBR322
derivatives reduces the reproductive fitness of plasmid-containing Escherichia
coli. Gene 39, 173-180.
Lee, K., Yong, D., Yum, J.H., Kim, H.H., and Chong, Y. (2003). Diversity ofTEM-
52 extended-spectrum B-lactamase-producing non-typhoidal Salmonella
isolates in Korea. Journal ofAntimicrobial Chemotherapy 52, 493-496.
194
Leflon-Guibout, V., Speldooren, V., Heym, B., and Nicolas-Chanoine, M. (2000).
Epidemiological survey of amoxicillin-clavulanate resistance and
corresponding molecular mechanisms in Escherichia coli isolates in France:
new genetic features ofbla(TEM) genes. Antimicrobial Agents and
Chemotherapy 44, 2709-2714.
Lenski, R.E., Rose, M.R., Simpson, S.C., and Tadler, S.C. (1991). Long-term
experimental evolution in Escherichia coli. 1. Adaption and divergence during
2,000 generations. The American Naturalist 138, 1315-1341.
Lenski, R.E., Simpson, A.C., and Nguyen, T.T. (1994). Genetic analysis of a
plasmid-encoded, host genotype-specific enhancement of bacterial fitness.
Journal ofBacteriology 176, 3140-3147.
Levin, B.R., Stewart, F.M., and Rice, V.A. (1979). The kinetics of conjugative
plasmid transmission: fit of a simple mass action model. Plasmid 2, 247-260.
Levin, B.R., Perrot, V., and Walker, N. (2000). Compensatory mutations, antibiotic
resistance and the population genetics of adaptive evolution in bacteria.
Genetics 154, 985-997.
Levy, S.B., and McMurry. L. (1974). Detection of an inducible membrane protein
associated with R-factor-mediated tetracycline resistance. Biochemical and
Biophysical Research Communications 56, 1060-1068.
Levy, S.B. (1976). Spread of antibiotic-resistance plasmids from chicken to chicken
and from chicken to man. Nature 260, 40-42.
Levy, S.B. (1987). Antibiotic use and antibiotic resistance worldwide. Reviews of
Infectious Diseases 9 (supplement 1), 231-316.
Levy, S.B. (1998) Antimicrobial resistance: bacteria on the defence. British Medical
Journal 317, 612-613.
Licht, T.R., Christensen, B.B., Krogfelt, K.A., and Molin, S. (1999). Plasmid transfer
in the animal intestine and other dynamic bacterial populations: the role of
community structure and environment. Microbiology 145, 2615-2622.
Linton, A.H. (1977a). Antibiotic resistance: the present situation reviewed.
Veterinary Record 100, 354-360.
Linton, A.H. (1977b). Animal to man transmission ofEnterobacteriaceae. Royal
Society ofHealth Journal 97, 115-118.
Linton, A.H. (1984). Antibiotic-resistant bacteria in animal husbandry. British
Medical Bulletin 40, 91-95.
Lipsitch, M., and Levin, B.R. (1997). The population dynamics of antimicrobial
chemotherapy. Antimicrobial Agents and Chemotherapy 41, 363-373.
195
Livermore, D.M., and Chen, H.Y. (1999). Quality of antimicrobial susceptibility
testing in the UK: a Pseudomonas aeruginosa survey revisited. Journal of
Antimicrobial Chemotherapy 43, 517-522.
Livermore, D.M., Stephens, P., and Weinberg, J., Johnson, A.P., Gifford, T.,
Northcott, D., James, D., George, R.C., and Speller, D.C. (2000). Regional
variation in ampicillin and trimethoprim resistance in E. coli in England from
1990 to 1997, in relation to antibacterial prescribing. Journal ofAntimicrobial
Chemotherapy 46, 411-422.
Livermore, D.M., and Brown, D.F. (2001). Detection of beta-lactamase-mediated
resistance. Journal ofAntimicrobial Chemotherapy 48, Supplement 1, 59-64.
Maison, T.G., and Richardson, G. (1981). A review: Escherichia coli and the human
gut: Some ecological considerations. Journal ofApplied Bacteriology 1, 1-16.
Marshall, B., Petrowski, D., and Levy, S.B. (1990). Inter- and intraspecies spread of
Escherichia coli in a farm environment in the absence of antibiotic usage.
Proceedings ofthe National Academy ofSciences USA. 87, 6609-6613.
Martin, I.E., Tyler, S.D., Tyler, K.D., Khakharia, R., and Johnson, W.M. (1996).
Evaluation of ribotyping as epidemiological tool for typing Escherichia coli
serogroup 0157 isolates. Journal ofClinical Microbiology 34, 720-723.
Martin, A.P. (2002). Phylogenetic approaches for describing and comparing the
diversity ofmicrobial communities. Applied and Environmental Microbiology
68, 3673-3682.
Martinez, J.L., Alonso, A., Gomez-Gomez, J.M., and Baquero, F. (1998). Quinolone
resistance by mutations in chromosomal gyrase genes. Just the tip of the
iceberg? Journal ofAntimicrobial Chemotherapy 42, 683-688.
Masterton, R.G. (2000). Surveillance studies: how can they help the management of
infection? Journal ofAntimicrobial Chemotherapy 46, Supplement T2, 53-58.
Mathis, L.S., and Scocca, J.J. (1982). Haemophilus influenzae and Neisseria
gonorrhoeae recognize different specificity determinants in the DNA uptake
step of genetic transformation. Journal ofGeneral Microbiology 128, 1159-
1161.
Mazodier, P., and Davies , J. (1991). Gene transfer between distantly related bacteria.
Annual Review ofGenetics 25, 147-171.
McCaig, A.E., Glover, L.A., and Prosser, J.I. (1999). Molecular analysis of bacterial
community structure and diversity in improved and unimproved upland grass
pastures. Applied and Environmental Microbiology 65, 1721-1730.
McCracken, A., O'Brien, J. J., and Campbell, N. (1976). Antibiotic residues and their
recovery from animal tissues. Journal ofApplied Bacteriology 41, 129-135.
196
McGeer, A.J. (1998). Agricultural antibiotics and resistance in human pathogens:
Villain or scapegoat? Canadian Medical Association Journal 159, 1119-1120.
Mee, B.J., and Nikoletti, S.M. (1983). Plasmids encoding trimethoprim resistance in
bacterial isolates from man and pigs. Journal ofApplied Bacteriology 54, 225-
235.
Modi, R.I., Castilla, L.H., Puskas-Rozsa, S., Helling, R.B., and Adams, J. (1992).
Genetic changes accompanying increased fitness in evolving populations of
Escherichia coli. Genetics 130, 241-249.
Monod, J. (1949). The growth of bacterial cultures. Annual Review ofMicrobiology
2,371-394.
Moosden, F. (1997). The evolution of resistance to cephalosporins. Clinical
Infectious Diseases 24, 487-493.
Muela, A., Pocino, M., Arana, I., Justo, J.I., Iriberri, J., and Barcina, I. (1994). Effect
of growth phase and parental cell survival in river water on plasmid transfer
between Escherichia coli strains. Applied and Environmental Microbiology 60,
4273-4278.
Mueller, U.G., and Wolfenbarger, L.L. (1999). AFLP genotyping and fingerprinting.
Trends in Ecology and Evolution 14, 389-394.
Mugnier, P., Podglajen, I., Goldstein, F.W., and Collatz, E. (1998). Carbapenems as
inhibitors ofOXA-13, a novel, integron-encoded beta-lactamase in
Pseudomonas aeruginosa. Microbiology 144, 1021-1031.
Murray, N.E. (2002). Immigration control ofDNA in bacteria: self versus non-self.
Microbiology 148, 3-20.
Naas, T., Zerbib, M., Girlich, D., and Nordmann, P. (2003). Integration of a
transposon Tnl-encoded inhibitor-resistant beta-lactamase gene, bla(TEM-67)
from Proteus mirabilis, into the Escherichia coli chromosome. Antimicrobial
Agents and Chemotherapy 47, 19-26.
Negri, M., Lipstitch, M., Blazquez, J., Levin, B.R., and Baquero, F. (2000).
Concentration-dependant selection of small phenotypic differences in TEM p-
lactamase-mediated antibiotic resistance. Antimicrobial Agents and
Chemotherapy 44, 2485-2491.
Nelson, E.C., and Elisha, B.G. (1999). Molecular basis ofAmpC hyperproduction in
clinical isolates of Escherichia coli. Antimicrobial Agents and Chemotherapy
43, 957-959.
Nijsten, R., London, N. and Van den Bogaard, A., and Stobberingh, E. (1995). In-
vivo transfer of resistance plasmids in rat, human or pig-derived intestinal flora
using a rat model. Journal ofAntimicrobial Chemotherapy 36, 975-985.
197
Nijsten, R., London, N., Van den Bogaard, A., and Stobberingh, E. (1996).
Antibiotic resistance among Escherichia coli isolated from faecal samples of
pig farmers and pigs. Journal ofAntimicrobial Chemotherapy 37,1131-1140.
Nikaido, H., Basina, M., Nguyen, V., Rosenberg, E.Y. (1998). Multidrug efflux
pump AcrAB of Salmonella typhimurium excretes only those (3-lactam
antibiotics containing lipophilic side chains. Journal ofBacteriology 180,
4686-4692.
Nikolich, M.P., Shoemaker, N.B., Wang, G.R., and Salyers, A.A. (1994a).
Characterisation of a new type ofBacteroides conjugative transposon, TC-R-
EM(R)-7853. Journal ofBacteriology 176, 6606-6612.
Nikolich, M.P., Hong, G., Shoemaker, N.B., and Salyers, A.A. (1994b). Evidence for
natural horizontal transfer ofTetQ between bacteria that normally colonise
humans and bacteria that normally colonise livestock. Applied and
Environmental Microbiology 60, 3255-3260.
Noack, D., Roth, M., Guether, R., Muller, G., Undisz, K., Hoffmeier, C., and Gaspar,
S. (1981). Maintenance and genetic stability of vector plasmids pBR322 and
pBR325 in Escherichia coli K12 strains grown in a chemostat. Molecular and
General Genetics 184, 121-124.
Noller, A.C., McEllistrem, M.C., Stine, O.C., Morris, J.G.Jr., Boxrud, D.J., Dixon,
B., and Harrison, L.H. (2003). Multilocus sequence typing reveals a lack of
diversity among Escherichia coli 0157:H7 isolates that are distinct by pulsed-
field gel electrophoresis. Journal ofClinical Microbiology 41, 675-679.
O'Brien, T.F. (1997). The global epidemic nature of antimicrobial resistance and the
need to monitor and manage it locally. Clinical Infectious Diseases 24,
Supplement 1, S2-8.
Ochman, H., and Selander, R.K. (1984). Evidence for clonal population structure in
Escherichia coli. Proceedings ofthe National Academy ofSciences, USA 81,
198-201.
Oethinger, M., Jellen-Ritter, A.S., Conrad, S., Marre, R., and Kern, W.V. (1998).
Colonisation and infection with fluoroquinolone-resistant Escherichia coli
among cancer patients: Clonal analysis. Infection 26, 379-384.
Ofek, I., Mirelman, D., and Sharon, N. (1977). Adherence ofEscherichia coli to
human mucosal cells mediated by mannose receptors. Nature 265, 623-625.
Okusu, H., Ma, D., and Nikaido, H. (1996). AcrAB efflux pump plays a major role in
the antibiotic resistance phenotype of Escherichia coli multiple-antibiotic-
resistance (Mar) mutants. Journal ofBacteriology 178, 306-308.
Olsen, R,H., Siak, J. and Gray, R.H (1974). Characteristics ofPrDl, aplasmid
dependant broad host range DNA bacteriophage. Journal ofVirology 14, 689-
699.
198
Oppegaard, H., Steinum, T.M., and Wasteson, Y. (2001). Horizontal transfer of a
multi-drug resistance plasmid between coliform bacteria of human and bovine
origin in a farm environment. Applied and Environmental Microbiology 67,
3732-3734.
Oram, M., and Fisher, L.M. (1991). 4-Quinolone resistance mutations in the DNA
gyrase ofEscherichia coli clinical isolates identified by using the polymerase
chain reaction. Antimicrobial Agents and Chemotherapy 35, 387-389.
Orman, B.E., Pineiro, S.A., Arduino, S., Galas, M., Melano, R., Caffer, M.I.,
Sordelli, D.O., and Centron, D. (2002). Evolution ofmultiresistance in
nontyphoid salmonella serovars from 1984 to 1998 in Argentina. Antimicrobial
Agents and Chemotherapy 46, 3963-3970.
Orskov, F., Whittam, T.S., Cravioto, A., and Orskov, I. (1990). Clonal relationships
among classic enteropathogenic Escherichia coli (EPEC) belonging to different
O groups. The Journal ofInfectious Diseases 162, 76-81.
Osek, J. (2000). Clonal analysis ofEscherichia coli strains isolated from pigs with
post-weaning diarrhea by pulsed-field gel electrophoresis. FEMSMicrobiology
Letters 186, 327-331.
Osterblad, M., Hakanen, A. Manninen, R., Leistevuo, T., Peltonen, R., Meurman, O.,
Huovinen, P., and Kotilainen, P. (2000). A between-species comparison of
antimicrobial resistance in enterobacteria in fecal flora. Antimicrobial Agents
and Chemotherapy 44, 1479-1484.
Papaparaskevas, J., Vatopoulos, A., Tassios, P.T., Avlami, A., Legakis, N.J., and
Kalapothaki, V. (2000). Diversity among high-level aminoglycoside-resistant
enterococci. Journal ofAntimicrobial Chemotherapy 45, 277-283.
Parsonnet, K.C., and Kass, E.H. (1987). Does prolonged exposure to antibiotic-
resistant bacteria increase the rate of antibiotic-resistant infection?
Antimicrobial Agents and Chemotherapy 31, 911-914.
Pearce, B.J., Naughton, A.M., Campbell, E.A., and Masure, H.R. (1995). The rec
locus, a competence-induced operon in Streptococcus pneumoniae. Journal of
Bacteriology 111, 86-93.
Perilli, M., Dell'Amico, E., Segatore, B., Rosaria de Massis, M., Bianchi, C.,
Luzzaro, F., Rossolini, G.M., Toniolo, A., Nicoletti, G., and Amicosante, G.
(2002). Molecular characterization of extended-spectrum P-lactamases
produced by nosocomial isolates of Enterobacteriacae from an Italian
nationwide survey. Journal ofClinical Microbiology 40, 611-614.
Perlada, D.E., Smulian, A.G., Cushion, M.T. (1997). Molecular epidemiology and
antibiotic susceptibility of enterococci in Cincinnati, Ohio: a prospective
citywide survey. Journal ofClinical Microbiology 35, 2342-2347.
199
Pezzella, C., Ricci, A., DiGiannatale, E., Luzzi, I., and Carattoli, A. (2004).
Tetracycline and streptomycin resistance genes, transposons, and plasmids in
Salmonella enterica isolates from animals in Italy. Antimicrobial Agents and
Chemotherapy 48, 903-908.
Philippon, A., Arlet, G., and Jacoby, G.A. (2002). Plasmid-determined AmpC-type
p-lactamases. AntimicrobialAgents and Chemotherapy 46, 1-11.
Phillips, I., Casewell, M., Cox, T., De Groot, B., Friis, C., Jones, R., Nightingale, C.,
Preson, R., and Waddell, J. (2004). Does the use of antibiotics in food pose a
risk to human health? A critical review of published data. Journal of
Antimicrobial Chemotherapy 53, 28-52.
Piddock, L.J.V. (1996). Does the use of antimicrobial agents in veterinary medicine
and animal husbandry select antibiotic-resistant bacteria that infect man and
compromise antimicrobial chemotherapy? Journal ofAntimicrobialAgents and
Chemotherapy 38, 1-3.
Pitout, J.D., Hanson, N.D., Church, D.L., and Laupland, K.B. (2004). Population-
based laboratory surveillance for Escherichia co/z-producing extended-
spectrum beta-lactamases: importance of community isolates with blaCTX-M
genes. Clinical Infectious Diseases 38, 1736-1741.
Piatt, D.J., Smith, I. (1991). Gentamicin-resistant Salmonella typhimurium phage
type 204C: molecular studies and strain diversity in a putative bovine outbreak.
Epidemiology and Infection 107, 213-217.
Pohl, P., Glupczynski, Y., Marin M., Van Robaeys, G., Lintermans, P., Couturier, M.
(1993). Replicon typing characterization of plasmids encoding resistance to
gentamicin and apramycin in Escherichia coli and Salmonella typhimurium
isolated from human and animal sources in Belgium. Epidemiology and
Infection 111, 229-238.
Poulsen, L.K., Lan, F., Kristensen, C.S., Hobolth, P., Molin, S., and Krogfelt, K.A.
(1994). Spatial distribution ofEscherichia coli in the mouse large intestine
inferred from rRNA in situ hybridisation. Infection and Immunity 62, 5191-
5194.
Pournaras, S., Ikonomidis, A., Kristo, I., Tsakris, A., and Maniatis, A.N. (2004).
CTX-M enzymes are the most common extended-spectrum beta-lactamases
among Escherichia coli in a tertiary Greek hospital. Journal ofAntimicrobial
Chemotherapy 54, 574-575.
Power, E.G.M. (1996). RAPD typing in microbiology - a technical review. Journal
ofHospital Infection 34, 247-265.
200
Poyart, C., Mugnier, P., Quesne, G., Berche, P., and Trieu-Cuot, P. (1998). A novel
extended-spectrum TEM-type beta-lactamase (TEM-52) associated with
decreased susceptibility to moxalactam in Klebsiella pneumoniae.
Antimicrobial Agents and Chemotherapy 42, 108-113.
Provence, D.L., and Curtiss, R. (1994). Gene transfer in gram-negative bacteria. In:
Gerhardt P, murray RGE, Wood WA, Kreig N (eds) Methodsfor general and
molecular biology. American Society for Microbiology, Washington, DC,
pages 338-339.
Quale, J., Bratu, S., Landman, D., Heddurshetti, R. (2003). Molecular epidemiology
and mechanisms of carbapenem resistance in Acinetobacter baumannii
endemic in New York City. Clinical Infectious Diseases 37, 214-220.
Radstrom, P., Swedberg, G., and Skold, O. (1991). Genetic analyses of sulfonamide
resistance and its dissemination in Gram-negative bacteria illustrate new
aspects ofR plasmid evolution. Antimicrobial Agents and Chemotherapy 35,
1840-1848.
Randall, L.P., Cooles, S.W., Sayers, A.R., Woodward, M.J. (2001). Association
between cyclohexane resistance in Salmonella of different serovars and
increased resistance to multiple antibiotics, disinfectants and dyes. Journal of
Medical Microbiology 50, 910-924.
Recchia, G.D., and Hall, R.M. (1995). Gene cassettes: A new class ofmobile
element. Microbiology 141, 3015-3027.
Reynolds, M.G. (2000). Compensatory evolution in rifampin-resistant Escherichia
coli. Genetics 156, 1471-1481.
Rios, M., Prado, V., Trucksis, M., Arellano, C., Borie, C., Alexandre, M., Fica, A.,
and Levine, M.M. (1999). Clonal diversity of Chillean isolates of
enterohemorrhagic Escherichia coli from patients with haemolytic-uremic
syndrome, asymptomatic subjects, animal reservoirs and food products.
Journal ofClinical Microbiology 37, 778-781.
Rivera, M.J., Rivera, N., Castillo, J., Rubio, M.C., and Gomez-Lus, R. (1991).
Molecular and epidemiological study of Salmonella clinical isolates. Journal of
ClinicalMicrobiology 29, 927-932.
Roberts, M.C. (1990). Characterisation of the TetM determinants in urogenital and
respiratory bacteria. Antimicrobial Agents and Chemotherapy 34, 476-478.
Roberts, M.C., Pang, Y.J., Spencer, R.C., Winstanley, T.G., Brown, B.A., and
Wallace, R.J.Jr. (1991). Tetracycline resistance in Moraxella-(branhamella)-
catarrhalis - demonstration of two clonal outbreaks by using pulsed-field gel-
electrophoresis. Antimicrobial Agents and Chemotherapy 35, 2453-2455.
201
Rosenberg, E., Ma, D., and Nikaido, H. (2000). AcrD ofEscherichia coli is an
aminoglycoside efflux pump. Journal ofBacteriology 182, 1754-1756.
Roy, P.H. (1999). Horizontal transfer of genes in bacteria. Microbiology today 26,
168-170.
Rudin, L., Sjostrom, J.E., Lindberg, M., and Philipson, L. (1974). Factors affecting
competence for transformation in Staphylococcus aureus. Journal of
Bacteriology 118, 155-164.
Salauze, D., Otal, I., Gomez-lus, R., and Davies, J. (1990). Aminoglycoside
acetyltransferase 3-IV (aaC4) and hygromycin B 4-1 phosphotransferase
(hphB) in bacteria isolated from human and animal sources. Antimicrobial
Agents and Chemotherapy 34, 1915-1920.
Salisbury, J.G., Nicholls, T.J., Lammerding, A.M., Turnidge, J., and Nunn, M.J.
(2002). A risk analysis framework for the long-term management of antibiotic
resistance in food-producing animals. International Journal ofAntimicrobial
Agents 20, 153-164.
Salyers, A.A., and Shoemaker, N.B (1996). Resistance gene transfer in anaerobes:
New insights, new problems. Clinical Infectious Diseases 23, S36-S43.
Salyers, A.A., and Amabile-Cuevas, S.F. (1997). Why are antibiotic resistance genes
so resistant to elimination? Antimicrobial Agents and Chemotherapy 41, 2321-
2325.
Salyers, A.A (1999a). Beware the commensals! Their role in antibiotic resistance
spread may be greater than we think. ASMNews 65, 459-469.
Salyers, A.A. (1999b). Agricultural use of antibiotics and antibiotic resistance in
human pathogens: Is there a link? Reservoirs ofAntibiotic resistance (ROAR)
report www.healthsci.tufts.edu/apua/roarhome.htm
Sanger, F., Nicklen, S., and Coulson, A.R. (1977). DNA sequencing with chain-
terminating inhibitors. Proeedings ofthe National Academy ofSciences, USA
74, 5463-5467.
Schiappa, D.A., Hayden, M.K., Matushek, M.G., Hashemi, F.N., Sullivan, J., Smith,
K.Y., Miyashiro, D., Quinn, J.P., Weinstein, R.A., and Trenholme, G.M.
(1996). Ceftazidime-resistant Klebiella pneumoniae and Escherichia coli
bloodstream infection: a case-control and molecular epidemiologic
investigation. Journal ofInfectious Diseases 174, 529-536.
Scholz, P., Haring, V., Wittmann-Liebold, B., Ashman, K., Bagdasarian, M., and
Scherzinger, E. (1989). Complete nucleotide sequence and gene organization of
the broad-host-range plasmid RSF1010. Gene 75, 271-288.
202
Schrag, S.J, Perrot, V., and Levin, B.R. (1997). Adaption to the fitness costs of
antibiotic resistance in Escherichia coli. Proceedings ofthe Royal Society of
London Series B-Biological Sciences 264, 1287-1291.
Schwarz, S., Kehrenberg, C., and Walsh, T.R. (2001). Use of antimicrobial agents in
veterinary medicine and food animal production. International Journal of
Antimicrobial Agents 17, 431-437.
Scott, J.R. (1992). Sex and the single circle - conjugative transposition. Journal of
Bacteriology 174, 6005-6010.
Sears, H.J., and Brownlee, I. (1952). Further observations on the persistence of
individual strains of Escherichia coli in the intestinal tract ofman. Journal of
Bacteriology 63, 47-57.
Selander, R.K., and Levin, B.R. (1980). Genetic diversity and structure in
Escherichia coli populations. Science 210, 545-547.
Selander, R.K., Caugant, D.A., Ochman, H., Musser, J.M., Gilmour, M.N. and
Whittam, T.S. (1986). Methods ofmultilocus enzyme electrophoresis for
bacterial population genetics and systematics. Applied and Environmental
Microbiology 51, 873-884.
Select Committee on Science and Technology (1998). House of Lords Seventh
Report, www.parliment.the-stationarv-office.htm
Seurinck, S., Verstraete, W., and Siciliano, S.D. (2003). Use of 16S-23S rRNA
intergenic spacer region PCR and repetitive extragenic palindromic PCR
analyses ofEscherichia coli isolates to identify nonpoint fecal sources. Applied
andEnvironmental Microbiology 69, 4942-4950.
Shanahan, P.M., Thomson, C.J., and Amyes, S.G.B. (1995) Beta-lactam resistance in
normal faecal flora from South Africa. Epidemiology and Infection 115, 243-
253.
Shaw K.J., Rather P.N., Hare R.S., and Millwe, G.H. (1993). Molecular genetics of
aminoglycoside resistance genes and familial reslationships of the
aminoglycoside-modifying enzymes. Microbiological Reviews 57, 138-163.
Shedlofsky, S., and Freter, R. (1974). Synergism between ecological and
immunological control mechanisms of intestinal flora. Journal ofInfectious
Disease 129, 296-303.
Shen, D., Biedenbach, D.J., Winokur, P.L., Pfaller, M.A. and Jones, R.N. (1999).
Phenotypic and genotypic characterizations of Chinese strains of Escherichia
coli producing extended-spectrum (3-lactamases. Diagnostic Microbiology and
Infectious Diseases 34, 159-164.
203
Shoemaker, N.B., Smith, M.D., and Guild, W.R. (1980). DNAse-resistant transfer of
chromosomal cat and tet insertions by filter mating in pneumococcus. Plasmid
3, 80-87.
Shoemaker, N.B., Getty, C., Guthrie, E.P., and Salyers, A.A. (1986). Regions in
Bacteroides plasmids pBFTMlO and pB8-51 that allow Escherichia coli-
Bacteroides shuttle vectors to be mobilized by IncP plasmids and by a
conjugative Bacteroides tetracycline resistance element. Journal of
Bacteriology 166, 959-965.
Sigler, W.V., and Zeyer, J. (2002). Microbial diversity and activity along the forefold
of two receeding glaciers. Microbial Ecology 43, 397-407.
Silveira, W.D., Lancellotti, M., Ferreira, A., Solferini, V.N., Castro, A.F.P., Stehling,
E.G. and Brocchi, M. (2003). Determination of the clonal structure of avian
Escherichia coli strains by isoenzyme and ribotyping analysis. Journal of
Veterinary Medicine 50, 63-69.
Simonsen, L., Gordon D.M., Steward, F.M., and Levin, B.R. (1990). Estimating the
rate of plasmid transfer: an end-point method. Journal ofGeneral Microbiology
136, 2319-2325.
Simpson, I.N., Harper, P.B., and O'Callaghan, C.H. (1980). Principal beta-lactamases
responsible for resistance to beta-lactam antibiotics in urinary tract infections.
Antimicrobial Agents and Chemotherapy 17, 929-936.
Skirrow, M.B. (1977). Campylobacter enteritidis: a "new" disease. British Medical
Journal ii: 9-11.
Smets, B.F., Rittermann, B.E., and Stahl, D.A. (1993). The specific growth rate of
Pseudomonas putida PAW1 influences the conjugal transfer rate of the TOL
plasmid. Applied and Environmental Microbiology 59, 3430-3437.
Smith, H.E., and Crabb, W.E. (1961). The faecal bacterial flora of animals and man:
its development in the young. Journal ofPathology and Bacteriology 82, 53-
66.
Smith, H.W. (1975). Persistence of tetracycline resistance in pig E. coli. Nature 258,
628-630.
Smith, H.O., Danner, D.B., and Deich, R.A. (1981). Genetic transformation. Annual
Review ofBiochemistry 50, 41-68.
Sokal, R.R., and Rohlf, F.J. (1995). Biometry. 3rd Ed. W.H. Freeman and Company,
New York.
Son, R., Rusul, G., and Karim, M.I.A. (1997). Conjugal transfer of plasmids and
antibiotic resistance among Escherichia coli isolated from animals in a rural
area in Sarawak (Malaysia). Journal ofAppliedMicrobiology 82, 240-244.
204
Spika, J.S., Blake, P.A., and Cohen, M.L. (1987). Chloramphenicol-resistant
Salmonella-newport traced through hamburger to dairy farms. New England
Journal ofMedicine 317, 632-632.
Stanier, R.Y., Adelberg, E.A., and Ingraham, J.L. (1983). Symbiotic associations
between two nonphotosynthetic partners. In: General Microbiology. 4th Edition.
The Macmillan Press Ltd. London and Basingstoke (UK). Chapter 28, p782-
783.
Steward, C.D., Stacker, S.A., Swenson, J.M., O'Hara, C.M., Edwards, J.R., Gaynes,
R.P., McGowan, J.E. Jr., and Tenover, F.C. (1999). Comparison of agar
dilution, disc diffusion, MicroScan, and Vitek antimicrobial susceptibility
testing methods to broth microdilution for detection of fluoroquinolone-
resistant isolates of the familiy Enterobacteriaceae. Journal ofClinical
Microbiology 37, 544-547.
Sulavik, M.C., Houseweart, C., Cramer C., Jiwani, N., Murgolo, N., Greene, J., Di
Domenico, B., Shaw, K.J., Miller, G.H., Hare, R., and Shimer, G. (2001).
Antibiotic susceptibility profiles ofEscherichia coli strains lacking multidrug
efflux pump genes. Antimicrobial Agents and Chemotherapy 45, 1126-1136.
Swann Committee (1969). Report of the joint committee on the use of antibiotics in
animal husbandry and veterinary medicine, HMSO. http://www.parliament.the-
stationerv-office.co.uk/pa/ldl99798/ldselect/ldsctech/081vii/st0701 .htm Date
last accessed: August 9th 2004.
Swartley, J.S., Mcallister, C.F., Hajjeh, R.A., Heinrich, D.W., and Stephens, D.S.
(1993). Deletions of TN916-like transposons are implicated in tetM-mediated
resistance in pathogenic Neisseria. Molecular Microbiology 10, 299-310.
Tarkka, E., Ahman, H., and Siitonen, A. (1994). Ribotyping as an epidemiologic tool
for Escherichia coli Epidemiology and Infection 112, 263-274.
Tascini, C., Menichetti, F., Bozza, S., Fedele, M., Preziosi, R., Allegrucci, M., Del
Favero, A., Micozzi, A., Martino, P., and Bistoni, F. (1999). Molecular typing
of fluoroquinolone-resistant and fluoroquinolone-susceptible Escherichia coli
isolated from blood of neutropenic cancer patients in a single centre. Clinical
Microbiology and Infection 5, 457-461.
Tenney, J.H., Maack, R.W., and Chipendale, G.R. (1983). Rapid selection of
organisms with increasing resistance on subinhibitory concentrations of
norfloxacin in agar. Antimicrobial Agents and Chemotherapy 23, 188-189.
Tenover, F.C., Arbeit, R.D., Goering, R.V., Mickelson, P.A., Murray, B.E., Persing,
D.H., and Swaminathan, B. (1995). Interpreting chromosomal DNA restriction
patterns produced by pulsed-field gel electrophoresis: Criteria for bacterial
strain typing. Journal ofClinical Microbiology 33, 2233-2239.
205
Tenover, F.C., Mohammed, M.J., Stelling, J., O'Brien, T., and Williams, R. (2001).
Ability of laboratories to detect emerging antimicrobial resistance: Proficiency
testing and quality control results from the World Health Organization's
external quality assurance system for antimicrobial susceptibility testing.
Journal ofClinical Microbiology 39, 241-250.
Teuber, M., and Perreten, V. (2000). Role ofmilk and meat products as vehicles for
antibiotic- resistant bacteria. Acta Veterinaria Scandinavica 93,75-87.
Thomas, D.J.I., Morgan, A.W., Whipps, J.M., and Saunders, J.R. (2001). Plasmid
transfer between Bacillus thuringiensis subsp. israelensis strains in laboratory
culture, river water, and dipteran larvae. Applied and Environmental
Microbiology 67, 330-338.
Thomson, C.J., Tait, S., Jesudason, M.V., Amyes, S.G.B. (1993). Dissemination of
the TEM-I beta-lactamase gene into disparate plasmids in faecal strains of
Escherichia coli isolated in Vellore, south India. Journal ofInfection 27, 47-50.
Threlfall, E. J., Frost, J. A., Ward, L. R., and Rowe, B. (1994). Epidemic in cattle and
humans ofSalmonella-typhimurium DT-104 with chromosomally integrated
multiple-drug resistance. Veterinary Record 134, 577-577.
Threlfall, E.J. (2002). Antimicrobial drug resistance in Salmonella: problems and
perspectives in food- and water-borne infections. FEMSMicrobiology Reviews
26, 141-148.
Timoney, J.F., and Linton, A.H. (1982). Experimental ecological-studies on H-2
plasmids in the intestine and feces of the calf. Journal ofApplied Bacteriology
52,417-424.
Toivanen, P., Vaahtovuo, J., and Eerola, E. (2001). Influence ofmajor
histocompatibility complex on bacterial composition of faecal flora. Infection
and Immunity 69, 2372-2377.
Towner, K.J., Venning, B.M., and Pinn, P.A. (1982). Occurrence of transposable
trimethoprim resistance in clinical isolates of Escherichia coli devoid of self-
transmissible resistance plasmids. Antimicrobial Agents and Chemotherapy 21,
336-338.
Traub, P., and Nomura, M. (1986). Streptomycin resistance mutation in Escherichia
coli: altered ribosomal protein. Science 160, 198-199.
Tzouvelekis, L.S., Tzelepi, E., Tassios, P.T., and Legakis, N.J. (2000). CTX-M-type
beta-lactamases: an emerging group of extended-spectrum enzymes.
International Journal ofAntimicrobial Agents 14, 137-42.
Vahaboglu, H., Fuzi, M., Cetin, S., Gundes, S., Ujhelyi, E., Coskunkan, F., and
Tansel, O. (2001). Characterization of extended-spectrum B-lactamase (TEM-
52) producing strains of Salmonella enterica Serovar Typhimurium with
diverse resistance phenotypes. Journal ofClinical Microbiology 39, 791-793.
206
Valentine, P.J., Shoemaker, N.B., and Salyers, A.A (1988). Mobilization of
Bacteroides plasmids by Bacteroides conjugal elements. Journal of
Bacteriology 170,1319-1324.
Vali, L., Wisely, K.A., Pearce, M.C., Turner, E.J., Knight, H.I., Smith, A.W., and
Amyes, S.G.B. (2004). High genotypic variations and antibiotic sensitivity
among Escherichia coli 0157 strains isolated from two Scottish beef cattle
farms. Applied and Environmental Microbiology. In Press.
Van Belkum, A., Bax, R., Peerbooms, P., Goessens, W.H., van Leeuwen, N., and
Quint, W.G. (1993). Comparison of phage typing and DNA fingerprinting by
polymerase chain reaction for discrimination ofmethicillin-resistant
Staphylococcus aureus strains. Journal ofClinical Microbiology 31, 798-803.
Van den Bogaard, A.E., Jenson, L.B., and Stobberingh, E.E. (1997). Vancomycin-
resistant enterococci in turkeys and farmers. New England Journal ofMedicine
337, 1558-1559.
Van den Bogaard, A.E. and Stobberingh, E.E. (2000). Epidemiology of resistance to
antibiotics - Links between animals and humans. International Journal of
Antimicrobial Agents 14, 327-335.
Van den Bogaard, A.E., Bruinsma N., and Stobberingh, E.E (2000). The effect of
banning avoparcin on VRE carriage in The Netherlands. Journal of
Antimicrobial Chemotherapy 46, 146-148.
Verma, V., Qazi, G.N., Parshad, R., and Chopra, C.L. (1989). Introduction of a
Micrococcus plasmid in Escherichia coli. Plasmid 22, 265-267.
Versalovic, J., Koeuth, T., and Lupski, J.R. (1991). Distribution of repetitive DNA
sequences in eubacteria and application to fingerprinting of bacterial genomes
Nucleic Acids Research 19, 6823-6831.
Veterinary Medicines Directorate (2002). Sales of antimicrobial products authorised
for use as veterinary medicines, antiprotozoals, antifungals, growth promoters
and coccidiostats and in the UK in 2002. Report of the Veterinary Medicines
Directorate 2002. http://www.vmd.gov.uk/general/publications/salesanti02.pdf
Date last accessed, 9th August 2004.
Vila, J., Marcos, A., Marco, F., Abdalla, S., Vergara, Y., Reig, R., Gomez-Lus, R.,
and Jimenez de Anta, T. (1993). In vitro antimicrobial production of beta-
lactamases, aminoglycoside-modifying enzymes, and chloramphenicol
acetyl transferase by and susceptibility of clinical isolates ofAcinetobacter
baumannii. Antimicrobial Agents and Chemotherapy 37, 138-141.
Vila J., Ruiz J., Marco F., Barcelo, A., Goni, P., Giralt, E., and Jimenez de Anta, T.
(1994). Association between double mutation in gyrA gene of ciprofloxacin-
resistant clinical isolates of Escherichia coli and MICs. Antimicrobial Agents
and Chemotherapy 38, 2477-2479.
207
Vos, P., Hogers, R., Bleeker, M., Reijans, M., van de Lee, T., Homes, M., Frijters,
A., Pot, J., Peleman, J., Kuiper, M., and Zabeau, M. (1995). AFLP: a new
technique for DNA fingerprinting. Nucleic Acids Research 23, 4407-4414.
Walmsley, R.H. (1976). Temperature dependence ofmating-pair formation of
Escherichia coli. Journal ofBacteriology 126, 222-224.
Wang, Y., and Taylor, D.E. (1990). Natural transformation in Campylobacter
species. Journal ofBacteriology 172, 949-955.
Wang, M., Tran, J.H., Jacoby, G.A., Zhang, Y., Wang, F., and Hooper, D.C. (2003).
Plasmid-mediated quinolone resistance in clinical isolates ofEscherichia coli
from Shanghai, China. Antimicrobial Agents and Chemotherapy 47, 2242-
2248.
Welsh, J., and McClelland, M. (1990). Fingerprinting genomes using PCR with
arbitrary primers. Nucleic Acids Research 18, 7213-7218.
Wheat, P.F. (2001). History and development of antimicrobial susceptibility testing
methodology. Journal ofAntimicrobial Chemotherapy 48, Supplement SI, 1-4.
Whittam, T.S., Wolfe, M.L., Wachsmuth, I.K., Orskov, F., Orskov, I., and Wilson,
R.A. (1993). Clonal relationships among Escherichia coli that cause
hemorrhagic colitis and infantile diarrhea. Infection and Immunity 61, 1619-
1629.
Wiener, J., Quinn, J.P., Bradford, P.A., Goering, R.V., Nathan, C., Bush, K., and
Weinstein, R.A. (1999). Multiple antibiotic-resistant Klebsiella and
Escherichia coli in nursing homes. Journal ofthe American Medical
Association 281, 517-523.
Wierup, M. (2001). The Swedish experience of the 1986 year ban of antimicrobial
growth promoters, with special reference to animal health, disease prevention,
productivity, and use of antimicrobials. Microbial Drug Resistance 7, 183-190.
Winokur, P.L., Canton, R., Cassellas, J.M., Legakis, N. (2001). Variations in the
prevalence of strains expressing an extended-spectrum beta-lactamase
phenotype and characterization of isolates from Europe, the Americas, and the
Western Pacific region. Clinical Infectious Diseases 15, Supplement 2, S94-
103.
Wise, E.M.Jr. and Abou-Donia, M.M. (1975). Sulfonamide resistance mechanism in
Escherichia colv. R plasmids can determine sulfonamide-resistant
dihydropteroate synthases. Proceedings ofthe National Academy ofScience,
USA. 72, 2621-5.
World Health Organisation (1997). The medical impact ofthe use ofantimicrobials
in food animals, Report of a WHO meeting, Berlin, Germany.
208
Wray, C., Hedges, R.W., Shannon, K.P., and Bradley, D.E. (1986). Apramycin and
gentamicin resistance in Escherichia coli and salmonellas isolated from farm
animals. Journal ofHygiene: Cambridge 97, 445-456.
Yagi, T., Kruokawa, H., Shibata, N., Shibayama, K., and Arakawa, Y. (2000). A
preliminary survey of extended-spectrum (3-lactamases (ESBLs) in clinical
isolates of Klebsiella pneumoniae and Escherichia coli in Japan. FEMS
Microbiology Letters 184, 53-56.
Yamamoto, T., Yamagata, S., Horii, K., and Yamagishi, S. (1982). Comparison of
transcription of beta-lactamase genes specified by various ampicillin
transposons. Journal ofBacteriology 150, 269-276.
Yang, H.H., Vinopal, R.T., Grasso, D., and Smetts, B.F. (2004). High diversity
among environmental Escherichia coli isolates from a bovine feedlot. Applied
and EnvironmentalMicrobiology 70, 1528-1536.
Young, H.K., and Amyes, S.G.B. (1986). A new mechanism of plasmid
trimethoprim resistance. Characterization of an inducible dihydrofolate
reductase. The Journal ofBiological Chemistry 261, 2503-2505.
Zelazna-Kowalska, I. (1977). [3H] dihydrostreptomycin accumulation and binding to
ribosomes in Rhizobium mutants with different levels of streptomycin
resistance. Journal ofBacteriology 132, 8-12.
Zeph, L.R., Onaga, M.A., and Stotzky, G. (1988). Transduction ofEscherichia coli
by bacteriophage PI in soli. Applied and Environmental Microbiology 54,
1731-1737.
Zhao, S., White, D.G., McDermott, P.F., Friedman, S., English, L., Ayers, S., Meng,
J., Maurer, J.J., Holland, R., and Walker, R.D. (2001). Identification and
expression of cepamycinase blacuv genes in Escherichia coli and Salmonella
isolates from food animals and ground meat. Antimicrobial Agents and
Chemotherapy 45, 3647-3650.
Zund, P., and Lebek, G. (1980). Generation time-prolonging R plasmids: correlation
between increases in the generation time of Escherichia coli caused by R
plasmids and their molecular size. Plasmid 3, 65-69.
209
Appendix 1. Results of a sensitivity analysis to determine how different parameters
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Figure Al. The effect of donor growth rate on the transconjugant population during
the transfer of pUK2002 between J53 and J62-2.
Figure Al demonstrates that the best fit for the T population is a low donor growth
rate (vD) (vD of 0.5 cfu/mL), but this results in very inaccurate modelling of the D
population. Additionally, resource limitation is reached at too low a cell density
compared to the experimental data, indicating that the model should be run with a




Figure A2. The effect of donor growth rate on the recipient population during the
transfer of pUK2002 between J53 and J62-2.
The effect of donor growth rate (vD) on R (Figure A2) is one of direct competition.
When vD > vR, D constitutes a greater proportion of the total population at resource
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Figure A3. The effect of recipient growth rate on the transconjugant population
during the transfer of pUK2002 between J53 and J62-2.
Figure A3 is almost identical to that of the effect of vD on T (Figure Al), with the
best fit of the experimental T population being achieved with the lowest recipient




























Figure A4. The effect of recipient growth rate on the donor population during the
transfer of pUK2002 between J53 and J62-2.
In a similar way to the effect of vD on R (Figure Al), if vR > vD, R will occupy a
greater proportion of the broth than D (Figure A4). The reduction in D as a function
of increasing vR is less than the reduction in R due to increasing vD because D only
acts in competition with the other strains in the broth, whereas R is affected by




Figure A5. The effect of different initial D densities on the population dynamics of
pUK2002 transfer.
When the initial density of D (iD) is greater than initial density of R (iR) the density
of R is not affected throughout the experiment (Figure A5). When iD > iR, D reaches
resource limitation before R, therefore R occupied a smaller proportion of the broth
than D throughout the experiment. When the model was run with different initial
densities of R, similar results were obtained in that when iR < iD, the density of D is
not affected but when iR > iD, R occupies a greater proportion of broth than D
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Figure A6. The effect of resource limitation on the population dynamics of pUK2002
plasmid transfer. The resource concentrations used are listed in the key as D or T and
the concentration of glucose added (200-1000).
There is a trade off between an increase in resource concentration, enhancing the fit of
the donor (and recipient) populations, but resulting in a reduced fit to the
transconjugant population. This graph also makes it clear that the model is unable to
take into account an initial lag in growth of the donors (and recipients). The sigmoid
curve of these populations is not reproduced by the model, which assumes bacterial
growth is constant and exponential from the moment of initial inoculation.
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Appendix 2. Results of different combinations of the three parameters (resource
concentration, lag in D and R growth, and lag in transfer) found to enhance the fit of
the model to the experimental data.
Three different values of each of the three parameters were tested. In each of the
following graphs (1-27) the value of each parameter is listed in the title according to
the following key:
R200; 200pg/mL of resource.
R500; 500pg/mL of resource.
R1000; lOOOpg/mL of resource.
L0.5; 05h lag before D and R growth.
LI; lh lag before D and R growth.
LI.5; 1.5h lag before D and R growth.
TO; Oh lag before plasmid transfer.
TO.5; 0.5h lag before plasmid transfer.
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